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SUMMARY
One of the major functions of macrophages is to provide the body with an 
immediate innate defence against pathogenic micro-organisms. This defence is largely 
dependent on the generation of nitric oxide (NO) and superoxide by macrophages which 
leads to the killing of these pathogens, NO is also important in many other biological 
functions. It is derived from L-arginine and molecular oxygen by the enzyme NO synthase 
(NOS). There are a number of classes of NOS including neuronal NOS (nNOS), 
endothelial NOS (eNOS) and cytokine-inducible NOS (iNOS). iNOS is upregulated and 
activated by several immunological stimuli including interferon gamma (IFN-y); 
lipopolysaccharide (LPS) and tumor necrosis factor-a (TNF-a), such activation leads to 
the production of large quantities of NO which can be cytotoxic. The potential toxicity of 
NO makes it important to understand the regulation of its production. In the study 
presented here, J774 cells, a murine macrophage cell line, were used as a model system 
for studying the induction and regulation of iNOS activation. These cells and murine 
peritoneal macrophages produce large amounts of NO in response to the T cell-derived 
lymphokine, IFN-y and/or the potent macrophage activator, LPS in a dose-dependent 
manner. Northern and Western blotting revealed the process of induction of NO synthesis 
in J774 cells: The maximal induction of NO synthase mRNA was at 4 h while the 
maximum levels of NOS protein was observed at 8 to 12 h after treatment with IFN-y and 
LPS. IFN-y and LPS-induced NO2 " accumulation was abolished in the culture 
supernatants of samples that were pre-treated with cycloheximide. These suggest that 
iNOS is regulated transcriptionally in a manner that requires de novo protein synthesis.
Protein phosphorylation plays a crucial role in regulating the signal transduction 
cascades leading to many biological responses in eukaryotes. Signals that are reversibly 
controlled by protein phosphorylation are modulated not only by a protein kinase but also 
by a protein phosphatase. In this project, I have shown that the induction of iNOS activity 
in J774 cells by IFN-y and LPS was reduced by more than 50% if the cells were pre­
treated with protein tyrosine kinase (PTK) inhibitors such as Tyrphostin 25, Tyrphostin
21
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AG 126, and Herbimycin A. In contrast, iNOS was unaffected by pre-incubation with
 :Tyrphostin 1, an inert analogue of these PTK inhibitors. Consistent with these findings,
IFN-y and LPS-induced iNOS activity was enhanced by 30% in the presence of vanadate, 
a protein tyrosine phosphatase inhibitor. These results suggested that the activation of 
tyrosine kinase(s) plays a role in induction of NO synthesis.
To identify which protein tyrosine kinases, and their downstream targets, might be 
involved in the iNOS signalling pathway, I used a combination of immuno-precipitation 
and Western blotting techniques. This approach identified a role for the Janus kinases 
(JAKl, JAK2) in the induction of iNOS. Moreover, Tyrphostin AG490, a specific JAK2
inhibitor strongly inhibited NO production in J774 cells in response to IFN-y. Further
experiments demonstrated an inducible STATl (signal transducer and activator of
transcription factor 1) binding activity to IFN-y activated site (GAS) in the IRFl
(interferon regulatory factor 1) promoter after treatment with IFN-y. In addition. Northern 
blot analysis showed an enhanced IRF-1 and IRF-2 expression after IFN-y treatment. 
Furthermore, IRF-1 and IRF-2 were demonstrated to have the ability to bind to IRF-E
within the iNOS promoter region. Thus IFN-y appears to transduce the signals through a 
JAK-STAT pathway (JAKl, JAK2, and STATl), activation of some early expression 
genes ( such as IRFs), and perhaps cross-talk with other signalling elements, such as 
NFkB, to achieve transcriptional activation of iNOS.
I have also demonstrated that LPS induces two GAS-binding complexes in J774 
cells. These binding proteins are different from the GAS-binding STAT protein induced 
by IFN-y. Antibody supershift and cold-probe competition assays indicated that the i
transcription factors in such complexes contained NFkB (p65). NFkB was also 
demonstrated to have the ability to bind to NFkB element within iNOS promoter region in
response to LPS and/or IFN-y. The binding activity of NFkB induced by either LPS or 
IFN-y was independent of protein synthesis. Northern blot analysis demonstrated that 
IFN-y and LPS synergistically up-regulate IRF-1 but down-regulate IRF2 expression. 
Moreover, the induction of NO by IFN-y and LPS also appears to involve the co­
rf:;
  .
operation of NFkB and IRF-E in the activation of iNOS promoter. The co-operation of 
signals indicated by these data provide a rational explanation for the synergistic effect of 
IFN-y and LPS in the induction of iNOS expression.
An additional transcription factor(s) was found to be activated by LPS which was 
involved in iNOS gene regulation. This factor is a protein encoded by an early expressed 
gene whose activation is dependent on protein synthesis. It binds to IRF-E on the murine 
iNOS promoter. Antibody-supershift and cold probe-competition assays ruled out the 
possibility that it was NFkB, or IRF-1. Although, as yet, it has not been possible to 
identify this factor, it may well be the IRF-like protein or perhaps the interferon consensus 
sequence binding protein (ICSBP) which has been shown by others to play a crucial role 
in LPS-induced IFN-y production in spleen cells. Further experiments are required to 
identify this potentially important factor.
In addition to IFN-y and LPS, IL-4 is another cytokine that plays an important role 
in the regulating iNOS expression in murine macrophages. IL-4 is a multipotent cytokine 
characteristically derived from Th2 and mast cells. Since IFN-y and IL-4 have been shown 
to display opposite effects and to antagonize each other's actions on a number of cell 
types, I studied the mechanism by which IL-4 regulates iNOS expression in murine 
macrophages. I have shown that IL-4 inhibits expression of iNOS (both at the protein and 
mRNA level) induced by IFN-y and LPS in a dose- and time- dependent manner. To 
down regulate iNOS expression, IL-4 has to be added to the cells at the initial stages 
(before or simultaneously with addition of IFN-y and/or LPS) of iNOS induction. Thus, 
comparison of these kinetics of IL-4 mediated inhibition of NOS activation suggest that 
the effect of IL-4 on iNOS induction is most likely to be at the stage of transcriptional 
activation.
Following the idea that IL-4 may interfere with the signalling pathways of NO
synthesis, the activation of a number of signalling elements by IFN-y or LPS was
'examined in the presence of IL-4. Western blotting and EMSA analysis showed results 
that IL-4 did not affect the early intracellular signalling pathways induced by IFN-y, such
23
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as the tyrosine phosphorylation and activation of JAKl and JAK2 and ST ATI (p91). 
Furthermore, it did not interfere with LPS-induced NFkB binding. Unexpectedly, the 
induction of IRF-1 and IRF-2 by IFN-y alone was enhanced by IL-4. In contrast, IL-4 
inhibited the expression of IRF-1 and enhanced the expression of IRF-2, when the cells 
were stimulated with IFN-y and LPS.
Finally, I have shown that while the production of NO by macrophages from wild- 
type mice in response to IFN-y and LPS was strongly inhibited by IL-4, cells from 
STAT6 knockout mice (STAT6-/-) were completely refractory to inhibition by 11^4. These 
results therefore suggest that STAT6 plays a crucial role in the IL-4-induced inhibition of 
iNOS expression in murine macrophages. Further experiments are required to investigate 
whether STAT6 itself works as a transcription factor binding directly to iNOS gene, or 
involved in the activation of some other IL-4 regulated genes which in interfere with iNOS 
induction.
24
Chapter 1 
General Introduction
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Part I. Cytokine inducible nitric oxide synthase 
1.1 Nitric Oxide (NO) and nitric oxide synthase
1.1.1 Historical perspective
Nitric oxide is a multifunctional effector molecule synthesized by nitric oxide 
synthase (NOS). NOS represents a family of cytochrome P4 5 0  -like flavohaeme- 
proteins that catalyze the 5-electron oxidation of L-arginine to form L-citmlline and NO. 
The quest to identify endothelium-derived relaxing factor (EDRF) (Furchgott, et al,
1980) led to the discovery in the vasculature of an enzyme, nitric oxide synthase 
(reviewed in Moncada, et al., 1993). The early studies on EDRF demonstrated that 
EDRF was a very short-lived substance, with a half-life of only seconds in oxygenated 
physiological salt solutions (Griffith, eta l, 1984; Cocks, etal., 1985). The effects of 
EDRF were shown to be inhibited by haemoglobin (Hb), methylene blue (Martin, et 
at., 1985) and other agents such as dithiothreitol and hydroquinone (Griffith, et at., 
1984) and to be mediated by stimulation of the soluble guanylate cyclase with the 
consequent elevation of intracellular cyclic GMP (cGMP) levels (Rapoport, et at., 
1983). Superoxide anions (O2") contribute to the instability of EDRF, because the 
effects of EDRF were prolonged by the addition of SOD (Gryglewski, et al, 1986a; 
Rubanyi, etal., 1986) and inhibited by Fe^+ (Gryglewski et al, 1986b). In 1987, 
Furchgott and Ignarro independently suggested that EDRF was either NO or an NO- 
related molecule. The first direct demonstration of the release of NO by mammalian 
cells was in experiments on vascular tone and platelet aggregation (Palmer, eta l, 1987; 
Moncada, et a l, 1990).
Meanwhile, an independent line of investigation found that when humans were 
fed a low nitrite diet, endogenously synthesized NO3 " was excreted (Green, et a l,
1981). Similar results were obtained with germ-free rats, thus ruling out the 
participation of gut microflora in the reaction. During the course of the human 
experiments, one of the subjects coincidentally became ill and showed a large increase
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in urinary NO3 " excretion. Subsequent experiments in rats showed that the urinary 
NO3 - levels could be elevated about tenfold when fever was induced by an 
intraperitoneal injection of Escherichia coli (E. coli ) lipopolysaccharide (LPS). These 
findings suggested that this elevated synthesis might be related to the 
immunostimulation known to be brought about by LPS. The LPS-induced synthesis of 
NO in vivo was then reproduced by stimulation of murine peritoneal macrophages in 
culture (Stuehr, et al., 1985). Some cytokines could also stimulate macrophages to 
carry out this synthesis. Subsequent experiments showed that the major lymphokine 
involved in the synthesis response was interferon-gamma (IFN-y) (Stuehr, et a i, 
1987). The stimulatory effects of LPS and IFN-y were synergistic (reviewed in 
Marietta, et al., 1989). Later studies showed that NO is synthesised from the semi­
essential amino acid L-arginine by NO synthase (Hibbs, et al. 1987; Stuehr, et al. 1987; 
Iyengar, et al. 1987; Palmer, et al 1988). This process can be inhibited by guanidino- 
substituted arginine analogues, including N^-monomethyl-L-arginine (L-NMMA) 
{Hibbs, e ta l, 1987).
1.1.2 Characteristics of isoforms of nitric oxide synthase
Three isoforms of NOS are known to exist and can be classified into two 
categories, constitutive and inducible ( reviewed by Nathan 1992). The inducible nitric 
oxide synthase (iNOS or NOS-II) was first found in murine macrophages. Under basal 
conditions, iNOS activity in macrophages is negligible, while on stimulation with IFN-y 
and LPS, macrophages can produce massive enhancement of NO synthase within few 
hours (Nathan and Hibbs, 1991). iNOS is independent. The other two forms of 
NOS were originally identified in blood vessels and neurones, they are constitutively 
expressed and their activity depends on elevated levels of Ca^+. Recently they have been 
named ecNOS (NOS-III) and ncNOS(NOS-I) (reviewed by Nathan and Xie, 1994).
All three NO synthases are flavoproteins containing bound flavin mononucleotide 
(FMN) and flavin adenine dinucleotide (FAD). They are dependent on NADPH as a co­
factor and tetrahydrobiopterin (BH4) enhances enzyme activity (Palmer, et a l, 1989;
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Hevel, et al.,, 1991; Mayer, et al., 1991; Schmidt, et al., 1992; Bredt, et al., 1992; 
Tayeh, et al, 1989; Kwon, et al., 1989). The derived sequence of ncNOS from rat brain 
was the first to indicate that the C-terminus showed a significant homology to NADPH 
cytochrome P-450 reductase (Bredt, et al., 1991). The nucleotide binding sequence as 
well as those sequences associated with FAD and FMN binding were highly conserved 
when compared with P-450 reductase from rat liver. This same homology has been 
observed in all the reported NOS sequences (Fig. 1.1). The N-terminus in all sequences 
of the three forms shows a great deal of similarity suggesting a common functional role, 
most likely related to the arginine binding site and catalysis (reviewed by Marietta, 1993). 
A comparison with other arginine binding enzymes, however, has not provided any clear 
cut answers (Lowenstein, et al. 1992).
Genes encoding the three distinct NOS isoforms have been cloned and located to 
different human chromosomes (ncNOS: 12q24.2; ecNOS: 7q35-36; iNOS: 17cen-ql2) 
(reviewed by Nathan and Xie, 1994). The three genes are differentially expressed: NOS 
was found originally in the neuro-systems but has now also been found in extra-neuronal 
sites such as skeletal muscle, pancreas, and kidney (Kobzik, et al., 1994; Lukic, et al., 
1991; Mundel, et al., 1992; Imai, et al., 1992). The isoform first purified and cloned from 
endothelial cells is also expressed in neurones (Dinerman, et al., 1994). Unlike the limited 
tissue distribution of the cNOS isforms, multiple cell types exhibit the capacity to express 
the iNOS gene when appropriately stimulated, among them neurons and endothelial cells 
(Oswald, et al, 1994). Recent reports showed that one or more isoforms could also 
express in the same cell type (Reiling, et a l, 1994; Dusting, et a l, 1995).
1.1.3 The functions of NO
Small amounts of NO are generated by ncNOS and neNOS, while high levels of 
NO are produced by iNOS. In many systems, NO derives from two or more different 
cellular sources, forming networks of paracrine communication. Neurones produce NO to 
regulate transmitter release of adjacent neurones and also to match cerebral blood flow 
with neuronal activity. Endothelium-derived NO is vasoprotective by potentially
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antagonizing smooth muscle contraction and all stages of platelet activation. The 
production of NO is a double-edged sword however, (as although it is essential as a 
messenger or modulator, and in high concentration for host defence against pathogens), 
excessive amounts of NO can also lead to a range of immunopathologies (Fig. 1.2). In the 
present project, I will concentrate on the regulation of the inducible NOS which catalyses 
the high output of NO.
1.2 Inducible nitric oxide synthase (iNOS)
1.2.1 iNOS gene cloning and expression
Several groups reported molecular cloning of iNOS cDNA from murine 
macrophage RAW 264.7 cells (Xie, e ta l, 1992; Lyons, et al, 1992; and Lowenstein, et 
a l, 1992) and also from rat vascular smooth muscle cells (Nunokawa, et al., 1993). 
Human iNOS from different cell types (chondrocyte, hepatocyte, and smooth muscle) 
have also been subsequently cloned (Charles, et a l, 1993; Geller, et a l, 1993; Sherman, 
et al, 1993). More recently, iNOS cDNA from murine macrophage J774 cells has been 
cloned in this laboratory (Moss, et al, 1995). Furthermore, human hepatocyte iNOS was 
found to have 80% sequence identity to the murine (macrophage) iNOS at both the 
nucleotide and amino acid levels (Geller 1993), suggesting that the iNOS gene may be 
functionally and structurally conserved.
Although resting unstimulated cells express little iNOS, the capacity to express 
this enzyme exists in nearly every tissue in the body. The list of cell types capable of 
expressing iNOS now includes macrophages, neutrophils, kératinocytes, respiratory 
epithelium, retinal pigment epithelium, renal tubular epithelium, myoepithelium, 
adenocarcinomas, hepatocytes, pancreatic islet cells, endothelium, endocardium, 
mesangial cells, cardiac myocytes, vascular smooth muscle, uterine and fallopian tube 
smooth muscle, fibroblasts, chondrocytes, osteoclasts, neurons and astrocytes 
(Lorsbach, et a l, 1993; Cunha, et a l, 1993; Geller, et a l, 1993; Nussler, et a l, 1992; 
Wood, et a l, 1993; Eizirik, et a l, 1993; Corbett, et a l, 1993; Nakayama, et a l, 1992;
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Koide, et al, 1993; Galea, et a l, 1992; Goureau, et al, 1993; Heck, et a l, 1992). Many 
agents have the ability to induce iNOS expression in various cell types to different levels. 
Most of these described so far are microbes, microbial products, or inflammatory 
cytokines, and there is often strong synergy between these agents. For example, IFN-y 
can synergistically enhance iNOS expression induced by bacterial lipopolysaccharide.
1.3 The role of inducible nitric oxide synthase
1.3.1 Non-specific defence
It has been known for many years that micro-organisms, or microbial 
components, can increase host resistance to the growth of tumours by an antigen-specific 
step that involves sensitised lymphocytes and by a non-specific step that is mediated by 
activated macrophages (Alexander, et a l, 1971; Keller, et a l, 1971; Hibbs, et a l, 1972). 
Present evidence suggests that this non-specific immunity is associated with the induction 
of NOS. If this is the case, NO-dependent non-specific immunity is a general 
phenomenon involving not only the reticuloendothelial system but also non- 
reticuloendothelial cells such as hepatocytes (Nussler, et a l, 1992), vascular smooth 
muscle (Rees, et a l, 1990) and the vascular endothelium (Radomski, et al, 1990), in all 
of which the inducible NOS has been detected. The role of the lung and liver in NO- 
dependent non-specific immunity appears to be crucial, since both organs are strategically 
placed in the circulation to serve as immunologic filters. Lymphocytes release NO (Kirk, 
et a l, 1990), and murine macrophages reduce lymphocyte activation by an NO-dependent 
mechanism (Hoffman, et al, 1990; Albina, et al, 1991). Furthermore, NO has been
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shown to be involved in immune rejection of allografted organs (Langrehr, et a l, 1991), 
graft-versus-host disease, and sepsis (reviewed by Schmidt, et a l, 1994). These data 
suggest that NO is also involved in specific immunity, but its precise role is not clear.
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Fig 1.1, Binding sites for cofactors (NADPH, FMN and FAD) on ncNOS, 
ecNOS, iNOS and P-450 reductase.Calmodulin binding (CAL), protein 
phosphorylation (P) and consensus site for heme binding (H) are also shown.
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NO Synthase .(a) 02+L-arginine ■ '► NO + Citrulline
L-NMMA
S N = 0
(b) NO + enyzme[4Fe-4S]  ^  enyzm e'^ ^  F e ^
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(c) 0 =  + NO , ONOÔ + H ' ^  ONOOH
HO + NOj NOr + H+
Fig. 1.2 The generation of NO and the possible mechanisms of its anti­
microbial effects, (a) NO synthesis is catalysed by NO synthase and can 
be competitively inhibited by an L-arginine analogue, L-NMMA. (b) NO 
could react with the Fe-S groups forming an iron-nitrosyl complex 
causing the inactivation and degradation of the Fe-S prosthetic groups of 
aconitase and complex I and complex II of the mitochondrial electron 
transport chain, (c) Alternatively, NO can react with 02- to form ONOO- 
(peroxynitrite) which decays rapidly once protonated to form the highly 
reactive HO..
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NO has also been shown to be important in parasitic infections and has been most 
extensively studied in leishmaniasis. Mouse peritoneal macrophages stimulated in vitro, 
with IFN-y in the presence of LPS are efficient in killing Leishmania and this 
leishmanicidal activity can be completely abrogated by L-NMMA in a dose-dependent 
manner, but not by its D-enantiomer (D-NMMA) (Green, et al, 1990; Liew, et a l, 
1990). Furthermore, culture supernatants of macrophages activated by IFN-y contain 
significantly increased levels of N02' (Stuehr, et a l, 1987; Ding, et a l, 1988; Drapier, et 
al, 1988), the production of which is also inhibited by L-NMMA (Liew, et al, 1990). 
Leishmania major (L. major) promastigotes are killed when incubated in vitro at room 
temperature in phosphate buffer saline containing NO (Liew, et a l, 1990). The 
importance of NO in vivo is demonstrated by the finding that disease in CBA mice 
infected with L. major is exacerbated when L-NMMA is injected into the lesions resulting 
in a lO^-fold increase in the number of parasites in the lesions (Liew, et al, 1990). More 
recently, work carried out in our laboratory using iNOS-deficent mice has shown that 
while wild-type and heterozygous mice were resistant to L. major infection, the mutant 
mice were highly susceptible to the infection and developed visceral disease (Wei et al, 
1995).
1.3.2 Inflammation
Increasing evidence indicates that NO may play a part in acute and chronic 
inflammation. Treatment with L-NMMA reduced the degree of inflammation in rats 
(lalenti, et al, 1992) with acute inflammation or adjuvant arthritis (lalenti, et a l, 1993) 
whereas L-arginine enhanced it. Immune complex-induced vascular injury in rat lung and 
dermal vasculature could be attenuated by inhibitors of NOS (Mulligan, et a l, 1991). In 
the carrageenin-induced acute inflammation model, the NO inhibitor (L-NMMA) could 
reduce inflammation and down-regulate inflammatory cytokines in mice (lanaro, et al 
1994). Furthermore, colonic synthesis of NO was increased in patients with ulcerative 
colitis (Middleton, et al, 1993), and inhibitors of NOS ameliorated experimentally 
induced chronic ileitis (Miller, et al, 1993). In addition, nitrite concentrations in plasma
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and synovial fluid are increased in patients with rheumatoid arthritis and osteoarthritis 
(Farrell, et at., 1992). The origin of NO in the inflammatory process is remains unclear.
1.3.3 Autoimmunitv
NO may play a role in tissue damage, because it is cytostatic or cytotoxic not only 
for invading micro-organisms but also for the cells that produce it and for neighbouring 
cells (Moncada,. 1992). In MRL-lpr/lpr mutant mice, NOS inhibitors prevent anti-DNA 
immune complex glomerulonephritis and reduce the intensity of inflammatory arthritis 
(Weinberg, et al, 1994) (MRL-lpr/lpr is a lupus mouse strain which was developed by 
Murphy and Roths in 1979). Pancreatic p cells have a limited capacity for free radical 
scavenging and are thus highly sensitive to NO cytotoxicity. In chemically induced 
models of insulin-dependent diabetes mellitus and non-obese diabetic mice, progressive 
insulitis, dysfunction and eventual killing of pancreatic p cells correlate with the induction 
of iNOS and are, in some reports, abrogated by NOS inhibitors (Lukic, et al., 1991; 
Kolb, etal., 1991; Green, etal., 1994).
1.3.4 NO mediates apoptosis in human cells
Previous reports have demonstrated that biochemical reactions involving NO may 
also lead to DNA damage (Wink et al, 1991; Nguyen et al., 1992; Fehsel et al, 1993). 
High concentrations of NO have been shown to cause deamination of deoxynucleotides 
and bases within intact DNA in vitro and are mutagenic in vivo (Wink 1991; Arroyo et 
al., 1992). Exposure of human cells to NO under aerobic conditions results in DNA 
strand breakage and nitrosative deamination of DNA bases. Therefore, NO can cause 
DNA damage as well as mutation in human cells. NO may also play a role in cytokine- 
induced and activated macrophage-mediated apoptosis of tumor cells (Xie et al., 1993; 
Cui et al., 1994). On the other hand, p53 which plays an important role in the cellular 
response to DNA damage from exogenous chemical and physical mutagens, is 
accumulated in response to over-expression of iNOS. This p53 accumulation, via a
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.negative feedback loop, resulted in down-regulated NO production through inhibition of 
the NOS promoter (Forrester et ah, 1996).
Since iNOS is essential for the defence against pathogens, and can also cause
.tissue injury, it is important to understand the mechanisms of regulation of iNOS utilised 
by cytokines and other stimuli.
;
1.4 Regulation of the biosynthesis of nitric oxide from iNOS
Induction of iNOS is regulated at different levels: genomic, transcriptional control, 
post-transcriptional/translational control, and post-translational control.
At the genetic level, using the gene-targeting method, strains of mice deficient in 
iNOS have been successfully constructed ( MacMicking, et al., 1995; Wei, et al., 1995). :
These mice provide a powerful tool that will not only facilitate formal demonstration of 
the effector roles of NO in microbicidal and tumoricidal activities, transplantation, and in a 
range of immunopathologies, but will also help to define the involvement of NO in 
immune regulation, immunological tolerance and antigen processing and presentation.
I
At the transcription level, both mouse and human iNOS promoters have been 
identified (Xie, et al., 1993; Lowenstein, et al., 1993, Chartrain, et al., 1994). By 
transfection of murine macrophage RAW 264.7 cells with promoter-reporter gene 
cassettes, the function of promoter / enhancer elements was shown for both murine (Xie, 
et al., 1993) and human genes (reviewed by Marris, et al., 1994). In the murine iNOS 
promoter, there are at least 24 oligonucleotide elements homologous to consensus 
sequences for the binding of transcription factors involved in the inducibility of other 
genes by cytokines or bacterial products.
.For the post-transcriptional control, stability of mRNA is a major control point in 
the regulation iNOS induction. For example, TGF-p suppresses macrophage iNOS
:expression via decreased iNOS mRNA stability and translational efficiency, by decreased
stability of iNOS protein but not modulation of iNOS transcription (Vodovotz, et a l,
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1993). At least some of these regulatory effects may be cell-type specific, as TGF-p not 
only attenuates iNOS mRNA induction in RAW 264.7 cells but also enhances induction 
in Swiss 3T3 cells (reviewed by Morris, et al., 1994). Conversely, cycloheximide 
markedly stabilises iNOS mRNA in the latter cells (Imai, et al, 1994), while in mouse 
macrophages, the same protein synthesis inhibitor prevents expression of iNOS mRNA.
Finally, iNOS is also regulated at the level of post-translational control. Unlike the 
other two NOS isoforms (ncNOS and ecNOS), iNOS contains calmodulin which is 
tightly bound to each subunit of the enzyme, making iNOS Ca^+ independent (Stuehr, et 
al 1991). The other post-translational regulatory factor is L-arginine. L-arginine is the 
only physiological nitrogen donor for the NOS-catalysed reaction, consumption of L- 
arginine by L-arginase in activated macrophages leads to the inactivation of iNOS which 
can be restored by addition of excess L-arginine in the culture medium (Vodovotz et al,
1994). Therefore regulation of availability of this essential substrate by arginine synthesis 
and uptake could determine cellular rates of NO synthesis (Nussler, et a l, 1994; Bogle, et 
a l,  1994). Tetrahydrobioptein (BH4 ) is synthesised from GTP and its levels can be 
influenced by the activities of recycling or salvage pathways that convert the oxidised 
forms, quinoid-dihydrobiopterin and dihydrobiopterin, respectively to BH4 . GTP- 
cyclohydrolase I (GTP-CH) levels are absent or very low in unstimulated cells, but it is 
strongly co-induced with iNOS in these cells by cytokines and LPS. However, it is 
unknown whether the activities of the recycling or salvage pathways for BH4  synthesis 
are co-regulated with iNOS expression (reviewed by Morris, et a l, 1994). Electrons 
donated by NADPH are essential for NO formation by NOS. The requirement of NOS for 
NADPH implies that the activities of the metabolic-pathways that generate or compete for 
this co-factor could play an important role in determining rates of cellular NO production. 
Although there have been relatively few studies on this point, observations that the 
activity of the NADPH-generating pentose phosphate pathway, and of the rate-limiting 
enzyme glucose-6-phosphate dehydrogenase (G-6-PDH), in particular, is correlated with 
NO production in some cells, support this possibility.
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Although the regulation of iNOS gene has been intensively investigated in recent 
years, the early signal events that transduce the receptor signal to the activation of 
transcription factors involved in iNOS gene regulation is not clear. The aim of this project 
is to clarify the signalling pathways that lead to iNOS induction in murine macrophages.
Part II, Signal transduction mechanisms regulating transcription
1.5 Cytokines and Growth factors
1.5.1 Cytokines and cytokine receptors
Cell communication in the immune system is through cell-cell contact and 
secretion of soluble molecules named cytokines. Most cytokines were identified originally 
according to their cells of origin and /or biological effects on target cells. Products 
originally classified as "growth factors" also may be designated more generally as 
"cytokines".
Cytokines are a diverse group of glycoproteins, expressed constitutively or 
inducibly by a wide variety of cell types, in membrane-bound or secreted forms (reviewed 
in Nicola, 1989; Arai et al, 1990; Howard et al, 1993). They can act in a paracrine or 
autocrine manner to potentiate survival (or death), proliferation, and development. In 
addition to controlling haematopoietic development, cytokines mediate many 
physiological responses, such as immunity, inflammation, and antiviral activity. The 
corollary of this is that the cytokines or their antagonists (which are sometimes naturally 
occurring) have immense clinical potential. This in part explains the massive growth in 
cytokine literature over the past few years. A single cytokine can exhibit multiple 
functions depending on its target cell type, and different cytokines often show similar 
biological functions on the same target cell population (Metcalf, 1986). Combinations of 
cytokines can interact synergistically (Metcalf and Nicola, 1991; Hey worth et al, 1988,
1992) or antagonistically (reviewed in Graham and Pragnell, 1990; Ruscetti et a l, 1991)
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to give novel responses. Thus, a complex network is formed among various types of cells 
through cytokines (reviewed in O'Farrell et a l, 1996).
In recent years, much progress has been made in delineating the signal 
transduction mechanism underlying the induction of such responses. Cytokines bind to 
specific transmembrane receptor proteins expressed on target cells. Binding of a cytokine 
to its receptor triggers intracellular signal transduction processes, ultimately leading to 
altered gene expression and other cellular changes (Ihle et al., 1994; Kan et a l, 1992). 
Molecular cloning of cytokine receptor (CR) genes in the last decade has revealed that 
CRs can be grouped into several novel receptor families. Members of one family, the CR 
superfamily, are defined by extracellular domain sequence and structural homology 
(Cosman, 1993; Miyajima et a l, 1992). These new receptor families are distinct from 
classical growth factor receptors with intrinsic tyrosine kinase activity or hormonal 
receptors with seven transmembrane domains. One important conclusion from the cloning 
of many CR genes is that the multiple functions of a given cytokine are mediated, in most 
cases, by the same receptor and therefore must be explained by differential activation of 
distinct intracellular pathways.
1.5.2 Classification of cvtokine receptors
The majority of receptors for haematopoietic cytokines, including many 
interleukins (IL) and colony-stimulating factors (CSF), belong to the CR superfamily and 
are more specifically referred to as class I CRs. These include receptors of pc family (IL- 
3R, GM-CSFR, and IL-5R: they share common pc chain), the gpl30 family (receptors 
for IL-6 , IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary 
neurotrophic factor (CNTF), cardiotropin 1 (CT-1), and possibly IL-12: they share the 
gpl30 subunit), the IL-2Ryc family (receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and 
possibly IL-13: they share the IL-2Ryc chain), and single-chain receptor family (receptors 
for erythropoietin (EPO), prolactin (PRL), and growth hormome (GH)) (reviewed in 
O'Farrell e ta l, 1996).
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Table 1.1 Classification of cytokine receptors
Family
Class I
Pc
gpl30
YC
Class II
TNF-R
RTK
t g f -p
Chemotactic
Ig-like 
Single chain
receptors for cytokines
IL-3, GM-CSF, IL-5
IL-6 , LIF, OSM, IL-11, IL-12 
IL-2, IL-4, IL-7, IL-9, IL-15
IFN-a/p, IFN-y, IL-10
TNF-a, TNF-p, CD40, Fas 
PDGF, c-fms, c-kit, flk2/flt3
TGF-p
IL-8
IL-1
EPO, G-CSF, TPO, GH
common
gpl40pc, identical 
signalling
gpl30 (like) subunits
share yc subunit 
differ in signals
two or more distinct 
subunits
TRAF/CRAF 
intrinsic TK activity
intrinsic ser/thr 
kinase domain
seven transmembrane 
regions
consist single chain
Abbreviations: IL, interleukin; IFN, interferon; GM-CSF, granulocyte-macrophage 
clonoy -stimulating factor; OSM, oncostatin M; LIF, leukaemia inhibitory factor; 
CNTF, ciliary neurotrophic factor; PDGF,platelet-derived growth factor recptor; 
colony-stimulating factor; EPO, erythropoietin. TPO, thrombopoietin; GH, growth 
hormone; TNF-ot, tumor necrosis factor-alpha; RTK, receptor tyrosine kinase. TGF-p, 
transforming growth factor beta.
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A second group within the CR superfamily, designated as class II receptors, are 
structurally related to class I receptors and include the receptors for interferon (IFN) 
(IFN-a/p as type I, and IFN-y as type II) and interleukin-10 (IL-10). They are defined by 
structural homology of extracellular domain sequence. The class I and II receptors are 
also functionally related by the use of similar signalling pathways (reviewed in O* Farrell 
e ta l, 1996).
A number of CRs belong to other receptor superfamilies; members of the tumor 
necrosis factor receptor (TNFR) family exhibit characteristic extracellular domain 
cysteine-rich motifs but do not possess the domain structure common to class I and II 
receptors (Bazan, 1993). The receptors for a subset of haematopoietic cytokines such as 
M-CSF, SCF and ]ît3/flk2 belong to the classical tyrosine kinase (TK) growth factor 
receptor family (Ullrich and Schlessinger, 1990), TK receptors contain a large 
glycosylated extracellular ligand-binding domain, a single membrane-spanning 
hydrophobic region, and a cytoplasmic domain that possesses intrinsic tyrosine activity 
which mediates signalling (Hunter and Cooper, 1985). The receptors for TGF-p and its 
relatives form a unique receptor family that possess serine/threonine kinase domains 
(Massague et al, 1994). Chemotactic cytokines such as IL-8  (Holmes et a l, 1991), also 
known as chemokines have receptors with seven transmembrane regions, and they are 
classical G-protein coupled receptors. The interleukin-1 receptor belongs to the 
immunoglobulin receptor superfamily (Sims et al, 1988). The summary of classification 
of cytokine receptors is shown in Table 1.1 (pp39).
1.5.3 Cvtokine receptor signalling
Although signalling events have been defined for a wide range of distinct receptor 
classes, the major signalling mechanisms appear to be common to all of these receptors.
The initial activation steps for receptors with intrinsic tyrosine kinase (TK) activity 
are ligand-induced dimerization and auto-transphosphorylation of receptor monomers. 
When activated, TK-Rs recruit and interact with a number of SH2-domain-containing
40
signalling molecules, by means of phosphorylated tyrosine residues (Kashishian et al, 
1992; Lev et a l, 1992; Reedijk et ah, 1992). Ligand-induced homo- or hetero- 
dimerization of receptor components is also the initial step of activation of receptors of the 
CR superfamily.
Although receptors of the class I and II CR families do not contain intrinsic kinase 
domains, most cytokines stimulate rapid tyrosine phosphorylation of a number of cellular 
substrates, including components of their receptors (Isfort and Ihle, 1990; Sorensen et 
al, 1989; Welham et al, 1992; Welham and Schreder, 1992; Izuhara and Harada, 1993; 
Yin and Yang, 1994). Furthermore, cytokine-stimulated tyrosine phosphorylation is 
essential to mediate the biological effects of cytokines (Kanakura et a l, 1990; Saroh et 
al, 1992). A number of mitogenic cytokines such as IL-2, IL-3, IL-5, GM-CSF, IL-6 , 
G-CSF, and EPO are known to induce activation of Ras as well as its downstream 
cascade including Raf and mitogen-activated protein kinase (MARK) (Duronio et a l, 
1992; Kan et a l, 1992; Welham et a l, 1992). Certain cytokines also activate Piml kinase 
(Sato et a l, 1993) and protein kinase C (PKC) ( Heyworth et a l, 1993; Shearman et a l,
1993) and induce expression of nuclear protooncogenes, including c-myc, c-fos, and c- 
jun, and cell cycle regulators (Sherr, 1993; Ihle eta l, 1994a; Mataushime et al, 1991,
1994). Many of these signalling molecules are also activated by TK-Rs (reviewed in 
O'Farrell et al., 1996), where the receptor can directly phosphorylate signalling 
substrates. Key questions currently under investigation are: how cytokine receptors 
without intrinsic kinase activity transduce signals, how receptors induce signals common 
to various cytokines as well as specific to each cytokine, how a given receptor can elicit 
different biological responses, and whether distinct regions of receptor cytoplasmic 
domains are required to mediate such effects.
The signalling pathways that are implicated in playing key roles in cytokine 
receptor signal transduction will be reviewed in the following two sections (Section 1.6; 
1.7).
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1.6 Receptor tyrosine kinases and cytokine receptor signalling
The role of phosphorylation in the control of cellular function has been well 
documented (review by Walton and Dixon 1993). The vast majority of these phosphoryl 
modifications occur on serine and threonine residues (Roach 1991) and until 1980, only 
phosphoserine and phosphothreonine had been identified as naturally occurring 
phosphoamino acids. However, tyrosine phosphorylation began to receive greater 
attention when it was determined that v-Src, the transforming principle of the Rous 
sarcoma virus, had tyrosine kinase activity (Hunter et al .,1980; Levinson et al., 1980;
Collet et al., 1980). Upon transformation by V-Src, cellular phosphotyrosine content 
increased dramatically. It has since been demonstrated that several other viral oncogenes 
are also tyrosine kinases (Bishop 1985). Coincident with this discovery, it was shown 
that epidermal growth factor receptor also had tyrosine kinase activity (Ushiro et al.,
1980). With the increasing numbers of identified tyrosine kinases, both intracellular and 
receptor-linked, it has become clear that tyrosine phosphorylation is an important 
regulator of cellular function (Hunter 1987).
Protein tyrosine kinases (PTK) are found in all multicellular organisms and can be 
divided into two main categories: transmembrane receptors (Schlessinger et al., 1992) and 
cytosolic kinases (Bolen 1993). They are also called receptor tyrosine kinases and non­
receptor tyrosine kinases (The later will be in the next section 1.7).
1.6.1. Receptor tyrosine kinases
Polypeptide growth factors represent a group of extracellular signals that are
■critically important for influencing a diverse array of cellular responses including 
proliferation, differentiation, and cell survival. The effects of many growth factors are 
known to be mediated by high-affinity receptor tyrosine kinases (RTKs) (reviewed by 
Fantl a/., 1993).
Within the past decade, several distinct sub-families of RTKs have been 
identified. Members of a given sub-family share common structural features that are
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distinct from those found in other sub-families (Fantl et al., 1993). Despite the diversity 
of RTKs, there is a degree of commonality in the types of intracellular signalling 
pathways initiated by these proteins. In the mammalian systems, biochemical and 
molecular genetic analyses have shown that for all RTKs, the binding of ligand to the 
extracellular domain activates the tyrosine kinase in the cytoplasmic domain. This leads to 
downstream activation of a number of common signalling molecules.
Interestingly, a single type of RTK can elicit very different biological responses in 
different cell types. Upon ligand binding, RTKs phosphorylate themselves on tyrosine 
residues, a process commonly termed autophosphorylation. In the case of some RTKs, 
ligand binding is known to induce receptor dimerization (Ueno et al., 1991; Kashi es et 
al., 1991; Rodrigues and Park 1994). Following autophosphorylation, individual 
phosphotyrosine residues located in the cytoplasmic domains of receptors serve as highly 
selected binding sites that interact with specific cytoplasmic molecules. These signalling 
molecules mediate the cellular responses to growth factors. Studies using synthetic 
peptides representing the sites on the receptor that interact with signalling molecules have 
demonstrated the structural basis for the specificity of the interaction between RTKs and 
signalling molecules (Fantl et al., 1992), examples of which are the short sequences 
flanking receptor phosphotyrosines which determine the remarkable specificity of the 
interaction between signalling molecules and PTKs. The residues on the carboxyl- 
terminal side of the phosphotyrosine appear to be more important in determining the 
affinity and specificity of the interaction than residues on the amino-terminal side of the 
phosphotyrosine.
Tyrosine-phosphorylated proteins interact with Src homology 2 (SH2) domain 
containing proteins. SH2 domains are regions of about 100 amino acids that are 
homologous to a non-catalytic region present in the c-src proto-oncoprotein which binds 
with high affinity to specific phosphotyrosine-containing motifs on stimulated RTKs or 
other signal transducers. The specificity of the interaction depends on both the amino acid 
sequence surrounding the phosphotyrosine, and the amino acid sequence of the SH2
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tyrosine kinase modifies the signalling molecule by phosphorylation (Fantl et al., 1993).
I will now outline the common features of signal processes which have been
1.6.2 Cvtokine receptors signalling through the Ras /MAP kinase pathway
are the mammalian extracellular signal-regulated kinases ERKl and ERK2 and the 
Saccharomyces cerevisiae pheromone-regulated kinases KSSl and FUS3.
domain (Cantley et al., 1991; Schlessinger 1992; Koch et al, 1991; Kazlauskas 1994).
The functional consequences of the associations between receptors and signalling 
molecules are not entirely clear. Nonetheless, tyrosine kinase activity of RTKs has two 
functions: first, it is responsible for creating high-affinity binding sites for localising
'signalling molecules to site near their substrates or activated receptors and second, the
proposed to transduce signals from the receptor at the cell surface to the initiation of 
transcription events in the nucleus via the key pathway, Ras-MAPK, which has been 
implicated in the transduction of proliferation and/or differentiation signals.
i
Treatment of leukocytes with cytokines that enhance their functional properties is 
associated with an increase in serine/threonine and tyrosine phosphorylation of cellular 
proteins. One of the signals most clearly implicated in the initiation of nuclear signalling 
from growth factor receptors is the ras pathway. Ras activation triggers a serine threonine 
kinase mediated signal amplification cascade culminating in the activation of mitogen- 
activated protein (MAP) kinase (Blumer and Johnson 1994), which regulates the 
expression of mitogen-responsive genes by phosphorylating specific transcription factors.
MAP kinases (MAPKs) are a family of protein kinases whose prototype members -■S'
Receptor tyrosine kinases activate a signalling cascade involving transient 
formation of Ras/GTP and activation of raf kinase at the membrane, followed by 
sequential activation of MAPK kinase (MAPKK) and ERK1/ERK2 (refered as ras /ERK 
pathway); only the latter signalling elements enter the nucleus (reviewed by Marshall,
1994; Leevers et at., 1994; Stokoe et al., 1994). Only recently, the mechanism of 
activation of the ras pathway have been identified. For example, EPO and IL-3 activate
“
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the ras pathway through their ability to induce tyrosine phosphorylation of SHC (a protein 
implicated in signalling through Ras). Following phophorylation, GRB2 (growth factor 
receptor-bound protein 2, it contains SH2 and SH3 domains) associates with SHC, and 
subsequently with SOS (Son of Sevenless, the Ras guanine nucleotide exchange factor); 
there are increases in GTP-bound Ras activation of m /-l; tyrosine phosphorylation of 
MAP kinases; and induction of immediate early genes such as pim-1, cmyc, and c-fos 
(reviewed in Ihle et al., 1995). These signalling events are summarised in digram Fig. 
1.3.
1.6.3 MAP kinase and JNK/SAPK pathway
Until recently, ERKl and ERK2 were the only cloned and well-characterized 
mammalian MAP kinases. However, the recent discovery of two other MAP kinase 
subtypes, the c-jun kinase (JNK) superfamily and p38/RK MAP kinase, reveals the 
existence of parallel MAP kinase cascades that can be activated independently and 
simultaneously (reviewed in Cano and Mahadevan 1995; Beyaert et al., 1996). As a 
family of MAPKs, JNK/SAPKs (for Jun N-terminal/stress-activated protein kinases) are 
distinct from the ERKs but are also regulated by extracellular signals (reviewed by Hill 
and Treisman 1995). Within the MAP kinases, ERKs are activated predominantly by 
growth factors or phorbol esters, but activation by TNF or IL-1 has also been 
demonstrated (Marshall 1995; Van Lint et al., 1992 ). In contrast, JNK and p38/RK MAP 
kinases are generally activated by inflammatory cytokines and cellular stresses such as 
heat shock, osmotic stress or UV light (revewed in Beyaert 1996).
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Fig. 1.3 The Ras/MAP kinase cascade. MAPK is activated by 
phosphorylation on thr and tyr by a MAP kinase kinase (MEK), MEK is 
activated by ser/thr phosphorylation by a MAPkinase kinase kinase (Raf), 
Raf(p74) is a ser/thr kinase and it is downstream of Ras. Ras is a GTPase 
and acts as a molecular switch for the key signal transduction pathway that 
control growth and differentiation. Grb2 is complexed with the guanine- 
nucleotide exchange factor (GEF), Sos (Son of Sevenless). The SH3 
domains of Grb2 bind Sos via proline rich regions. The complex then 
translocate to the plasma membrane, where it catalyzes the conversion of 
inactive, GDP-bound Ras to the activated, GTP-bound state.
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1.7 Nonreceptor tyrosine kinases and cytokine receptor signallings
1.7.1 Nonreceptor tyrosine kinases
The non-receptor PTKs represent a collection of cellular enzymes that are grouped 
together because of their lack of extracellular sequences. A number of the non-receptor 
PTKs have been found to be associated with other cell surface proteins (which generally 
lack endogenous enzyme activity) and shown to be capable of facilitating cell surface 
initiated signal transduction much like the receptor class of PTKs. Thus, in many 
instances, characterization of these PTKs as non-receptor kinases reflects more the history 
surrounding their discovery rather than their physiologic functions (Bolen 1993).
More than 20 individual PTKs comprising eight different groups of nonreceptor 
PTKs have been identified (reviewed by Bolen 1993). There are Abl, Jak, Fak, Fes/Fps, 
Syk/Zap, Itk, Src, and Csk families. With the exception of the Focal Adhesion Kinase 
(Fak) which is the only known membrane of this group of PTK, all the other groups 
appear to represent distinct families of protein kinases. They range in size from around 
50kDa for the C-src kinase (Csk) family to approximately ISOkDa for the Abl kinase 
family. About half of the nonreceptor PTKs have demonstrable oncogenic potential, 
whereas others whose activity appears to be primarily related to suppressing the activity 
of Src-related protein kinases may be involved in the modulation of growth, 
differentiation, and mature cell function. Within the nonreceptor PTKs, Src-related 
enzymes represent the largest known family. To data, nine distinct members of the src 
gene family have been cloned and the encoded protein kinases characterized (Bolen 1992; 
Brickell 1992). These include Src, Yes, Fyn, Lyn, Lck, Blk, Hck, Fgr, and Yrk PTKs.
1.7.2 Cvtokine signaling through non-receptor protein tyrosine kinases
The non-receptor tyrosine kinases play a critical role in cytokine signalling. Most 
of the cytokine receptors that constitute distinct superfamilies do not possess intrinsic 
protein tyrosine kinase domains, yet receptor stimulation usually invokes rapid tyrosine 
phosphorylation of intracellular proteins, including the receptors themselves. It is now
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clear that these receptors are capable of recruiting or activating (or both) a variety of 
nonreceptor PTKs to induce downstream signalling pathways (reviewed by Taniguchi
1995).
Initially, the involvement of nonreceptor PTKs in cytokine signalling was shown 
for the Src-family PTK p56lck (Lck) which is found physically associated with the IL-2 
receptor p-chain (IL-2Rp) in the absence of IL-2 stimulation (Hatakeyama et al., 1991), 
and it is rapidly activated upon ligand binding to IL-2R (Hatakeyama et al., 1991; Horak 
et al., 1991). IL-2R has an unusual variety of intracellular signalling partners and its p 
and Y chains are often shared by many other cytokines, such as IL-3, IL-4, IL-5, IL-7, 
IL-9 and IL-15 (Sarah, e ta l, 1994). Following studies of the IL-2R system, Lck, Fyn, 
and Lyn have been shown to be activated through their interaction with the specific region 
of IL-2RP (Minami et al., 1993; Torigoe et al., 1992; Kobayashi et al., 1993).
An abundance of evidence now indicates that a recently identified family of non­
receptor tyrosine kinases, the Janus kinase (JAK) family, play a crucial role in signalling 
of class I and class II cytokine receptors (CRs). To data, four members of JAK family 
have been identified (JAKl, JAK2, JAK3, Tyk2) (reviewed in Ihle 1994). Both class I 
and class II CRs can activate one or more of the members of JAK family (Ihle et a l, 
1994). Evidence for the involvement of the JAK-family PTKs in cytokine signalling was 
first provided by genetic complementation experiments, which a mutant cell line defective 
in the type I interferon (IFN-a and -P) signalling pathway was rescued by transfection 
with a genomic DNA encoding Tyk2 (Velazquez et al., 1992). More experiments revealed 
that JAKl and Tyk2, and JAKl and JAK2 molecules play essential roles in IFN-a/p and 
IFN-y-induced gene expression respectively (Velazquez et al, 1992: Muller et a l, 1993; 
watling et al, 1993). The critical role of the JAK-family PTKs has also been shown in 
the case of the growth-promoting type I cytokine receptors (Ihle 1994).
4S
1.7.3 JAK-STAT pathway
JAK kinases lack SH2 and SH3 domains but contain an active kinase-like 
domain. These kinases associated directly with receptors, that either possess or lack 
tyrosine kinase activities of their own, in the absence of cytokines and are activated and 
phosphorylated upon cytokine binding to the receptors (Ihle et a l, 1994; Darnell et al,
1994).
What are the substrates of JAKs? The activated JAKs phosphorylate both 
themselves and the receptor subunits, creating docking sites for SH2-containing proteins 
including SHC, which couples receptor engagement to activation of the ras pathway, and 
HCP (haematopietic cell phosphatase), a protein tyrosine phosphatase which negatively 
affects the response , such as proliferation and cell growth (reviewed in Ihle et al,, 1995).
In addition, extensive studies on transcriptional activation mediated by the IFNRs 
have unveiled a novel signal transduction pathway that provides a direct link between 
receptor activation and gene transcription (Fu et a l, 1992; Schindler et al, 1991; Shuai et 
al, 1993, 1994). This is mediated by a recently identified novel family of transcription 
factors known as STATs (signal transducers and activators of transcription), which are 
substrates for JAKs. STATs contain a well-conserved SH2 domain and normally reside 
in the cytoplasm in latent forms. STATs are tyrosine phosphorylated by JAKs on 
cytokine stimulation, leads to dimerization of the STATs. Dimérisation may involve either 
homodimerization or heterodimerization with a different ST AT protein. STAT dimers can 
then translocate to the nucleus, where they bind specific DMA sequences in the promoters 
of target genes (Darnell et al, 1994; Shuai et a l, 1994). The signalling of hematopoietic 
cytokine receptors is summarised in Fig. 1.4 (O'Farrell et al., 1996).
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Fig. 1.4 Cytokine receptors and signal transduction The GM-CSF/ÏL- 
3 receptor is depicted as a representative receptor, and signaling pathways that 
may couple to these receptors are also depicted. Broken lines denote hypothetical 
pathways, and molecules that associate with receptor cytoplasmic domains are 
shaded in gray. PTK denotes protein tyrosine kinases, whose identities are not
yet clear, Pase denotes phosphatase. The cytoplasmic domain of pc can be
divided into functional domains, the membrane proximal region including box 1 
and box 2, which mediates the JAK-STAT pathway and induction of c-myc, and 
the distal region that activates the Ras pathway (adopted from O’Farrell et al.,
1996)
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Table 1.2 Activation of JAKs and STATs by different cytokines and growth 
factors (reviewed in Hill and Treisman 1995)
Receptor
IFN-a/p
IFN-y
IL-3, GM-CSF, IL-5 
(common p subunit) 
IL-6 , OSM, LIF, CNTF 
(common gpl30 chain) 
IL-2, IL-4, IL-7, IL-9 
(common y subunit)
XL-12
EGF, PDGF, CSFl 
(receptor tyrosine kinase) 
EPO
Growth hormone
FYolactin
G-CSF
JAK activated
JAKl, TYK2 
JAKl, JAK2 
JAK2
JAKl, JAK2, TYK2
JAKl, JAIC3
JAK2, TYK2 
JAKia
JAK2
JAK2
JAKl, JAK2 
JAKl, JAK2
STAT activated
STAT1,STAT2,STAT3
STATl
unknown
STATl, STAT3
STAT5*, STAT6 
(for IL-4)
STAT4
STATl, STAT3b
unknown
unknown
STATS
unknown
a JAKl activation has been demonstrated only in the case of EGF, and its role in STAT 
activation remains unclear.
b STAT3 activation has been demonstrated directly only in the case of EGF.
* STATS activation only in the case of IL-2 (Beadling et al., 1996)
Abbreviations: IL, interleukin; IFN, interferon; GM-CSF, granulocyte-macrophage clonoy 
-stimulating factor; OSM, oncostatin M; LIF, leukaemia inhibitory factor; CNTF, ciliary 
neurotrophic factor; PDG, platelet-derived growth factor recptor; colony-stimulating factor; 
EPO, erythropoietin. EGF, epidermal growth factor.
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To date, a number of the STAT members have been cloned and characterized, 
these include STAT la, STATip, STAT2, STATS, STAT4, STAT5A, STAT5B, STAT6 
(Fu et al., 1992; Schindler et al., Zhong et al., 1994; Jacobson et al., 1995; Mui et al., 
1995; Wakao et al, 1992, 1994; Hou et al, 1994;). Although the association of different 
receptors with particular JAKs and STATs appears to be complex, JAKs implicated in 
signalling by various cytokines and growth factors are shown in Table 1.2 (see pp51). 
They act downstream of many receptors of the class I and class II cytokine receptors. The 
increased availability of reagents related to the JAK-STAT signalling pathways have 
provided useful tools to study the involvement of early signal events leading to the 
regulation of iNOS expression.
1.8. Tyrosine phosphatases and dephosphorylation
Cytokine receptors are also negatively regulated, in part by haematoietic cell 
phosphatase (HCP, also termed PTP-IC or SH2-PTP1). A comparison of the protein 
tyrosine phosphatases (PTPase) and tyrosine kinase families reveals an interesting 
similarity. The general structures of the two tyrosine-directed enzymes parallel each other 
in that these are both transmembrane or receptor-linked proteins as well as proteins that 
are wholly intracellular.
Protein phosphatases (PP) are classified as serine/threonine phosphatases or as 
tyrosine phosphatases according to amino acid sequence and substrate selectivity. There 
are four major classes of serine/threonine phosphatases (PP-1, PP-2A, PP-2B, PP-2C), 
each of which has isozymic forms, and several related but distinct novel enzymes 
(reviewed by Cohen 1989). The tyrosine phosphatases can be classed as either receptor­
like or non-receptor molecules, and they encompass a rapidly expanding number of 
members (reviewed by Fischer et a l, 1991; Fallen et a l, 1992).
The particular functions performed by the PTPases have yet to be identified. A 
number of PTPases are expressed in a tissue-specific manner, and this should provide
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tclues to determining their functions (Walton and Dixon 1993). However, it is known that,
■in the cell, tyrosine phosphorylation is a reversible, dynamic process. Thus, the net level i
of phosphate in a target substrate reflects not only the activity of PTKs that catalyse 
phosphorylation, but also the protein tyrosine phosphatases (PTPs) that are responsible 
for dephosphorylation of tyrosyl residues (reviewed by Sun and Tonks 1994). The PTPs 
and PTKs do not exert their effects in isolation, but rather coordinate their effects in 
controlling flux through tyrosine-phosphorylation-dependent signalling pathways.
Like PTKs, the PTPs are a large and structurally diverse family of receptor-like 
and cytoplasmic enzymes. They play important roles in the regulation of diverse functions 
including control of cell-cell adhesion, growth factor signal transduction, and the cell 
cycle. Moreover, dysfunctional PTPs have been implicated in disease states. The 
characterization of the PTP family now represents a major research effort in many 
laboratories (reviewed by Tonk 1993).
1.9 Promoter regulation and transcription factors
1.9.1 Promoters, enhancers and regulation of transcription
Most genes are silent unless they are specifically turned on. Transcription requires 
binding of RNA-polymerase (RNA-pol) to non-transcribed regions of the gene, called 
promoters, upstream (S') of the start site. For eukaryotic promoters, there is a TATA box
3located at -25 and flanked by GC-rich sequences which is necessary but not sufficient for 
strong promoter activity. Additional elements located between -40 and -110 are called 
CAAT and GC boxes. Activities of promoters are greatly increased by enhancers located 
upstream /downstream or even within transcribed gene.
:i
mRNA
Start
Site-25-40-110 GC box TATA boxCAAT box
& 2 upstream activating 
sequences
Transcription factors binding to regulatory sites on DNA can be regarded as 
passwords that co-operatively open multiple locks to give RNA-pol access to specific 
genes. Activators and repressors of gene expression act by altering the rate of formation 
of the basal transcriptional complexes. Multiple proteins may be required for a single 
gene, and different combinations of transcription factors provide the specificity for 
switching on of particular genes. Fig. 1.5 illustrates the process of regulation of 
transcription.
Changes in cellular behavior induced by extracellular signalling molecules require 
execution of a complex program of transcriptional events to activate or repress 
transcription. Transcription factors must be located in the nucleus, bind DNA, and interact 
with the basal transcription apparatus. Activation of transcription factors by extracellular 
signals therefore always involves a nuclear translocation step. Some pathways involve 
migration of signalling molecules (eg. MARK, see section 1.6.2) themselves into the 
nucleus, while in others activated transcription factors (eg, STATs) which migrate to the 
nucleus following their activation in the cytoplasm. Moreover, although in many cases 
activation of a single intracellular signalling pathway is sufficient for transcription factor 
activation, some transcription factors are complexes in which the activity of each 
component is regulated by different cellular signalling pathways.
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Fig. 1.5 Regulation of transcription. Multisubunit transcription appartus must 
assemble first at TATA box on genes. RNA ploymerase II is unable to initiate 
transcription on its own, it is guided to the start site by a set of transcription 
factiors collectively known as TFII. Initiation begins with binding of the 
TATA-binding protein of TFII-D which then recruits TFII-A and B, RNA-pol 
and THI-E to form a basal transcription apparatus. This units can transcribe 
DNA at low rate, however, addtional transcription factors are required for high 
level transcription of specific mRNA.
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1.9.2 Nuclear factor NFkB
In contrast with JAK/STAT pathways, which JAK involved in the transcriptional 
activation of many cytokine- and growth factor-inducible genes (see section 1.7.3), 
NFkB is activated by many agents that induce acute phase responses, such as IL-1, IL-2, 
TNF-a, LPS, viral infection, etc. NFkB was originally identified as a transcription factor 
that binds to the kB site in the intronic enhancer of the immunoglobulin k  light-chain gene 
in B lymphocytes (Sen and Baltimore 1986). NFkB controls the expression of numerous 
genes of the immune and inflammatory responses and of various viral genes (including 
those of human immunodeficiency virus, HIV) ( Baeuerle et al, 1994). The NFkB 
protein is a heterodimer consisting of two proteins, p50 (also designated NFkBI) and 
p65 (also designated Rel A). p50 and p65 are members of the Rel/NFKB family of 
proteins. These proteins serve as inducible eukaryotic transcription factors that form 
various homo- and heterodimers. NFkB (i.e., the p50-p65 complex) is present in 
essentially all cells and is the most abundant of the Rel/NFxB family heterodimers.
NFkB is retained in an inactive form in the cytoplasm as a consequence of the 
binding of particular proteins of the IkB family (i.e., IkB-o and IkB-P). The activation 
and nuclear translocation of NFkB can be correlated with the phosphorylation of IkB, 
which triggers the proteolytic degradation of one or both of the IkB proteins. A recent 
report (Joseph e t a l 1996), mapping the inducible IkB phosphorylation sites, indicated 
that activation of a single IkB kinase, or closely related IkB kinases, is the first critical 
step in NFkB activation. Once phosphorylated, IkB is ubiquitinated. Poly-ubiqui tination 
is required for inducible IkB degradation.
The activation of NFkB can be triggered by different stimuli, e.g ,, 
lipopolysaccharide (LPS), muramyl peptides, viruses, the inflammatory cytokines TNF-a 
and IL-lp, UV irradiation, reactive oxygen intermediates (H2O2) (Baeuerle PA 1991; 
Baeuerle et al., 1994), phorbol esters {e.g., phorbol myristate acetate [PMA]), and 
double-stranded RNA. Of these agents, TNF-a and PMA elicit the inactivation and
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degradation of only IkB -a  and the transient activation of NFk B. IL-ip and LPS , 
however, elicit the inactivation and degradation of both IkB-a  and IkB-P and a more 
persistent activation of NFkB (Wang et al., 1996).
1.9.3 Interferon regulatory factor family (IRFsI
Many of IFN regulated genes (ISGs) have a short DNA motif in their promoter 
region, a motif that has been designated IFN consensus sequence (ICS) or the IFN 
stimulated response element (ISRE) (Williams 1991; Levy and Darnell 1990; Friedman 
and Stark 1985). A similar hexamer motif has also been found in the promoters of both 
IFN-p and IFN-a genes and since it confers viral as well as dsRNA responsiveness, it 
has been designated positive regulatory domain (PRD)-I (Fan and Maniatis 1989). A 
number of different transcription factors have been identified by exploiting their ability to 
bind either the ICS/ISRE or the PRDI motifs. Among them are ISGF3 (Veals et a l, 1992; 
Schindler et al, 1992; Fu et al, 1992), IRF-1 (Miyamoto et al, 1988; Pine et al, 1990), 
IRF-2 (Harada et a l, 1989) and ICS binding protein (ICSBP) (Weisz et al., 1992; 
Driggers 1990), that share a similar DNA binding domain, and PRDI-BFl (Keller and 
Maniatis 1991), a unique zinc finger binding protein.
The ISGF3a subunit consists of three cytoplasmic polypeptides of 84, 91 and 
113 kDa . Following the exposure of cells to IFN-a, these polypeptides quickly 
translocate to the nucleus where they associate with the ISGFBy subunit (which confers 
sequence specific recognition) and bind to the ISRE motif (Schindler et al, 1992; Fu et 
al, 1992). The ISGF3y subunit is a 48kDa polypeptide found mainly in the cytoplasm of 
cells. Following exposure of the cell to IFN-a, it accumulates in the nucleus to generate 
active ISGF complex with the a-subunit.
A
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The transcription factors IRF-1 and IRF-2 were cloned because of their ability to 
bind the PRDI element, but it has also been reported that they bind to the ICS/ISRE motif 
(Reis et a l, 1992; Fujita etal., 1988). IRF-1 expression can be induced within a few 
hours following exposure of cells to IFNs, viral infection, dsRNA and cytokines
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(Abdollahi et a l, 1991; Harroch et al, 1993). IRF-1 has been demonstrated to be a 
transcriptional activator of those ISGs that are repressed by IRF-2 (Harada et a l, 1990).
IRF-1 was shown to play a critical role in the regulation of IFN-p at least in certain cells 
(Reis et al, 1992); it can affect the expression levels of IFN-p and IFN-inducible gene 
expression depending on the differentiation state of the cells (Ruffner et al, 1992). The 
importance of IRF-1 is emphasized by the findings that it may play a role in the inhibition 
of cell growth (Yamada et a l, 1990; Kirchhoff et a l, 1992) and manifests anti-oncogenic
■properties in NIH 3T3 cells (Harada et al, 1993; Willman et a l, 1993). Moreover, it has 
been shown recently that IRF-1 is required for the induction of NO synthase in 
macrophages (Kamijo eta l, 1994).
IRF-2 shares sequence similar with IRF-1 and is also constitutively expressed in #|
many cell lines. Co-transfection studies have shown that IRF-1 can act as a transcriptional 
activator on promoters containing multiple copies of PRDI hexamer, while IRF-2 can 
function as a repressor of IRF-l-activated gene expression (Harada et a l, 1989 & 1990).
Normally, IRF-2 is bound to the IFN genes in uninduced cells to the same sequence
elements as IRF-1, Upon induction, IRF-2 is replaced by IRF-1, which would co-operate
:with other factors to promote transcription. Both IRF-1 and IRF-2 are virus inducible and
.iIFN inducible. The induction of IRF-2 mRNA by virus is a critical event to reverse the
S 'IRF-1-mediated gene activation, thus making the genes accessible for subsequent signals.
ICSBP is another member of IRFs family, which has been cloned and shown to 
be a 425 amino acid polypeptide which shows restricted homology to IRF-1, IRF-2 and 
ISGF3y in the first 120 amino acids, a region that encompasses the DNA binding domain
. a-(Weisz et a l, 1992; Driffers etal., 1990). Additional homology also exists between 
ICSBP and ISGFBy in a short segment at the C-terminus; a segment that is involved in the 
association of ISGF3y with ISGFct (Veals et al, 1993). ICSBP is expressed primarily in 
cell lines of hematopoietic origin, mainly in monocytic cells, but it has been found in B 
cells and T cells. It appears to function as a trans-acting negative regulator of ICS/ISRE 
and PRDI containing promoters (Weisz et a l, 1992; Nelson et a l, 1993).
Part III. IFN-y, LPS and IL-4 regulation of macrophage functions
Mononuclear phagocytes are target cells for a large and diverse range of micro­
organisms that demonstrate an obligate requirement for an intracellular environment in 
which to survive and replicated. Macrophage activation is essential for enhanced 
microbicidal activity during host resistance to these infections. Antimicrobial activities of 
macrophages have been broadly categorised into either oxygen-dependent or oxygen- 
independent systems (reviewed in Reiner 1994). Oxygen-dependent systems include 
production of reactive oxygen intermediates, mediated by the phagocyte oxidative burst, 
and the reactive nitrogen intermediate, nitric oxide, via oxidation of a terminal guanidino- 
nitrogen atom of arginine (Wilson 1990; Stamler et al, 1992). Oxygen-independent 
microbicidal mechanisms of macrophages are also multifactorial and may involve: 
acidification of the phagolysosomal vacuole; the action of hydrolytic lysomal enzymes; 
nutrient deprivation; defensins and other antimicrobial proteins (Lehrer et al., 1993; 
Hiemstra et al., 1993).
The range of agonists that augment macrophage functional properties is large and 
diverse. Amongst the most potent are bacterial LPS, chemotactic peptides, colony- 
stimulating factors (CSFs) and cytokines including IFN-y.
1.10 IFN-y and its receptors
Interferon gamma (IFN-y) is a dimeric glycoprotein produced by activated T cells 
and natural killer cells. Although originally isolated on the basis of its antiviral activity, 
IFN-y also displays powerful antiproliferative and immunomodulatory activities. These 
activities are essential for developing appropriate cellular defences against a variety of 
infectious agents. It enhances bacterial phagocytosis and proteolytic enzyme synthesis by 
macrophages (Huang et al., 1971; Pestka et al., 1987; Adams and Hamilton 1984), and 
increases granulocyte superoxide production (Perussia et al, 1987; Berton et al, 1986; 
Klein et a l, 1991). Immunomodulatory actions of IFN-y include increased natural killer 
(NK) cell activity (Weigent et al, 1983) and enhanced membrane expression of class II
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:histcxîompatibility antigens and other various immunomodulating receptors (Adams and 
Hamilton 1987; Lindahl et aL, 1976; Fertsch and Vogel 1984; Naray and Guyre 1984;
'Tweardy et al., 1986).
IFN-y exerts its pleiotropic effects on cells through an interaction with a specific
.high affinity receptor expressed at the cell surface (Farrar and Schreiber 1993). IFN-y 
receptors are composed of two distinct, species-specific polypeptides. IFN-yRa and IFN- 
yRpl are members of the class-2 cytokine receptor family. Although the receptor a  chain 
(90kDa) binds IFN-y with high affinity, signal transduction requires a species specific 
accessory protein (Schreiber et ah, 1992; Soh et al., 1994; Hemmi et al., 1994) which 
associates with the extracellular domain of the receptor, the IFN-y receptor p-chain. The 
intracellular part of the IFN-y receptor is more promiscuous, as it can be inter-changed 
between species without loss of function (Pellegrini and Schinkler 1993; Hemmi et al, 
1994). IFN-y receptor does not express endogenous kinase or phosphatase activities, yet 
may become rapidly and reversibly tyrosine phosphorylated following ligation in intact 
cells. Mutational studies of the IFN-y receptor have defined two cytoplasmic domains 
necessary for biological function, a membrane-proximal region and a C-terminal sequence 
including an essential tyrosine (Cook et a l, 1992; Farrar et a l, 1992).
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As reviewed in Part II, IFN-y signalling pathway involves JAK-STAT activation. 
The other signalling pathways utilised by IFN-y to induce cellular changes are a subject of 
controversy (reviewed in Scheoers et al, 1992). Evidence supporting and refuting a role 
for activation of phospholipase C has been reported. IFN-y has been shown to increase 
intracellular concentrations of calcium ([Ca^+]), stimulate generation of inositol-1,4,5- 
triphosphate (IP3) and diacylglycerol (DAG), and modulate protein kinase C activity 
(Celada and Schreiber 1986; Klein et a l, 1987; Somers et al, 1986; Yap et a l, 1986; 
Hamilton et al, 1985; Sebaldt et a l, 1990). Protein kinase C activation by phorbol 
diesters and an increase in [Ca^+] by calcium ionophores mimic some of the functional 
effects of IFN-y (Celada and Schreiber 1986; Somers et a l, 1986; Strassman et a l,
1986). Additionally, inhibition of protein kinase C activation by H-7 or staurosporine has
been reported to prevent IFN^-induced expression of class II histocompatibility antigens 
(Politis and Vogel 1990; Nezu et ah, 1990). On the other hand, some reports showed that 
PKC activation was not involved in IFN-y regulation of class II antigens in HL-60 cells 
(Inae/ ah, 1987) or in murine macrophages (Celada and Maki 1991). There is, however, 
much evidence suggesting that protein phosphorylation is an intermediate event in the 
signal transduction pathways activated by IFN-y. Some kinases different from, or in 
addition to, protein kinase C and calcium-calmodulin-dependent protein kinase stimulates 
protein phosphorylation induced by IFN-y. We now know that JAK kinases play 
important roles in such signalling.
1.11 LPS and its receptors
1.11.1 Lipopolysaccharide (LPSl
LPS is a complex glycolipid found in the outer membrane of all Gram-negative 
bacteria. It is composed of two chemically dissimilar structural regions: the hydrophilic 
repeating polysaccharides of the core and O-antigen structures and a hydrophobic domain 
known as lipid A (A schematic structure for LPS from Escherichia coli is shown in Fig 
1.6). Viturally all LPS-induced biologic responses are lipid A dependent (Rietschel etal., 
1994). The most compelling evidence supporting the concept that lipid A is biologically 
active moiety of LPS derives from studies with synthetic lipid A. This product has full 
endotoxic activity. Thus recognition of the lipid A of LPS by cells must be the initial step 
in LPS-induced cellular responses.
In humans and experimental animals the presence of bacterial lipopolysaccharide 
(LPS) signals the presence of Gram-negative bacteria. LPS is one of the most potent 
biological response modifiers known; picomolar concentrations are sufficient to stimulate 
cells of the immune / inflammatory / vascular systems. LPS triggers gene induction of 
which encode proteins that include produce low molecular weight proinflammatory
61
mediators. Together the products of these inducible genes upregulate host defense 
systems that participate in eliminating the bacterial infection. Unfortunately, these same 
mediators contribute to a serious human disease known as septic shock (Reviewed in 
Ulevitch and Tobias 1995).
A vast amount of information about molecular mechanisms of host defense 
responses and inflammatory mediators has been derived from studies using LPS as a 
stimulus (Raetz et al, 1991), but until recently, mechanism of LPS-induced cell activation 
were not well understood. Two major advances have helped to bridge this gap in our 
knowledge, have been the characterisation of the LPS receptor, CD14 and the LPS 
binding protein, LBP.
1.11.2 LPS binding protein (LBPl
First was the discovery of LPS binding protein (LBP) (Tobias et al, 1986), a 60- 
kDa serum glycoprotein that binds LPS, via the lipid A moiety. Analysis by cDNA 
cloning of the structure of LBP (Schuman et al, 1990) led to recognition of a structure- 
function relationships between LBP, the bactericial/permeability-increasing protein (BPI), 
and other proteins (Tobias et a l, 1988; Gray et a l, 1989; Day et a l, 1994). Most 
importantly, characterization of LBP function in determining cellular responses to LPS 
revealed an unanticipated mechanism for LPS-induced cell activation that involves a 
membrane receptor for LPS-LBP complexes (Ulevitch et a l, 1993; Mathison et al, 1992; 
Ulevitch et a l, 1994; Wright et a l, 1989). LBP is synthesized in hépatocytes as a single 
polypeptide, glycosylated, and released into blood as a 60-kDa glycoprotein (Ramadori et 
a l,  1990; Grube et a l, 1994). LBP synthesis is under the control of cytokines and 
steroid hormones (Grube et al, 1994). A major function of LBP is to enable LPS binding 
to its receptor, either the membrane or soluble form of CD 14. LBP appears to have two 
functional domains, one for LPS binding and another that fosters LPS-CD14 interactions. 
Measurements of induction of TNF with a series of LPS preparations as well as with 
synthetic lipid A showed that the presence of LBP lowered the threshold stimulatory 
concentration of LPS and markedly enhances the effects of LPS on the induction of other
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cytokines (Martin et al., 1994; Martin et al., 1992) as well as NO release (Corradin et al.,
1992).
1.11.3 LPS signais and CD 14
The second major advance was the identification of the LPS receptor as CD 14. 
Initial interactions of LPS with cell membrane are believed to involve the binding of the 
lipid A. polysaccharide, or both moieties of LPS to specific cell surface receptors (Wright 
et al., 1991; Raetz et al., 1990; Ulevitch et al., 1993). A diverse group of plasma 
membrane molecules that behave as LPS-binding proteins has been identified in many cell 
types. These include the CDl 1/CD 18 leukocyte integrins (Wright et al., 1986), an 80kDa 
protein of mouse and human splenocytes and macrophages (Lei et a l, 1988), the 
glycolipid-anchored CD 14 molecule (Wright e? a/., 1990), an 95kDa protein identified in 
a murine macrophage cell line (Hampton et a l, 1988), and the scavenger receptor for 
plasma protein (Hampton et a l, 1991). Of these proteins, only the 
glycosylphosphatidylinositol-linked molecule CD 14 has been shown to function as a bona 
fide LPS receptor with the capacity to initiate cell signalling.
CD 14 is a 55-kDa, glycosylphosphatidylinositol (GPI)-anchored membrane 
protein (mCD14) of myeloid cells; it is also found as a soluble serum protein (sCD14) 
lacking the GPI-anchor (Bazil et a l, 1989; Ziegler-Heitbrock and Ulevitch 1993). 
Although other surface proteins have been suggested to be LPS receptors, CD 14 is the 
only protein of full defined structure that binds LPS and mediates LPS-induced cell 
activation. A role for mCD14 has been defined in LPS activation of myeloid cells, while 
sCD14 has been shown to participate in activation of nonmyeloid cell types such as 
endothelial or epithelial cells that normally do not express mCD14 (Pugin et al, 1993; 
Frey et a l, 1992). CD 14 does not have significant sequence homologies with other 
known proteins; the major recognisable structure of CD 14 is the presence of repeating 
leucine-rich motifs (Ferrero et al, 1990). This motif appears to be present when protein- 
protein interactions represent a significant feature of function.
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Fig. 1.6 General chemical structure of bacterial lipopolysaccharides. LPS
is a complex glycolipid. It is composed two chemically dissmilar structural regions: the 
hydrophilic repeating polysaccharides of the core and O-antigen structures and a 
hydrophobic domain known as lipid A.
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CD14 does not directly communicate with the cell interior, therefore how does it 
mediate ligand-specific cell activation? Evidence has been presented to indicate that 
ligation of CD 14 results in rapid activation of Src family tyrosine kinases leading to the 
phosphorylation of target proteins on tyrosine (Weinstein et al., 1993; Stefanova et al,
1993). In addition, various investigators have reported that responses to LPS in a variety 
of cell types may involve a pertussis toxin-sensitive G protein (Jakway et a l, 1986; 
Dziarski 1989; Wang etal., 1988), hydrolysis of phosphatidylinositides (Prpic et al.,
1987) and activation of protein kinase C (PKC) (Kawamoto and Hidaka 1984; Novotney 
et a l, 1991; Bakouche et al, 1992; Liu et a l, 1994) or mitogen-activated protein (MAP) 
kinases (Liu et al, 1994; Nick et al, 1996). However, some of these findings have not 
been consistently reproducible (Dziarski 1989; Wang et al, 1988; Forehand et al, 1989; 
Grupp and Harmony 1985; Dong et a l, 1989) and it is not known to what extent they 
may be CD 14-dependent (reviewed in Liu et al, 1994). Thus, the question of how 
intracellular signalling in response to LPS is mediated remains to be fully explored.
1.12 IL-4 and its receptors
lL-4 is derived fron Th2 cells. lL-4 regulates T-cell development and also has 
numerous effects on both resting and activated B cells (Howard et al, 1993), is a mast 
cell growth factor, and acts synergistically on certain populations of myeloid cells 
(Rennick et a l, 1992). In general, the effects of lL-4 on cells of the monocyte 
/macrophage compartment could be described as "anti-inflammatory". The down- 
regulation of both Fey receptor expression and LPS receptor expression results in a 
reduction of antibody-dependent cellular cytotoxicity (ADCC) and in decreased 
responsiveness to LPS stimulation as characterised by a diminution in chemokine and 
growth factor secretion (Minty eZ a l, 1993; de Waal Malefyt et a l, 1993). The anti­
inflammatory action of lL-4 lead not only to a reduction in ADCC but also to decreased 
killing of phagocytosed bacteria such as Salmonella (Denich et a l, 1993) and parasites 
such as Leshmania (Lehn et al, 1989). Experiments using mouse macrophages cultured 
from bone marrow in the presence of lL-4 indicate reduced the production of nitric oxide
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weight species of 60-75kDa. The 140kDa IL-4R is expressed on a variety of cell types.
(NO) following LPS activation. This reduction in release of NO, one of the most
:important cytotoxic mechanisms of phagocytes, correlates with a lowering of parasiticidal 
activity against Leishmania major (Doherty et a l , 1993).
Initial characterization of IL-4 binding proteins revealed that IL-4 cross-links
■tfmultiple proteins, one of molecular mass approximately 140kDa and a lower-molecular-
including lymphoid cells, myeloid cells, and nonhematopoietic cells such as fibroblasts
and neuroblasts (reviewed in O'Farrell et a l, 1996). The cloned human and mouse IL- 
4Rs have approximately 50% amino acid identity (Galizzi et al., 1990; Idzerda et al.,
1990; Harada et al, 1990; Mosely et al, 1989). A soluble form of the mouse receptor, 
capable of high affinity IL-4 binding, has also been isolated (Mosley et al, 1989). In 
human B cells, the IL-4R is coupled to a transient PLC activation followed by a sustained 
generation of cyclic AMP (Finney et al, 1990). Although these signals are not observed 
in murine B cells, IL-4 can reduce the threshold of mig-mediated PKC activation (Harnett 
et a l, 1991). In addition, the IL-4R is also coupled to the PTK-mediated activation of PI- 
3-K, possibly via a novel docking protein, 4PS (reviewed in Keegan eta l, 1994; Harnett 
1996).
Although the 140kDa IL-4R binds IL-4 with high affinity, several lines of 
evidence have suggested that the functional IL-4R contains an additional subunit that 
enhances affinity and plays a role in signal transduction (Noguchi et a l, 1993; Zurawski 
et a l, 1993). Accordingly, it has recently been demonstrated that IL-4 cross-links IL- 
2Ry, and the combination of IL-4R plus IL-2Ry significantly increases IL-4 binding 
affinity relative to that observed with IL-4 R alone. Furthermore, IL-2Ry is required for 
IL-4-mediated signal transduction (Kondo et a l, 1993; Russell e ta l ,  1993). IL-4,
. junusually for an hemotopoietic receptor superfamily cytokine, does not stimulate Ras #
activation (Satoh et a l, 1991). I
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Part IV, Aims of the thesis
Macrophages activated by cytokines and microbial products protect the host from 
certain tumor cells and microbes, including parasite, fungi, bacteria and viruses, in large 
part by a pathway dependent on production of NO. On the other hand, cytokine and/or 
LPS-induced NO production contributes substantially to the suppression of lymphocyte 
proliferation, hypotension in sepsis, and a range of autoimmune disease (reviewed in 
BOgden et al., 1994). The potential function of NO in all these situations, whether 
protective or destructive, makes it important to understand the regulation of its 
production. Although iNOS regulation has been studied either at the genomic level, gene 
transcription level, or even post-transcriptional level, the early signalling events that lead 
to the transcriptional activation are still unclear.
IFN-y and IL-4 are produced by functionally distinct subsets of T helper cells
(Thl and Th2, respectively ) in the murine as well as in the human system. The opposing 
regulatory effects of IL-4 and IFN-y are crucial in the regulation of the immune response, 
as has been demonstrated in the murine Leishmaniasis model. The aims of this project are 
therefore to:
1. Investigate the signalling pathway leading to the induction of iNOS expression by 
IFN-y and LPS, with special attention to the roles of JAK-STATs and IRF 
molecules.
2. Investigate the mechanism of the regulation of the induction of iNOS expression 
by IL-4, leading to the understanding of the mechanism by which immunological 
balance is achieved.
These objectives will be investigated in the murine macrophage iNOS system in 
which the productions of high levels of NO has been well established.
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Chapter 2 
Materials and methods
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Part I. Materials
American Type Culture Collection J774; RAW264.7 (murine macrophage cell lines)
Amersham
Biogenesis Ltd. 
BioRad
Costar
Genosys 
Gibco, BRL
[a32p]-dATP, [35s]-dATP,
DNA sequence kit
ECL detection system
Rainbow protein molecular weight markers
RNAzo1™ B
acrylamide
Bis-acryiamide
Nitrocellulose membrane
All the tissue culture flasks and plates
Eppendorf tubes (1.5 ml; 0.5 ml)
All filter tips (MOGO pi)
Plastic scraper
Spin X centrifuge filter tube
All the oligo synthesis
Ikb DNA markers
Agarose
dATP, dGTP, dCTP, dTTP
Dubicco's Modified Eagle Medium (DMEM)
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Hoeffer Sentific Ltd. 
Kodak
Pharmacia
Fetal Calf Serum (FCS)
Formaldehyde
HEPES
High Salt Buffer (for annealing) 
Klenow (DNA polymerase) 
L-Glutamine 
Penicillin/Streptomycin 
Phosphate Buffered Saline (PBS) 
Polyethylene glycol 
Random priming kit 
RNA markers
Superscript II (reverse transcriptase)
T4 ligase
Urea
Whole electrophoresis system 
X-ray film cassettes 
X-omat AR autoradiography film 
Protein-A/Sepharose 4B beads 
Poly (dl-dC) poly (dl-dC)
Nylon membrane
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Santa Crutz Anti-STAT l(p91)
Anti-NFicB (p65)
Anti-NFkB (p50)
Anti-IRF-1
Anti-IRF-2
Sigma Aprotinin
BCA kit for measuring protein concentration
Cycioheximide
DEPC
Dithiothieitol (DTT)
Leupeptin
Lipopolysccharide (LPS)
Phenyl methyl sulphonyl fluoride (PMSF)
Sodium orthovanadate
TEMED
Scottish Antibody Production Unit
(SAPU) All the HRP-conjugated secondary antibodies
Tranduction Laboratories (Affiniti) Anti-phosphotyrosine (RC-20)
Anti-phosphotyrosine (PY-20) 
Anti-phosphotyrosine (PY54)
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Anti-macNOS 
Anti-MAP kinase (ERK2)
Upstate Biotechnology (UBI) Anti-phosphotyrosine (4G10)
Anti-JAKl, JAK2, JAK3,
Gifts IL-4 (Immunise, Seatle)
IFN-y (Dr. G. Adolf, Vienna)
Anti-STAT6 (Dr. J.N Ihle, Memphis)
All the other chemicals used in this study are comerical avilable in Sigma or BDH.
a■sr:
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Part II. Methods
2.1 Cell culture
The murine macrophage cell lines J774 and RAW 264.7 (American Type Culture 
Collection) were cultured in Dulbecco's modified Eagle medium (DMEM, Gibco, BRL) 
supplemented with 10% heat-inactivated fetal calf serum (Gibco, BRL), 2 mM L- 
glutamine, and 50 U/ml each of penicillin and streptomycin (complete culture medium), at 
37°C with 5% CQ2. Cells were dispensed in tissue culture flasks (5x10^ cells/80 cm^) or 
plates (10^ cells/250 pi) 24 h before stimulation.
Murine peritoneal macrophages were harvested 4 days after intraperitoneal 
injection with 4% Brewer's thioglycollate broth. The cells were cultured with complete 
culture medium in either flasks (10^ cells/ml, 8  ml/flask), or 96-well plates (10^ cells /ml, 
200 pl/well) at 37°C with 5% CO2 . After 2 h incubation period, non adherent cells were 
removed by washing with warm culture medium.
2.2 Griess reaction for NO2 measurement
Nitrite concentration in the culture supernatants was determined by a micro plate 
assay (Ding, et al., 1988). Briefly, 50 pi samples were mixed with an equal volume of 
Griess reagent (1% sulphanilamide / 0.1% naphthalene diamine dihydrochloride / 2.5% 
H3PO4) at room temperature for 10 min. The absorbance at 570 nm was monitored with 
a microplate reader (Dyrotech MR5000). Nitrite concentration was determined by using 
sodium nitrite as a standard. The results were expressed as: NO2 pM.
2.3 Antibodies
The antibodies used in this project are shown in Table 2.1 below.
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Table.2.1
Name specificity Clone Application Company
RC20 anti-Tyr*. mono Western Blot Affiniti
PY20 anti-Tyr*. mono Western Blot Affiniti
PY54 anti-Tyr*. mono Western Blot Affiniti
4G10 anti-Tyr. mono Western Blot UBI
JAKl anti-JAKl poly immunoprécipitation 
Western Blot
UBI
JAK2 anti-JAK2 poly immunoprécipitation 
Western Blot
UBI
JAK3 anti-JAK3 poly immunoprécipitation 
Western Blot
UBI
P91/84 anti-STATl poly Western Blot Santa crutz
STAT6 anti-STAT6 mono Western Blot 
super shift
Dr.Ihle
(U.S.A.)
MAPkinase anti-erk2 mono Western Blot Affiniti
NFkB(P65) anti“p65 poly Western Blot 
super shift
Santa crutz
NFkB(P50) anti-p50 poly super shift Santa crutz
îgG-HRP anti-mouse IgG poly Western Blot SAPU
IgG-HRP anti-rabbit IgG poly Western Blot SAPU
iNOS anti-macNOS mono Western Blot Affiniti
IRF-1 anti-IRF-1 poly super shift Santa crutz
IRF-2 anti-IRF-2 poly super shift Santa crutz
*: anti“phosphotyrosine
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2.4 Preparation of cell lysates for NOS activity assay
Macrophages in culture medium were dispensed into 6 -well plates (Costar) at 10^ 
cells/ml, 300 pi/well, and incubated for 24 h at 37°C and 5% CO2. Nonadherent cells 
were then removed by washing with pre-warmed medium and cytokines were added. The 
cultures (3 ml/well) were incubated as above for a designated period. At the end of 
incubation, supernatants were aspirated and 250 pi of 0.1 M HEPES (pH7.4) with 1 mM 
dithiothreitol (Sigma) was added to each well and the cells harvested with a plastic scraper 
and subjected to three cycles of freeze-thawing. The samples were then centrifuged at 
100,000 xg for 30 min at 4°C and the supernatant assayed for NO synthase activity.
2.5 NOS activity assay
NO synthase activity assay was carried out by a spectrophotometric method as 
described (F.Y Liew et aL, 1991): briefly, NO synthesis was measured in incubates (0.5 
ml) containing 5 mM oxyhemoglobin and 20% (v/v) macrophage cytosol in 40 mM 
potassium phosphate buffer (pH 7.2) containing MgCl2  (1 mM) in a dual wavelength 
spectrophotometer (Shimadzu UV-3000 Kyoto, Japan) using a band width of 2 nm, at 
37"C. NO synthesis was initiated by addition of L-arginine (100 pM) and NADPH (100 
pM). The shift in absorbance between the wavelength pair 401-421 nm is caused by the 
conversion of oxyhaemoglobin (oxyHb) to methaemoglobin (mrtHb) by nitric oxide and 
was measured as a function of time using the equation:
AAbs/min x 0.02 x 0.0005 100 x 77200
where: AAbs/min = the change in absorbance in 1 minute (% of 100)
0.02 = full scale deflection (i.e 0-0.02 = 100%)
0.0005 = reaction volume in litres 
77200 = extinction coefficient for haemoglobin in the 
spectrophotometer used.
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Results were expressed as moles of NO formed/sample volume/ minute or moles 
NO formed/mg protein/minute. In some assays the NO inhibitors L-N-guanidino 
monomethyl arginine (L-NMMA) and L-N-imino ornithine (L-NIO) were added.
2.6 Preparation of cell lysates for western blotting
Treated cells (l-2xl07 /sample) were washed twice in situ with ice-cold TBS (25 
mM Tris Cl pH7.4 , 150 mM NaCl, and 100 pM vanadate), and harvested in 5 ml TBS 
with a plastic scraper. Following 5 min centrifugation at 4,600 rpm at 4°C, the cell pellets 
were resuspended in 0.5-1 ml lysis buffer (LB) containing 25 mM Tris Cl pH7.4, 150 
mM NaCl, l%NP-40, ImM Sodium orthovanadate, 1 mM EDTA, 2 mM EGTA, 10 mM 
NaF, 1 mM dithiothreitol, 50 pg/ml each of leupeptin, aprotinin, and phenyl methyl 
sulphonyl fluoride (PMSF). The samples were kept on ice for 30 minutes, transferred to 
an Eppendorf tube, centrifuged at 13,000xg at 4”C for 10 min. Protein concentration was 
determined using the BCA method according to manufacture instructions (Sigma). The 
supernatants (solublilised proteins) were stored at -70°C if they were not to be used 
immediately.
2.7 Immunoprécipitation
Immunoprécipitation was performed according to the UBI instructions: briefly, 
500 pg solubilised protein per sample was pre-cleared by adding 50 pi of Protein- 
A/Sepharose 4B beads (Pharmacia) and incubated at 4°C for 10 min. After 30 seconds in 
the micro centrifuge at 13,000 xg, the supernatant was transferred to a tube, and mixed 
with 3 pi of antiserum in a micro centrifuge tube. The reaction mixture was gently rocked 
on a rocker at 4°C for 2 h. Immuno-complex was captured by adding 50 pi Protein- 
A/Sepharose bead slurry (50% in LB) and gently rocked for further 2 h. The Sepharose 
beads were collected by pulsing (5 seconds in the micro centrifuge at 13,000 xg), and 
supernatant drained off. The beads were washed 3 times with ice-cold LB (300 pi / wash 
followed by vortexing for 5 seconds and the beads were collected by a micro centrifuge 
pulse). The Sepharose beads were resuspended in 40pl Laemmli sample buffer (2x;
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Laemmli 1970) and mixed gently. This preparation was either kept at -20°C or boiled for 
5 min before loading onto the SDS PAGE gel ( 7 or 10% ).
2.8 SDS-PAGE
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS PAGE) was 
performed according to a previously published method (Laemmli, 1970). All gels had a 
ratio of 29:1 of acrylamide to bis-acrylamide (BioRad). Resolving gels were made at 
either 10% or 7.5% in 1.5 M Tris Cl buffer pH 8.8, 1% w/v SDS, 1% w/v ammonium 
persulphate (BDH) and 0.1% v/v N,N,N',N'-tetramethylenediamine (TEMED) (Sigma). 
Stacking gels (5%) were similarly prepared using 0.5% Tris HCl buffer, pH 6.8. All gels 
were run using a standard electrophoresis buffer containing 25mM Tris, 0.25 M glycine 
(BDH) and 0.1% SDS. Samples to be electrophoresed were mixed with 50% v/v of 2x 
concentrated sample buffer (IM Tris Cl, pH 6.8, 0.2 M DTT, 4% SDS, 0.4% 
bromophenol blue and 20% v/v glycerol, pH 6.8) (BDH), heated to 100"C for 5 min and 
cooled on ice prior to loading on gels. ’Rainbow’ molecular weight markers (range 14 to 
200kDa) (Amersham) were similarly treated prior to electrophoresis and run on all gels. 
Electrophoresis was carried out at a constant current of 5 mA/cm gel length until the 
bromophenol blue marker reached the bottom of the gel. The gels were then subjected to 
either Coomassie blue stain or Western blot analysis.
2.9 Coomassie blue staining of SDS-PAGE gels
At the end of electrophoresis, the gels were stained for 1 h with 0.5% Coomassie 
brilliant blue R250 (Sigma) in 40% methanol (BDH), 10% glacial acetic acid (BDH) and 
destained over 4-5 h in several changes of 40% methanol, 10% glacial acetic acid until the 
background was clear. Stained gels were transferred to 3 MM filter paper (Whatman) and 
dried under a vacuum at 80“C.
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2.10 Western blot analysis of SDS-PAGE separated proteins
Four pieces of 3 MM filter papers were cut to size slightly bigger than the gel 
selected for Western blot analysis and were soaked in transfer buffer (20 mM Tris, 40 
mM glycine, 20% methanol ) (BDH). Two of the filter papers were placed on the cathode 
of an electroblotter (Hoeffer scientific Ltd.). The gel, soaked in transfer buffer, was 
placed on the filter papers. A sheet of nitrocellulose (BioRad), cut to the same size as the 
gel and pre-wetted with transfer buffer, was placed on the top of the gel. The remaining 
two sheets of filter papers were placed on top of the nitrocellulose. Proteins were 
transferred to the nitrocellulose by applying a constant current of 0.8 mA/cm^ of gel area 
for 90 min. At the end of the transfer, the nitrocellulose was incubated in 2% bovine 
serum albumin (Sigma) in wash buffer (0.01 M Tris HCl pH 7.5, 0,1 M NaCl, 0.1% 
Tween-20) for at least 1 h to block non-specific protein binding sites. Primary antibodies 
were diluted 1:500-5000 (depending on the recommendation of the suppliers) in 1% BSA 
in wash buffer and applied to the blot for 1 h at room temperature or overnight at 4°C. 
Following incubation with primary antibodies, the blot was washed with 6 changes of 
wash buffer (each for 5 to 10 min) and then incubated with a secondary antibody, 
conjugated to horseradish peroxidase, and diluted up to 1:5000 in wash buffer containing 
1% BSA for Ih at room temperature. Immuno-reactive bands were visualised by using 
the Enhanced Chemiluminescence (ECL) system (Amersham).
2.11 Preparation of cell lysates for two dimensional gel electrophoresis:
For the NEPHGE gel, 10^ cells were washed twice in situ with ice-cold TBS and 
harvested in 200 pi lysis buffer (LBl) containing 9.5 M urea (Schwarz-Maun), 2% 
Nonidet P-40, 2% Ampholines (pH 3.5-10.0), 50 pM dithiothreitol, 50 pg/ml each of 
leupeptin and aprotinin (Sigma), 25 pg/ml PMSF, 0.1 mM EDTA, 100 pM sodium 
orthovanadate, and 50 mM sodium fluoride (NaF). The cells were kept on ice for 30 min, 
and then centrifuged in a microfuge for 15 min at 4°C. The supernatant fraction 
(containing cellular total proteins) was stored at -70"C until used.
I
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2.12 NEPHGE gel (first dimension)
NEPHGE gels were prepared according to the protocol from Dr. Mark Rogers 
(Glaxo-Wellcome). Briefly, for 10 tube gels, the following reagents were added: 2.75 g 
urea, 0.67 ml 30% polyacrylamide (ratio 1:17), 1 ml 10% Nonidet P-40, 1 ml dH20, and 
250 pi Ampholines (pH 3.5-10.0). After the mixture was completely dissolved, 7 pi 10% 
ammonium persulphate and 4.5 pi TEMED were added and gels were poured immediately 
in the tube gel tank (Hoeffer Scientific Ltd.) and an overlay solution (9 M urea, 1% total 
Ampholines pH 3.5-10.0) was applied to the top of the gel when it was polymerised. The 
gels were kept away from light till used.
The overlay solution was removed, 30 pg protein per sample was loaded onto the 
top of the gel followed by overlay solution. The lower chamber was filled with 1000 ml 
0.02 M NaOH (Cathode electrode solution), and the upper chamber was filled with 500 
ml 0.01 M orthophosphoric acid (Anode electrode solution). Electrophoresis was carried 
out at 550 V for 5 h at room temperature.
At the end of electrophoresis, the gel was extruded into 5 ml SDS sample buffer in 
a capped tube, rocked gently at room temperature for 15 min, freezed in dry ice-ethanol 
for at least 30 min, and stored at -70°C until use.
2.13 SDS PAGE gel (second dimension) I
SDS PAGE gel was used for the second dimension assay. A 10% SDS 
polyacrylamide (1:36) gel was prepared to a thickness of 1.5 mm as described above.
While the tube gel was thawing out at room temperature, 10 ml of Ix SDS sample buffer 
containing 0.1% agarose was boiled up. The tube gel was laid on the slab, and 1 ml hot 
agarose was poured onto the top of it. The gel was then run at 20 mA for 3 h followed by 
western blotting as described above. t
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2.14 Preparation of nuclear extracts (method 1)
Nuclear extracts were prepared as described previously (Dignam et aL, 1983; Lee 
et a l 1988 and Schreiber et al 1989) with some modifications. Treated cells were 
washed twice with 10 ml ice-cold TBS (Tris buffered saline) and pelleted by 
centrifugation at 1500 xg for 5 minutes. The pellet was resuspended in 1 ml TBS, 
transferred into an Eppendorf tube and pelleted again. The pellet was resuspended in 400 
pi cold Buffer A1 ( 10 mM HEPES pH7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 
1 mM dithiothreitol, o.5 mM PMSF, 100 pM sodium orthovanadate) by gentle pipetting. 
The cells were allowed to swell on ice for 15 min, after which 25 pi of a 10% solution of 
Nonidet NP-40 (Fluka) was added and the tube was vigorously vortexed for 10 seconds. 
The homogenate was centrifuged at 13,000xg for 30 seconds in a microfuge. The 
supernatant was removed, the nuclear pellet was resuspended in 50 pi ice-cold Buffer B1 
( 20 mM HEPES pH7.9, 0.4 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM 
dithiothreitol, 1 mM PMSF, 100 pM sodium orthovanadate) and the tube was vigorously 
rocked at 4°C for 15 min on a shaking platform. The nuclear extract was centrifuged for 5 
min in a microfuge at 4"C and the supernatant was frozen in aliquots at -70°C until use.
2.15 Preparation of nuclear extracts (method 2)
DNA-binding proteins were prepared as described by Andrews et al (1991) except 
all buffers were supplemented with 100 pM sodium orthovanadate. Typically, 10^ cells 
from tissue culture were washed with 10 ml TBS (Tris buffered saline) and pelleted by 
centrifugation at 1500xg for 5 min. The pellet was resuspended in 1 ml TBS, transferred 
into an Eppendorf tube and pelleted again by spinning for 15 seconds in a microfuge. 
TBS was removed and the cell pellet was resuspended in 400 pi cold Buffer A2 (10 mM 
HEPES-KOH pH7.9 at 4°C, 1.5 mM MgCli, 10 mM KCl, 0.5 mM dithiothreitol, 0.2 
mM PMSF, 100 pM sodium orthovanadate) by flicking the tube. The cells were allowed 
to swell on ice for 10 min, and then votexed for 10 seconds. Samples were centrifuged 
for 10 seconds, and the supernatant fraction removed. The pellets were resuspended in 
100 pi of cold Buffer B2 (20mM HEPES-KOH pH7.9, 25% glycerol, 420 mM NaCl,
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1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithithreitol, 0.2 mM PMSF, 100 pM sodium 
orthovanadate) and incubated on ice for 20 min for high-salt extraction. Cellular debris 
was removed by centrifugation for 2 minutes at 4°C and the supernatant fraction 
(containing DNA binding proteins) was frozen in aliquots at -70°C until use.
2.16 Synthetic oligonucleotide DNA probes:
Oligonucleotides designed for DNA-protein binding assays are shown in Table 
2.2. These probes are designed by Dr. X.Q. Wei.
Table 2.2.
Oligos Sequence binding site location
Probe A-1 
Probe A-2
Probe B-1 
Probe B-2
Probe C-1 
Probe C-2
Probe D-1 
Probe D-2
Probe E-1 
Probe E-2
Probe F-1 
Probe F-2
Probe G-1 
Probe G-2
Probe H-1 
Probe H-2
5'-CAATATTTCACTTTCAT 
5'-TTCCATTATGAAAGTGA ISREd
5'-GGGAACAGTTATGCAAA 
5’-CAGAGCTATTTTGCATA GAS
5’-TTCCTTTTCCCCTAA 
5'-CAGTGTTAGGGGAA GAS
5'-CCCAACTGGGGACTCTC 
5'-CCAAAGGGAGAGTCCCC NFkB
5’-GAACTTACTCTGTAGAC 
5'-GCCTGGTCTACAGAGTA GAS
5’-TACAACAGCCTGATTTCCCCG 
5'-GCCGTCATTCGGGGAAATCAG GAS
5'-CACTGTCAATATTTCAC 
5’-ATTATGAAAGTGAAATATTGACAG ISRE
5'-CTAGAAGTGAAAGTG
5'-TCACTTCACTTTCACTTC C-13
iNOS
promoter
iNOS
promoter
iNOS
promoter
iNOS
promoter
iNOS
promoter
IRF-1
promoter
iNOS
promoter
Fuiita 1987 
Harada 1989
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2.18 Protein-DNA binding assay
The binding reaction was initiated by pre-incubation of 5 to 10 pg of nuclear 
extract protein with 200 ng of double-stranded poly(dI-dC).poly(dI-dC) (Pharmacia) in
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2.17 Synthetic oligonucleotide DNA labelling
Double-stranded oligonucleotides were labelled with [a-^^P]dATP by using 
Klenow fragment of DNA polymerase, and purified on 8% non-denaturing 
polyacrylamide gels. Synthetic oligonucleotides were supplied freeze-dried and 
reconstituted by the addition of 500 pi of distilled water. Dilutions (1/100) were made in 
distilled water and the concentration determined by U.V. absorbance at 260nm against a |
water blank. For single stranded DNA, an absorbance of 1 = approximately 37 pg/ml.
The values obtained were converted to molarity on the assumption that the average 
molecular weight of 1 DNA base is equal to 324Da using the formula:
 1__________X oligo concentration in pg/pl x 10-6 = moles oligo/pl
Total oligo Mr in Da
Annealing was carried out in high salt buffer (H buffer: Gibco BRL): 40 nmoles 
of each single stranded oligo in 90 pi were pooled together with 20 pi of H buffer and 
boiled at 100°C for 10 min followed by cooling slowly for up to 3-4 h in the same water 
bath but with the heater turned off.
Double stranded DNAs were labelled with [a-^^P]-dATP using a commercially 
available random priming kit (Gibco BRL). The DNA (2 pi) in a 1.5 ml Eppendorf tube 
was mixed with 2 pi each of 0.5 mM dCTP, 0.5 mM dGTP and 0.5 mM dTTP, 5 pi of 
lOx H buffer, 2 pi (2pCi) of [a-^^P]-dATP (Amersham), 1 pi Klenow DNA 
polymerase (Exonuclase-free, 2 units/pi) and distilled H2O was added to 50 pi. The 
reaction was allowed to proceed for at least 2 hat 37°C and purified by electrophoresis in
polyacrylamide gel, using TBE as running buffer followed by incubating gel pieces in TE 
buffer overnight at 37 C.
40 mM KCl, 20 mM HEPES (pH 7.9), 1 mM MgCl, 0.1 mM EGTA, 0.5 mM 
dithiothreitol, 10% Glycerol, and 0.1% Nonidet P-40 for 20 min on ice in a volume of 
30pl (Wu, et al .,1994; Andrews et al., 1991). The radio-labelled synthetic oligo­
nucleotide DNA probe (0.5 ng in 1 pi) was then added, and the mixture was incubated on 
ice for another 20 min. For antibody super-shift assay, 1 pi of antiserum was added 
during the pre incubation, and pre-incubation without probe was extended to 1 h.
DNA-protein complexes were fractionated by electrophoresis at room temperature 
on a non-denaturing 6% polyacrylamide gel at 150 V for 3 h in 0.5X Tris-borate-EDTA 
buffer (TBE: described bellow in section 2.25 on sequencing). Gels were dried and 
visualised by auto radiography.
2.19 Non-denaturing polyacrylamide gels
The slab gel system was used ( SE400 Hoeffer scientific Ltd.) for separating 
DNA-protein complexes. In a final volume of 40 ml of 0.5x TBE buffer, 8 ml of 30% 
polyacrylamide solution (Acrylamide:bis = 29:1, BioRad) was added and mixed. 
Ammonium persulphate (100 pi of 30% solution) and TEMED (34 pi) were added 
immediately before pouring the gel. In the case of probe purification, the gel was made in 
Ix TBE.
2.20 Isolation of total cellular RNA
Total RNA was isolated using the 'RNAzol^M  g* method, following the 
manufacturer's instruction (Biogenesis Ltd.). Distilled water, treated for 12 hours with 
0.2% diethyl pyrocabonate (DEPC; Sigma) and then autoclaved, was used to make all 
solutions not supplied with the kit. Cells (lO^-lO^) were washed with ice-cold PBS and 
pelleted by centrifugation at 2000xg and lysed in 400pl of RNAzolT’M B. Effective lysis 
was facilitated by vigorous pipetting. Following disruption, lysates were vortexed for 15 
seconds in the presence of 40 pi chloroform. Samples were then centrifuged at 15,000xg 
for 15 min at 4“C and the colourless 200 pi upper phase (exclusively containing RNA)
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was removed into an Eppendorf tube. RNA was precipitated by the addition of 200 pi of 
isopropanol (BDH) and pelleted by centrifugation at 15,000xg for 15 min at 4°C. The 
RNA pellet was washed once in 75% ethanol by centrifugation at 13,000 xg for 5 min 
before being resuspended in 20 pi TE buffer. The concentration of RNA in samples was 
estimated using ultra-violet spectroscopy. The sample (1 in 500 dilution) was made in 
DEPC-treated distilled water and the absorbance at 260nm and 280nm was measured 
using quartz cuvettes and a water blank. The RNA was judged to be free from protein 
contaminants if the absorbance ratio 260 nm/280 nm was greater than 1.8.
2.21 Reverse transcription polymerase chain reaction (RT-PCR)
RT-PCR was performed using a commercially available 'GeneAmp RNA-PCR' 
kit (Perkin Elmer Cetus). Reverse transcription of RNA to cDNA was performed on 5 pg 
of total RNA, isolated as described above. RNA was mixed with the following reagents 
supplied with the kit: 4 pi 25 M MgCl2, 2 pi lOx concentrated PCR buffer (0.5 M KCl,
0.1 M Tris Cl, pH 8.3), 2 pi each of 10 mM deoxy adenosine triphosphate (dATP),
dCTP, dGTP, dTTP, Ipl RNase inhibitor (20 units/pl), 1 pi recombinant reverse
transcriptase from molnoey murine leukaemia virus (50 units/pl), 1 pi 50 pM random '
sequence hexanucleotides and 2 pi of DEPC treated distilled water. This mix was
incubated at room temperature for 10 min, 42°C for 15 min, 99°C for 5 min and finally
chilled on ice. This protocol allowed annealing of the random hexamers and conversion of
the RNA sequence (via reverse transcriptase) into cDNA. i
Following reverse transcription, 4 pi 25 mM MgCl2, and 8 pi lOx concentrated 
PCR buffer were added to each sample. Target sequence-specific oligonucleotide primer t
pairs were then added to a final concentration of 20 ng/ml (usually 5 pi of a 40 pg/ml 
solution) and distilled water added to take the final volume to 99.5 pi. Recombinant DNA 
polymerase (0.5 pi, 5 units/pl) from Thermus aquaticus ( Amplitaq') was added and the 
mixture was overlaid with 100 pi of mineral oil (Sigma).The entire reaction mixture was 
subjected to thermal cycling under the following standard conditions: Dénaturation at
I
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95°c  for 1 min, primer binding at 56°C for 2 min and sequence extension at 72°C for 3 
min for 35 cycles. The PCR products were then resolved by DNA-agarose gel 
electrophoresis.
2.22 Agarose gel electrophoresis of nucleic acid
Nucleic acid was routinely analysed by electrophoresis through agarose gels. 
Agarose gels were used (0.8%-1.0%). Gels were made by dissolving the required 
amount of dry agarose power (Gibco BRL) in 0.5x TBE buffer from lOx stock buffer 
[200 mM Tris Cl pH 8.0,900 mM Boric acid, 25 mM Ethylenediamine tetra-acetic acid 
(EDTA)] by boiling or in a microwave oven. The melted gels were allowed to cool to 
45°C and ethidium bromide (Sigma) was added at a final concentration of 10 ng/ml. Gels 
were cast in tanks with combs where they were allowed to set. After setting, gels were 
submerged in 0.5x TBE buffer and well-forming combs were removed. The samples of 
DNA and Ikb DNA ladder (Gibco BRL) were mixed with loading buffer (6x loading 
buffer: 0.25% bromophenol blue, 150 mM Tris Cl pH8.0, 10 mM EDTA, 40% sucrose) 
and loaded into the relevant wells on the gel. Gels were electrophoresed at a constant 
current of 10 mA/cm gel-length or a constant voltage of 1-5 V/cm of gel-length until the 
bromophenol blue had migrated the required distance. Gels were then analysed under 
ultra-violet light and photographed if necessary.
2.23 Purification of DNA fragments from agarose gels
DNA bands were visualised with Ethidium Bromide by short-wave UV 
illumination. The relevant band was excised with a scalpel and placed in a Eppendorf 
tube. Freeze-Squeeze buffer (1 ml, 25 mM Tris Cl pH7.4, 0.3 M sodium acetate, 1 mM 
EDTA pH7.0) was added and the sample kept in the dark at room temperature for 15 min. 
The buffer was then discarded and the Eppendorf tube with the agarose was placed in 
dry-ice for 10 min. The frozen gel slice was rapidly transferred to a Spin X centrifuge 
filter tube (Costar) and centrifuged for 15 min at 15,000xg. DNA in the supernatant was
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then extracted with phenol/chloroform followed by chloroform before precipitated with
ethanol.
2.24 Cloning of interferon response factors (IRF-1 and IRF-2)
Following gel purification, the PCR amplified IRF-1 and IRF-2 cDNA fragments 
were ligated with TA-vector (Invitrogen) using DNA ligase isolated from the 
bacteriophage T4 (Gibco BRL). Approximately equimolar amounts (usually about 0.1- 
0.5 pg DNA) of the fragments to be ligated and the appropriate amounts of TA-vector 
DNA were mixed and incubated with 1 pi of T4 ligase (1 unit/pl) in ligation buffer (50 
mM Tris Cl pH 7.6, 10 mM MgCl^, Im M ATP, 1 mM DTT and 5% w/v polyethylene 
glycol 8000) (Gibco BRL) in a total volume of 10 pi. Control ligations replacing the 
cDNA fragments with water but retaining the TA-vector plasmid DNA were also set up to 
calculate the degree of self ligation. Ligations were allowed to proceed either overnight at 
160C or at room temperature for 4 h. Following ligation, the reaction mixture were used 
for bacterial transformation directly.
2.25 DNA sequencing
The nucleotide sequence of cDNAs in plasmid vectors were analysed by a 
modification of the di-deoxy chain termination method (Sangar et al. 1983) using a 
commercially available kit (United States Biochemical) from which all reagents were 
obtained unless otherwise stated. Plasmid DNA (10 ng/ml) was denatured in the presence 
of 0.2 N NaOH for 15 min at 37°C in a total volume of 10 pi. A 17 base pair (bp) 
oligonucleotide sequencing primer, (10 pg), in a volume of 1 pi, is mixed with the
denatured DNA and allowed to anneal for 5 min at room temperature. The DNA-primer 
complexes were then precipitated by the addition of 3 pi of 3M KOAc pH 4.8 and 75 pi 
of 100% ethanol and incubated at -70°C for 20 min, followed by centrifugation at 
15,000xg for 15 min at room temperature. The ethanol was aspirated and the pellet 
washed once in 100 pi of 75% ethanol followed by centrifugation at 15,000xg for 5 min 
at room temperature. Following aspiration of the ethanol, the pellet was air-dried at room
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temperature for 10 min and resuspended in 8 pi of distilled water. To this was added 2 pi 
of 5x concentrated reaction buffer (0.2 M Tris Cl, pH 7.5, 0.1 M MgCl2 and 0.25 M 
NaCl), 1 pi of 0.1 M DTT, 2 pi of labelling mix (7.5 pM dCTP, 7.5 pM dGTP and 7.5 
pM dTTP) 2 pi of 'Sequenase' recombinant phage T7 DNA polymerase (13 units/pl) 
(prediluted 1 in 8 in 10 mM Tris HCl, pH7.5,5 mM DTT and 0.5 mg/ml BSA), 0.5 pi (5 
pCi) of [a-3%] dATP (specific activity; 1000 Ci /mmol, Amersham). The reaction was 
allowed to proceed at room temperature for 5 min and aliquoted into 4 Eppendorf tubes 
(3.3 pl/tube). To each tube was added 2.5 pi of one of the following termination mixes: 
1) ddA: 80 pM dATP, dCTP, dGTP, 8 pM dideoxy ATP (ddATP). 2); ddC: similar as 
above but ddCTP was used instead of ddATP; 3). ddG: the same too, except that ddGTP 
was used to replace ddATP; 4) ddT: again here ddTTP was used replacing ddATP. Each 
tube was indicated at 37°C for 5 min prior to the addition of 4 pi of stop solution (95% 
formamide 20 mM EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol). All tubes 
were heated at 80“C for 5 min and stored on ice before electrophoresis.
Electrophoresis was performed through 6% PAGE gels containing 8 M urea 
(Gibco BRL) in Ix TBE buffer. Samples were run at a constant power of 50 W at room 
temperature until the bromophenol blue marker reached the bottom of the gel. In some 
experiments, the xylene cyanol marker was run to the end of the gel to allow reading of 
the sequence further from the primer binding site. At the end of electrophoresis, gels were 
fixed for 30 min, transferred to 3 MM filter paper and dried under vacuum at 80“C for 1-2 
h. Dried gels were exposed to X-omat AR autoradiography film (Kodak) for at least 18 h 
at room temperature in cassettes (Kodak).
2.26 Double stranded DNA probe labelling for Northern blotting
Double stranded DNAs were labelled with [a-^^P]-dATP using a commercially 
available random priming kit (Gibco BRL), DNA was heated to 96°C for 10 min in a 1.5 
ml Eppendorf and then mixed with 2 pi each of 0.5 mM dCTP, 0.5 mM dGTP and 0.5 
mM dTTP, 15 pi of concentrated random primer reaction buffer, 5 pi (50 mCi) of [a- 
^^P]-dATP (Amersham), 1 pi Klenow DNA polymerase (Exonuclase-free, 2 units/pl)
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and distilled H2O was added to 50 pi. The reaction was allowed to proceed for at least 30 
min at 37°C and stopped by the addition of 50 pi of TE buffer (10 mM Tris HCl, pH7.5, 
ImM EDTA).
A Nick Column (Pharmacia) was pre-equilibrated with 2 ml of TE buffer and 100 
pi reaction mixture loaded onto the top of the gel bed and allowed to enter to the gel 
completely. After 400 pi of TE buffer was supplied to the column, DNA probe was eluted 
with another 500 pi of TE buffer and collected in a 1.5 ml screw cap tube. Un­
incorporated [a-^^P]-dATP was retained in the column and was discarded. The labelled 
cDNA was then denatured by heating for 10 minutes at 96°C and chilled on ice prior to 
addition into the pre-hybridisation solution. The sequence and location of cDNA probes 
used in the study is shown in Fig. 2.1.
2,27 Northern blotting
Total cellular RNA , isolated from cultured cells as described earlier was analysed 
by Northern hybridisation according to a modification of previously published method 
(Seed et al 1982). Total RNA (10 pg) in 3 pi of DEPC-treated water were denatured in 7 
pi of sample buffer (71% v/v formamide, 7% v/v 20x MOPS buffer (400 mM MOPS, pH 
7.0, 122 mM NaAc, 20 mM EDTA) and 22% v/v 37% formaldehyde) (Sigma) for 2 min 
at 68“C. Samples were chilled on ice and mixed with 16% v/v nucleic acid gel loading 
buffer.
Electrophoresis was carried out through 1.5% agarose gels containing 5% v/v 20x 
MOPS buffer, and 7.5% v/v 37% formaldehyde. Briefly, 3 g of agarose was melted in 
175 ml DEPC-treated water and was cooled to 60°C before adding 10 ml of 20x MOPS 
buffer, 151 of 30% formaldehyde, mixed and poured into the gel tray. After samples and 
RNA markers (Promega) were loaded side by side, gels were run in Ix MOPS buffer at a 
constant voltage of 100 V for 3-5 h.
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a. mouse IRF-1
4 1 I I I I I ! I I I I I I I I I ! L •2072
750bp
GACTTCAGCTGCAAAGAGGAACCAGA (1019) CCCCACAGCTGGAGCAGGTAGTGAGG (1766) 750bp
b. mouse IRF-2
, 1 i 1 1 1 1 1 1 1 1 1 1 1 1 : 1 1 1 1 ) 11 2435
511bp
GTGTCrrCCrACGCAGAAAGCGAAACTACC (832) 
ATCAATAATCrATCGTCAAGGCTTTCrCCC (1340) 511bp
c. mouse iNOS cDNA
J774 iNOS cDNA
500
I
1000 j __ 1500I 2000I 2500I 3000I 3500I 4000I
EcoRl 937
5* cDNA probe
Fig.2.1. The cDNA probes for Norhtern blot analysis, a. Cloned IRF-1 
PCR probe, b. Cloned IRF-2 PCR probe, c. 5’-iNOS cDNA probe was cut 
off from the full length murine iNOS cDNA clone (Wei, et al. 1995).
I
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Following electrophoresis, agarose-formaldehyde gels were rinsed twice in 
distilled water after electrophoresis. The RNA was then transferred onto a nylon 
membrane (Pharmacia) by capillary blotting as described previously (Southern, 1975). 
Capillary transfer was allowed to proceed overnight at room temperature. At the end of 
the blot, membrane was rinsed in 2xSSC (0.3 M NaCl, 42 mM Sodium citrate. PH 7.2), 
air dried and oven baked at 120°C for 20 min or UV-linked.
The nylon membrane was incubated in pre-hybridisation buffer containing 7% 
SDS, 40 mM NaH2P04, 1 mM EDTA and 100 mg/ml ssDNA for 3 hat 65°C. At the end 
of pre-hybridisation , a specific [a-^^P] dATP labelled cDNA probe, prepared as 
described previously, was added directly to the incubating solution and incubated for a 
further 18 h in a hybridisation oven. (Scot-lab). The filter was then washed sequentially 
twice in 2xSSC and 0.1% SDS for 30 min, twice in 0.2x SSC and 0.1% SDS for 60 min 
at 65°C. The membrane was dried between 2 sheets of 3 mm Whatman filter paper for 10 
min at room temperature and exposed to X-ray film for the period of 1-3 days depending 
on the signal.
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Chapter 3
The induction of inducible NO synthase by IFN-y and LPS in
macrophages
91
3.1 Introduction
Inducible NOS is expressed in many cell types after challenge with immunologic 
or inflammatory stimuli and thereupon generates large amounts of NO over periods up to 
several days (Vodovotz,Y. 1994). The list of agents known to induce iNOS expression is 
extensive. IFN-y and LPS are the only stimuli, and macrophages of the mouse are the 
only cells for which transcriptional induction of iNOS has been formally documented 
(Cho 1992).
Although the regulation of iNOS in macrophages and their cell lines has been 
studied in some detail, the intracellular signal transduction pathways involved in the 
induction of iNOS are still unclear. As a first approach to the better understanding of the 
intracellular signalling pathways involved, the kinetics of iNOS induced by IFN-y or /and 
LPS in a murine macrophage cell line, J774, were examined in this chapter.
3.2 NO production is induced by IFN-y and LPS in J774 cells
Firstly, the time course of iNOS induction was examined: J774 cells were 
incubated with IFN-y and LPS for 2 to 48 h and iNOS enzyme activity analysed (using a 
dual-wavelength method in the presence of oxyhaemoglobin, L-arginine and NADPH). 
NOS activity was detectable within 4 h following treatment with IFN-y and LPS, rose 
dramatically between 6 to 8 h, and reached peak activity at 10 h to the level of about 300 
pmoles NO formed /min /mg protein. NOS enzyme activity reached a plateau between 10 
to 18 h after stimulation, and declined thereafter, such that NO was undetectable at 48 h in 
most of experiments (Fig. 3.1).
culture supernatants from 8 h after stimulation (Fig. 3.2).
S
A':!'As a result of iNOS activation, nitrite (N02") significantly accumulated in the
"I
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Fig. 3.1 IFN-y LPS iNOS activity in J774 ceils. J774 cells were 
stimulated with IFN-y (lOOU/ml) plus LPS (lOng/ml) for the indicated period. 
Cells were lysed and NOS activity was measured using a dualwavelenth method 
in Chapter 2 (section 2.5). Data are presented as means of triplicates (±SD). Results 
are representative of three experiments.
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Fig. 3.2 N02" in culture supernatants. J774 cells were cultured in DMEM 
complete medium overnight, and IFN-y (lOOU/ml) and LPS (lOng/ml) were added. 
The culture supernatants were collected at indicated time points. N 02“ was 
measured by Griess reaction.
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3.3 Induction of iNOS activity is protein synthesis dependent
The previous enzyme assays showed that NOS activation in J774 cells occurred 3 
to 4 h after stimulation, indicating that a protein synthesis-dependent mechanism may be 
involved. Cycloheximide, a protein synthesis inhibitor, was used to show that protein 
synthesis is important for NO production. IFN^ and LPS-induced NO was completely 
blocked by pre-incubating cells with cycloheximide for 4 h. If cycloheximide was washed 
away at the end of the 4 h incubation period and the cells incubated in fresh medium, the 
ability to produce NO was recovered (Fig. 3.3), to a lower level that than in fresh cells 
(This may be due to the presence of trace amounts cycloheximide in the cells).
To confirm that the expression of iNOS in macrophages is inducible by IFN-y and 
LPS, iNOS expression in cultures of J774 cells was examined. Northern blots containing 
total RNA from IFN-y and LPS-treated cells were hybridised with ^^P labelled probe 
corresponding to the unique segment of murine iNOS cDNA. As shown in Fig. 3.4, 
mRNA encoded by the iNOS gene was induced following treatment of cells with IFN-y 
and LPS. iNOS mRNA was not detected in cells incubated with medium alone, but was 
detectable from 2 h after stimulation, reached a peak level at 4 h, and then declined by 6 h.
In order to determine whether the induction of iNOS mRNA reflects changes in 
the level of the corresponding proteins. Western blots were prepared using extracts from 
normal or primed J774 cells, and identified using a monoclonal anti-murine macrophage 
iNOS antibody. iNOS proteins were present in populations of cells stimulated with IFN-y 
and LPS but not untreated cells. Paralleling enzyme activity, iNOS protein was detectable 
from 4 h after treatment and peaked at 8 h, returning to basal level by 24 h (Fig. 3.5).
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Fig.3.3 iNOS activity is protein synthesis-dependent. J774 cells were 
cultured at 10^ cells/well in 96-well plate in the presence (column 1 and 2) or 
absence (column 3 and 4) of cycloheximide (30 pg/ml) for 4 h, then either washed 
(column 4) or unwashed (column 3) with warmed fresh medium followed by 
addition of IFN-y (100 U/ml) and LPS (10 ng/ml) (column 2,3, and 4) or medium 
alone (column 1). NO2" accumulated in culture supernatants was measured at 16 h 
by Griess Reaction. For column 1 and 3, NO2" levels were zero. Data are shown as 
the means of triplicates (±SD). Results are representative of two individual 
experiments.
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Fig. 3.4 Time course of the induction of iNOS mRNA in J774 cells.
J774 cells were treated with IFN-y and LPS for indicated times, and total RNA 
prepared as described in section 2.20. Northern blot analyses were conducted using 10 
pg of RNA per sample and probed with ^^p.i^belcd iNOS cDNA. Results are 
representative of two individual experiments (This photo was cut from the same film of 
that in chapter 6 Fig. 6.5).
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Fig. 3.5 Time course of induction of iNOS in J774 ceils stimulated with 
IFN-y and LPS. J774 cells were stimulated with IFN-y (100 U/ml) and LPS (10 
ng/ml) for indicated times (h) and cellular proteins extracted and 20 pg of each sample 
was resolved on a 7.5 % SDS PAGE gel, followed by immunoblotting. INOS was 
detected by a monoclonal antibody against macrophage NOS. ECL reagents were used 
for visualising protein bands. The molecular weight of iNOS protein is ~130kDa.
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3.4 LPS synergizes with IFN-y to induce NO synthase
To determine the relative contribution of IFN-y and LPS to the induction of NOS 
activity, J774 cells were treated with IFN-y and LPS separately at various concentrations. 
IFN-7 was used at a range of 1 to 100 U/ral. Cells were cultured at a density of 10^ cells 
/ml, 200pl/well, and stimulated with IFN-y for 24 h. IFN^ has the ability to induce NO 
in J774 cells (4 pM) at concentrations as low as 1 U/ml, and NO production reaches a 
maximum level of about 10 pM from 10 U/ml concentrations of IFN-y or upwards. When 
LPS (10 ng/ml) was added to the system, there was a strong synergistic effect for NO 
production, with the maximum level 25 pM) achieved at 1 U/ml of IFN-y (Fig. 3.6).
The ability of LPS alone to induce NO synthase in J774 cells was also 
investigated. Culture supernatants from J774 cells, treated with a range of LPS 
concentrations, was collected. LPS was capable of inducing NO (15 pM) in J774 cells at 
a concentration 1 ng/ml (15 pM). Maximum levels of NO (25 pM) being stimulated with 
40 ng/ml of LPS. NO levels were significantly elevated by the presence of IFN-y (10 
U/ml), under these conditions NO2 " was detectable in cultures with only 0. Ing/ml of LPS 
(22 pM) and the maximum level of NO production was increased to 40 pM (Fig. 3.7).
3.5 Discussion
Macrophages have many functions in the body. They scavenge dead and dying 
cells, form part of innate host resistance to infection by engulfing and killing pathgens. 
They can present antigens to T cells, and serve as effector cells in cell-mediated immune 
reactions, especially those directed at intracellular pathogens such as Mycobacteria and 
Leishmania. Macrophages exerts their functions, in large part,by a pathway dependent on 
production of nitric oxide (NO) (Nathan 1992). NO is an effector molecule used by 
macrophages for host protection against pathogens. Since the activation of NO is 
essentially not target specific, it is important that the synthesis of NO be tightly regulated.
99
30-
IFN- Y alone 
IFN-y+LPS
2 0 -
10 30 50 70 90 n o
IFN- Y (U/ml)
Fig. 3.6 IFN-y-induced NO synthesis is dose-dependent. J774 cells were 
cultured in a 96-well plate and stimulated with IFN^ at the indicated concentrations 
with or without LPS (10 ng/ml). Culture supernatants were collected at 24 h and 
assayed for NQz" using the Griess method. Data are presented as means of triplicate 
cultures (±SD).
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Fig. 3.7. LPS-induced NO synthesis is dose-dependent. J774 cells were 
cultured in 96-well plates and stimulated with indicated concentrations of LPS, with or 
without IFN-y (10 U/ml). At the end of 24h incubation, culture supernatants were 
assayed for N02" using the Griess reaction. Data shown are the means of triplicates 
(±SD).
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IFN-y is a lymphokine produced by activated T cells, and it exhibits a wide variety 
of biological effects. LPS is a potent macrophage activator (Adams and Hamilton 1984;
Hauschilft et al,, 1990). In the experiments presented here, J774 cells produce large 
amount of NO in response to IFN-y and LPS in a dose-dependent manner which is 
similar to that previously observed with peritoneal macrophages. When peritoneal 
macrophages were activated by IFN-y alone, they made a small amount of N 02' in 24h 
(Vodovotz et a i, 1994), and NÜ2" production largely plateaus within 1 to 3 days in vitro.
However, peritoneal macrophages stimulated by the combination of IFN-y plus LPS, 
produced significantly high amounts of NO, which ceased after 24 h in the cultures 
(Vodovotz et al, 1994). In J774 cells, the NO response is relatively fast, the maximum 
activity of NOS being reached between 8 to 18 h after stimulation. The inducible NOS is 
regulated transcriptionally in a manner that requires protein synthesis. These results reflect 
the natural response which proceeds in primary cultured murine macrophages except that 
the time-course in J774 cells is faster (Bogdan et al, 1994). For example, upon 
stimulation, either IFN-y or LPS alone is sufficient for both peritoneal macrophages and 
J774 cells to produce NO. Moreover, NO production is synergistically enhanced by the 
combination of these two stimuli. However, in some cases, J774 cells produces more NO 
then peritoneal macrophages in responses to IFN-y or LPS alone. This may due to the fact 
that J774 cell, as a cell line, is in a primed state, while primary cultured cells are akin to 
resting cells.
The results presented in this chapter confirm and extend previous reports that 
murine macrophages are capable of producing NO in response to IFN-y and LPS, and 
this induction is affected by IL-4 (Bogdan et al, 1994): IFN-y and LPS are potent 
inducers of iNOS, and LPS and IFN-y act synergistically in this system. This data also 
established the suitability of J774 cells as a model system for investgation of signal 
regulation of inducible NOS. This well-established homogeneous cell line provides a 
convenient way to investigate the molecular mechanisms involved the signalling pathways m.
i
g
of iNOS induction. J774 cells were therefore used for the studies of iNOS signal 
transduction presented in subsequent chapters.
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Chapter 4
The role of JAK l, JAK2 and ST ATI in the induction of NO
synthase by IFN-y
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4.1 Introduction
I
Cytokines are secreted proteins that regulate many aspects of cellular growth.
differentiation, activation, and effector function, and play an important role in immune 
and inflammatory responses. The induction of iNOS is a result of macrophage activation 
by IFN-y and/or LPS. Previous studies have shown that tyrosine phosphorylation is |
involved in the macrophage respiratory burst induced by LPS (Boulet, et al, 1992), and 
the tyrosine phosphatase/kinase signaling cascade is involved in the IFN-y pathway
(Igarashi et aL, 1993). Furthermore, the expression of iNOS mRNA is blocked by
; ' . g
genistein, a tyrosine kinase inhibitor. In recent years, through the study of transcriptional 
activation in response to interferons, a previously unrecognized direct signal transduction 
pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface 
leads to the activation of kinases of the JAK family that then phosphorylate substrate 
proteins, STATs, In this chapter, the involvement of tyrosine kinases in the regulation of «
iNOS induction was investigated.
J:s4.2 The induction of iNOS was inhibited by tyrosine kinase inhibitors
2To determine whether tyrosine kinase activation is required for the induction of 
iNOS by IFN-y and LPS, a number of tyrosine kinase inhibitors were used. As assayed 
by NOS activity, following treatment of IFN-y (100 U/ml) and LPS (10 ng/ml), NO 
produced in cell lysates was ^120 pmoles /min /mg protein at 16 h after stimulation.
When the cells were pre-treated with Tyrphostin 25, one of the tyrosine kinase inhibitors, 
iNOS activity induced by IFN-y and LPS was partially blocked. At the concentration of 
15 pM, Tyrphostin 25 reduced iNOS activity by 50% compared with cells treated with 
IFN-y and LPS alone. Tyrphostin 1, an inert analogue of tyrosine kinase inhibitor, had no "I
effect when used at the same or even higher concentrations (Fig. 4.1). Similar results 
were obtained from experiments with Herbimycin A, another tyrosine kinase inhibitor
I(Fig. 4.2).
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Fig. 4.1 Effect of Tyrphostin 1 and Tyrphostin 25 on iNOS acivity.
J774 ceils were cultured in 25 cm^ flasks. Tyrophostins were added 4 h prior to 
IFN-y (100 U/ml) and LPS (lOng/ml) stimulation. Cells were harvested at 16 h 
after stimulation, total cellular proteins were extracted, and iNOS activity measured 
using a dual-wavelenth method. Tyrphostin 1 is an inactivated protein tyrosine 
kinase inhibitor which was used as a negative control. Data are presented as means 
of triplicates (±SD). The results are representative of two experiments.
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Fig. 4.2 Effect of Herbimycin A on iNOS activation. J774 cells were 
cultured in 25 cm  ^flasks. Herbimycin A was added 4 h prior to IFN-y ( 100 U/ml) 
and LPS (10 ng/ml) stimulation. Cells were harvested at 16 h after stimulation. 
Total proteins were extracted, and iNOS activity measured using a dual-wavelenth 
method. Data are presented as means of triplicates (±SD) and results are 
representative of two experiments.
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To address if induction of transcription of iNOS activity is interfered by protein 
tyrosine kinase inhibitors, iNOS expression was examined by Western blot using a 
monoclonal anti-murine macrophage iNOS antibody. As shown in Fig. 4.3, iNOS protein 
was undetectable in untreated cells while it was strongly expressed in IFN-y and LPS- 
stimulated cells. When pre-treated with Tyrphostin 25 or Tyrphostin AG126 for 4 h, the 
iNOS protein produced in J774 cells was markedly reduced (Fig. 4.3). The reduction of 
iNOS expression correlated with the reduced generation of N02’ in the culture 
supernatants as measured by the Griess reactions (Fig. 4.4)
4.3 iNOS activity is upregulated by a tyrosine phosphatase inhibitor
Protein phosphorylation is reversibly controlled not only by protein kinases (PKs) 
but also by protein phosphatases (PPs). The extent of phosphorylation at a particular site 
can be regulated by changing the activity of the cognate PK or PP or both. The steady- 
state level of phosphotyrosine on cellular proteins is the result of opposing activities of 
protein tyrosine kinases and protein tyrosine phosphatases.
Vanadate has been shown in numerous studies to exert inhibitory actions on 
cellular protein tyrosine phosphatases (PTPases). The effect of vanadate on iNOS 
induction was examined by measuring iNOS activity. Vanadate was used in combination 
with IFN-y and LPS. Upon the stimulation of IFN-y and LPS, iNOS activity was 
markedly higher in vanadate-treated cells compared to untreated cells by 40% at a 
concentration of 20 pM vanadate (Fig. 4.5). This result indicates that one or more 
tyrosine phosphatase(s), acting as a negative regulating factor, is involved in iNOS 
induction or iNOS activation.
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FI g. 4.3 Inhibition of iNOS expression by protein tyrosine kinase 
inhibitors (Tyrphostin 25 and AG 126). J774 cells were cultured in 25 cm^ 
flasks and incubated with tyrphostin 25 (20 pM) or AG 126 (40 pM) for 4 h before 
stimulation with IFN-y (100 U/ml) and LPS (10 ng/ml). Non-adherent cells were 
removed before cells were lysed 16 h after stimulation. Total proteins (20 pg each) 
were resolved by 7.5% SDS PAGE, followed by immunoblotting using an antibody 
against murine macrophage iNOS and visualised by ECL reagents.
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Fig.4.4 Effect of protein tyrosine kinase inhibitors on NO 
production. J774 cells were cultured in a 96-well plate and incubated with 
Tyrphostin 25 (20 pM) or Tyrphostin AG126 (40 pM) for 4 h before stimulation 
with IFN-y (100 U/ml) and LPS (10 ng/ml). Culture supernatants were collected 24 
h later, and assayed for N02“ using the Griess reaction. Data shown are means of 
triplicates (±SD). The results are representative of two experiments.
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Fig. 4.5 Effect of a protein tyrosine phosphatase inhibitor, vanadate, 
on iNOS activity. J774 ceils were cultured in 25cm^ flasks. Sodium vanadate 
was added simultaneously with IFN-y (100 U/ml) and LPS (10 ng/ml) stimulation. 
Cells were harvested at 16 h after stimulation, total proteins extracted, and iNOS 
enzyme activity measured using a dual-wavelenth method. Data are presented as 
means of triplicates (±SD).
I l l
'-(g
4.4 JAKl is activated in response to IFN-y
To determine whether a PTK pathway could be activated by IFN-y, cell lysates 
from IFN-y and/or LPS-stimulated J774 cells were prepared and analysed by 
immunoblotting with the antibodies against protein tyrosine kinases, the JAK kinases.
Whole cell lysates were immunoprecipitated by an anti-JAKl antibody followed 
by immunoblotting using an anti-phosphotyrosine mAb. JAKl was tyrosine 
phosphorylated and hence presumably activated, in response to IFN-y and LPS. The 
appearance of tyrosine-phosphorylated JAKl in J774 cells over a time course stimulation 
is shown in Fig. 4.6. JAKl phosphorylation was absent in the lysates of the untreated 
cells, while its phosphorylation was detected within 30 seconds of treatment with IFN-y. 
The response was immediate and transient with a peak at 1 h. Re-blotting, using anti- 
JAKl, indicated that the amount of JAKl protein expression did not change within this 2 
h activation period. Further experiments indicated that JAKl phosphorylation was 
induced by IFN-y but not LPS. LPS had no effect on JAKl tyrosine phosphorylation 
induced by IFN-y (data not shown).
4.5 JAK2 is also activated in response to IFN-y
Typically, cell stimulation by a particular cytokine results in the activation of two 
of the four known JAK kinases. Similarly to JAKl, JAK2 kinase was tested for its 
activation in response to IFN-y and LPS as detected by tyrosine phosphorylation. Again, 
JAK2 was tyrosine phosphorylated upon stimulation with IFN-y (Fig. 4.7) with an 
identical response to that of JAKl in terms of the time course of activation in J774 cells: 
JAK2 tyrosine phosphorylation was detectable within 30 seconds of IFN-y-treatment and 
the maximum tyrosine phosphorylation was at Ih and declined thereafter. LPS, again had 
no effect on JAK2 activation, neither by itself nor by the combination with IFN-y within 
the period of 2 h (data not shown).
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Fig. 4.6 Tyrosine phosphorylation of JAKl in response to IFN-y and 
LPS. IFN-y and LPS-induced tyrosine phosphorylation of JAK 1 was assayed in 
whole ceil extracts of J774 cells. IFN-y ( 100 U/ml) and LPS ( 10 ng/ml) were added for 
30 seconds to 2 h. Extracts were immunoprecipitated with polyclonal antisera to JAKl 
and probed after SDS-PAGE (7.5%) analysis with (a) anti-phosphotyrosine (RC20) 
and, (b) after stripping, with antibody to JAKl. Data are representative of three similar 
experiments.
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Fig. 4.7 Time course of JAK2 tyrosine phosphorylation is similar to 
that of JAKl. J774 cells were cultured in 80 cm^ flasks and stimulated with IFN-y 
(100 U/ml) and LPS (10 ng/ml) for 30 seconds to 2 h. JAK2 was immunoprecipitated 
from each of the indicated samples and probed, after SDS-PAGE (7.5%), with (a) an 
anti-phosphotyrosine antibody (RC20), and (b) after stripping, with antibody to JAK2. 
Data are representative of three experiments.
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Tyrphostin AG490 has recently been shown to be a JAK2-selective inhibitor 
(Meydan et al, 1996). AG490 was therefore used to determine whether JAKl or JAK2 
activation is associated with iNOS induction. J774 cells were pre-treated with AG490 for 
4 h before being incubated with IFN-y and/or LPS for 24 h. N02" accumulated in the 
culture supernatants was measured and the results show in Fig. 4.8. IFN-y (100 U/ml) 
induced significant levels of NO (8 pM in 24 h). This was completely abolished by the 
pre-treatment with AG490 at concentration of 10 pM. NO synthesis induced by LPS as 
well as by IFN-y plus LPS was also inhibited by pre-treatment of AG490 but this 
required higher concentrations of AG490. This probably simply reflects a quantitative 
difference, because significantly higher concentrations of NO were induced by the 
costimulation. These results demonstrated that JAK2 is involved in the induction of iNOS 
and that it is particularly important for NO induced by IFN-y alone.
4.6 ST ATI (p91/84) is phosphorylated in response to IFN-y
JAK kinase activation is likely to occur via transphosphorylation by receptor- 
associated kinases brought into close proximity by binding of ligand. After activation, 
receptor-associated PTKs can phosphorylate several substrates critical for signal 
transduction. One important component of cytokine signalling is the specific 
transcriptional activation of target genes, which is rapid and does not require the synthesis 
of new proteins. This led to the identification and characterisation of the JAK-signal 
transducer and activator of transcription (STAT) signalling pathways.
To determine which STAT protein is activated following the activation of JAKl 
and JAK2 in J774 cells, immunoblotting was carried out in total cell lysates using an anti- 
phosphotyrosine antibody (RC20). As shown in Fig 4.9, stimulation of J774 cells by 
IFN-y induced an increase in the tyrosine phosphorylation of a wide range of proteins 
including those in the 90-95 kDa molecular mass region. The enhanced tyrosine 
phosphorylation was observed as early as 1 min after IFN-y stimulation. The
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phosphorylation band became stronger within 2 h in a time dependent manner. A possible 
candidate for the 90-95 kDa protein is p91-STATl.
Signal transducers and activators of transcription (STATs) were first identified as 
a unique family of DNA-binding proteins approximately five years ago. STATI (p91) is 
the one of first two identified STATs protein. It has been shown that STAT I and STAT2, 
in response to IFNa/IFN-p, is rapidly tyrosine phosphorylated and forms a DNA 
complex with a DNA-binding protein p48, which binds an IFN-stimulated response 
element (ISRE). To confirm that P91 is phosphorylated in response to IFN-y or LPS, a 
polyclonal anti-P91/84 antibody was used for immunoblotting in total cell lysates, p91 
appeared as a single band in untreated cells which was converted to two bands after the 
stimulation with IFN-y. The inducible slower migrating band is characteristic of 
phosphorylated p91. In J774 cells, there exists a naturally occurring splice variant, 
STATip-p84. p84 lacks the carboxyl 38 amino acids of ST ATI. Similarly, p84 was 
phosphorylated in response to IFN-y. LPS had no activation nor synergistic effect on P91 
phosphorylation (Fig. 4.10).
4.7 MAP kinase is tyrosine phosphorylated in response to LPS
Although I have detected no effect of LPS on JAK1/JAK2 activation, tyrosine 
kinases also play a role in LPS signalling: experiments using an anti-phosphotyrosine 
antibody (RC-20) showed that treatment of IFN-y and LPS, lead to an increase in tyrosine 
phosphorylation of a number of protein bands (Fig. 4.9 and Fig. 4.11). If the cells were 
pre-treated with Tyrphostin 25 (20 pM) for 4 h, phosphorylation of the bands was 
reduced. A major group of bands were in the range 80-95 kDa and could be related to 
P91/84 (Fig. 4.9 and Fig. 4.10). A second group of proteins of molecular weight 40-45 
kDa were tyrosine phosphorylated and it was postulated that these could be MAPK (Fig. 
4. 11).
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Fig.4.8 The involvement of JAK2 in the induction of iNOS. Tyrphostin 
AG490, a specific inhibitor to JAK2 was added 4 h before the addition of IFN-y 
(100 U/ml) and LPS (10 ng/ml). NO2" in the culture supernatants was collected at 
16 h and measured using the Griess Reaction. Data are shown as the mean values 
(±SD) obtained from triplicated samples.
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Fig. 4.9 Tyrosine phosphorylation pattern induced by IFN-y plus LPS in 
J774 cells. Cells were cultured in 25cm^ flasks and incubated with IFN-y (100 
U/ml) and LPS (10 ng/ml) for 1 to 120 min. Total lysates (30 pg) were loaded onto a 
7.5 % SDS PAGE gel and followed by immunoblotting, using anti-phosphotyrosine 
antibody (RC20). The lower molecular-weight (less than 45 kDa) proteins could not be 
seen clearly.
118
IFN-y
LPS 
97 kDa- 
69 kDa-
+ +
1 2  3 4
Fig. 4.10 ST ATI is phosphorylated in response to IFN-y but not to 
LPS. J774cells were cultured in 25cm^ flasks and incubated with IFN-y (100 U/ml) 
and/or LPS (10 ng/ml) for 30 min. Total proteins were extracted and 20 pg of each 
were resolved on 7.5% SDS PAGE gel, and transferred to nitrocellulose membrane 
followed by probing with a polyclonal anti-STATl antibcxly. The antibody recognised 
both P91 and P84 since they are two similar products from the same gene. The bands 
(from top to bottom) are phosphorylated P91, P91, phosphory lated P84, and P84.
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Fig. 4.11 IFN Y and LPS-induced tyrosine phosphorylation was 
decreased by pre-treatment with Tyrphostin 25. J774 cells were pre-incubated 
with Tyrphostin 25 (20 pM) or medium alone for 4 h phcf to addition of IFN-y (100 
U/ml) and LPS (10 ng/ml) for the indicated periods. Total lysates (20 pg each) were 
subjected to a 5-10% gradient SDS PAGE gel followed by Western blotting, and 
probed with RC20 (anti-phosphotyrosine antibody).
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Although there were some indications in either Fig. 4.9 and Fig. 4.11 that a 40-45 
kDa protein was tyrosine phosphorylated after treatment with IFN-y and LPS, the bands 
were not clear in either of these figures. It probably due to the low gel concentrations. To 
emphasis the lower molecular proteins, a 10% SDS PAGE gel was used and western 
blotting was carried out using an antibody (PY54) recognising proteins that 
phosphorylated on tyrosine residues. Basically, PY54 and RC-20 recognise the same 
protein, but RC20 was conjugated with horseradish peroxidase whereas PY54 was not. 
As shown in Fig. 4.12a , although the phosphorylated 40-45 kDa band was induced by 
LPS but not by IFN-y, IFN-y enhanced such protein phosphorylation induced by LPS 
under these condition. Re-blotting was carried out to determine whether these proteins 
were MAP kinase, using a monoclonal anti-MAP kinase (ERK2) antibody. The result 
was shown in Fig. 4.12b. The band detected by MAP kinase antibody was located at 
exactly the same molecular weight with the phosphorylated band in Fig 4.12a.
So far, the data suggested that MAP kinase (ERK2) is tyrosine phosphorylated in 
response to LPS treatment. Although MAP kinase tyrosine phosphorylation in LPS 
treated J774 cells clearly occurred, the characteristic shifting of the band to a higher 
molecular weight (mobility shift) was not observed (data not shown). Since 1 did not test 
whether MAPK was threonine phosphorylated in this system, it is not clear that whether 
the mobility shift reflect threonine phosphorylation of the protein. However, there are 
some evidence indicate the possible role of MAP kinase in NO induction in J774 cells. 
Tyrphostin AG 126 is a tyrosine kinase inhibitor which inhibits MAP kinase activity and 
iNOS induction. In these experiments, AG126 inhibits both iNOS protein expression (see 
Fig. 4.2) and NQ2" accumulation (Fig. 4.13). After pre-incubation with Tyrphostin 
AG126 for 4 h at the concentration of 1-100 pM, N02" produced by J774 cells was 
reduced markedly in a dose-dependent manner (Fig. 4.13).
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Fig. 4.12 Tyrosine phosphorylation induced by LPS. J774 cells were 
incubated with LPS ( 10 ng/ml) and/or IFN-y ( 100 U/ml) for 30 min. before lysis. Total 
Itsates (20 pg each) were resolved by 10% SDS PAGE gel and subjected to Western 
blotting using anti-phosphotyrosine (PY54) (a). Following stripping, the blot was re­
probed with anti-MAP kinase (erk2) antibody (b). Arrows indicate the same position of 
the blot.
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Fig. 4.13. Effect of tyrphostin AG126 on N 0 2 “ production.
Tyrphostin AG 126 was added 3 h before the addition of IFN-y (100 U/ml) and 
LPS (10 ng/ml). The culture supernatants were collected at 24 h and N 02 ' 
measured using the Griess Reaction. Data are shown as the mean values (±SD) 
obtained from triplicated samples. The results are representative of two 
experiments.
I
I
9i;=I!
I
.9
123
4.8 Discussion
Selective inhibitors are often used to detect the possible involvement of signalling 
elements such as protein kinases in biological responses. When Tyrphostins, protein 
tyrosine kinase inhibitors, were introduced to J774 cells, the NOS activity was markedly 
inhibited and N 02” accumulation in the culture supernatants was reduced. NO2 " 
measurements also indicated that tyrosine phosphorylation is required for IFN-y and LPS- 
induced NO synthesis.
JAKl or JAK2 have been shown to transduce IFN-y signalling. JAKl or JAK2 
mutant cell lines have proved that these kinases have the ability to either auto- or cross- 
phosphorylate each other and any defect in either of these kinases will influence the other 
(Mathias et al, 1993). Although it is difficult to place JAKl or JAK2 upstream or 
downstream of each other as yet, a numbers of studies consistent with the requirement for 
the presence of both JAK family proteins (JAKl and JAK2) for correct IFN-y receptor 
assembly. Both JAKl and JAK2 are approximately 130 kDa in molecular weight and they 
are tyrosine phosphorylated in response to IFN-y in J774 cells. To identify the tyrosine 
kinases that might be involved in the iNOS signalling pathway, Tyrphostin AG490, a 
specific JAK2 inhibitor was used to probe for JAK2 involvement. N02“ assay result 
shows that NO-produced in the cells treated with IFN-y and LPS was abolished by the 
pre-treatment of AG490. When used alone, IFN-y and LPS showed a similar ability to 
stimulate J774 cells to produce NO: however, although AG490 showed a strong 
inhibition on IFN-y-induced NO, LPS-induced NO was less affected. This suggested 
that JAK2 activation in response to IFN-y play a crucial role in induction of NO synthesis 
by IFN-y alone. For the effect of AG490 on LPS-induced NO, there are two 
explanations. It may due to non-specific inhibition of other kinases, since it was only 
effective when higher concentrations were used. The other possibility is that there may be 
some LPS-regulating gene products were involved in LPS-induced NO synthesis which 
transduce signals through JAK2 activation. Anyway, The results presented here
124
demonstrated that the induction of NO synthase in J774 cells by IFN-y involved the 
phosphorylation of JAK1/JAK2.
Since there is a rapid explosion of knowledge about JAK-STAT pathway in 
recently years, ST AT proteins are getting extensive attentions for its activation and 
transcriptional functions in cytokine receptor signallings. ST ATI proteins, in particular, 
have been shown to be phosphorylated on tyrosine in response to IFN-y (Shuai et al,
1992) in fibroblasts. STATI exists two isoforms in the cells: p91 and p84. P91 and P84 
were originally found as components of interferon-stimulated gene factor 3 (ISGF3), a 
transcription complex activated by IFN-a/p (Fu, et a l, 1992; Gutch et a l, 1992; 
Schindler et al, 1992). The P91 and P84 components of ISGF3 result from alternative 
splicing and differ only in a 38 amino-acid extension at the carboxyl terminus of P91. In 
the present study, both p91 and p84 were shown to be tyrosine phosphorylated (Fig. 4. 
10) and the phosphorylation of ST ATI which translocates to the nucleus (will be shown 
in chapter Fig. 6. 18) where the binding of ST ATI to the GAS element will lead to the 
activation of iNOS promoter in response to IFN-y in J774 cells. The experiments regard 
nuclear factors and GAS binding will be investigated in the study represented in the next 
chapter.
Furthermore, although there is not enough data at present to conclude a link 
between MAP kinase and iNOS induction, there are some possible indications. The 
sequence -Pro-Met-Ser-, which resembles the consensus sequence for MAP kinase 
substrate -Pro-X-Ser(Thr)-Pro- (Alvarez et al, 1991), is present in the conserved region 
in the COOH-terminus of STATl, STAT3, and STAT4. Thus, it is possible that the Jak- 
STAT pathway may be coupled functionally to and modulated by the MAP-kinase 
pathway (Zhang et a l, 1995). Tyrphostin AG126 is a tyrosine kinase inhibitor which 
inhibits MAP kinase activity and as well as iNOS induction. In these experiments, AG 126 
inhibits both iNOS protein expression and NO2" accumulation, but there is little or no 
effect of AG 126 On p91 nuclear translocation (data not shown). It is possible that MAP 
kinase (if participating in iNOS induction ) may act through a different signal pathway.
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Chapter 5 
iNOS gene regulations
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5.1 Introduction
Although abundant evidence indicates that nitric oxide (NO) which is generated by 
macrophage NO synthase (iNOS) mediates the ability of macrophages to kill or inhibit the 
growth of tumor cells, bacteria, and parasites (Lowenstein et al, 1992; Moncada et al, 
1991), the expression of NOS must be tightly controlled because NO is potentially 
capable of indiscriminately injuring host tissue. The expression of iNOS is regulated 
largely at the transcriptional level (Xie et al, 1992). The murine iNOS promoter has been 
cloned and characterised (Lowenstein et a l, 1993; Xie et a l, 1993) and shown to contain 
multiple positive and negative regulatory elements capable of responding to numerous 
transcription factors.
In the promoter region of the iNOS gene, two areas are required for maximal 
induction of its transcription (Lowenstein et a l, 1993). Both of region I and II are 
necessary for LPS-activated expression while region II mediates IFN-y regulation. 
Region I and II contain potential binding sites for numerous transcription factors. Region 
I contains more LPS-related response elements, including a particularly striking array of 
binding sites for the transcription factors octamer, NF-IL6, NFkB, and TNF-REs. In 
contrast, IFN-responsive elements are concentrated in region II, including an ISRE and a 
PU-box/IFN element or PIE. Both regions I and II contain potential binding sites for 
NFkB. NFkB is a well characterised transcription factor that is important in inflammatory 
responses and is thought also to be involved in the expression of several virus and many 
inducible cellular genes that encode cytokines, immunoregulatory receptors, and acute 
phase proteins (Lenardo and Baltimore, 1989). NFicB protein is a heterodimer consisting 
of two proteins, p50 (also designated NFkB 1) and p65 (also designated Rel A). p50 and 
p65 are members of the Rel/NFicB family of proteins. These proteins serve as inducible 
eukaryotic transcription factors that form various homo- and heterodimers. In mammalian 
cells activity of NFkB is regulated by its association with an inhibitory subunit, IkB, 
which retains the inactive factor in the cytoplasm. NFkB is activated by many agents 
including LPS. The NFKB-type proteins provide a case in which regulated factors either
127
activate or repress transcription in response to signals. Regulation of mammalian NFkB is 
not well understood. However, in vitro, rapid phosphorylation and subsequent 
degradation of IkB by various kinases leads to the loss of its ability to inhibit DNA 
binding by NFkB (Beg and Baldwin, 1993, Chen et al., 1995)
In the iNOS promoter region which is necessary for IFN-y activation, the 
complementary nucleotide sequence of the ISRE core closely matches a consensus 
sequence termed IFN-regulatory factor element (IRF-E) (Martin et a i, 1994; Tanaka et 
al, 1993). IRF-1 is an IRF-E binding protein (Lorsbach et al., 1993). IRF-1 is activated 
by viral infection, double-stranded RNA, IFN-a, and IFN-y (Fuijita et al, 1989; 
Miyamoto et a/., 1988), and serves as a transcriptional activator for type IIFN genes as 
well as for a number of IFN-inducible genes (Reis et al, 1992; Pine 1992). However, all 
these genes are also regulated in part if not predominatly by other transcription factors, 
such as interferon-stimulated gene factor 3 (ISGF3) and gamma-activating factor (GAF).
To activate or repress transcription, transcription factors must be located in the 
nucleus, bind DNA, and interact with the basal transcription apparatus. Many DNA- 
binding proteins bind DNA as oligomers, and signals can therefore regulate DNA binding 
by affecting factor oligomerization as well as protein-DNA interaction itself. Evidence for 
the role of transcription factors in the regulation of target genes is usually obtained either 
by the analysis of the binding of nuclear proteins to regulatory DNA sequences or on the 
basis of an intracellular activation of transfected constructs containing gene fragments 
linked to reporter genes. In this chapter, I will concentrate on transcriptional responses to 
IFN-y and /or LPS-activated signalling pathway.
5.2 IFNs regulatory factor (IRF-1) is activated by IFN-y or LPS
Interferon regulatory factor-1 (IRF-1) is a transcription factor which binds to IFN 
gene regulatory elements (IRF-E) (Miyamoto et a l, 1988; Levy et a l, 1988; Porter et a l, 
1988; Rutherford et a l, 1988). ÏRF-1 plays a critical and essential role in the induction of
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iNOS which is transcriptionally regulated by IFN^ (Kamijio et al., 1994; Martin et al,
1994).
An IFN-y-responsive element in the IRF-1 gene has been reported (Sims et a l,
1993) composing a IFN-y activation sequence (GAS) element. Thus a oligonucleotide
corresponding to GAS within the promoter of the IRF-1 gene was used to detect IFN-y or
LPS-induced DNA-protein binding activities, as defined by electrophoretic mobility shift
.assay (EMSA). The complexes induced in the nuclear extracts from the cells treated with 
IFN-y and LPS are shown in Fig. 5.1a. When the GAS specific oligonucleotide (5- 
TACAACAGCCTGATTTCCCCGAATGACGGC-3') was used as a probe, both extracts 
prepared from cells treated with IFN-y and LPS showed GAS-binding activities by 
different transcription complexes. Further experiments demonstrated that the IFN-y- 
induced GAS binding activity contains a tyrosine-phosphorylated p91 protein, since both 
anti-p91 and anti-phosphotyrosine (PY54) antibodies recognised this complex either by 
blocking (in the case of PY54) or supershifting (anti-p91) the GAS binding induced by 
IFN-y (Fig. 5.1b). LPS, however, induced two binding complexes. At least the top band 
contained NFkB (P65) since an antibody against NFkB (p65) recognised this complex 
(Fig. 5.1c). It was interesting that NFkB protein may involved in GAS binding activity.
Futher experiments were carried out to identify the protein in the LPS-induced GAS 
binding complex. As expected, when a cold GAS probe was used as a competitor, it 
abolished all the GAS-binding activités either by IFN-y or LPS. In contrast, when a 
NFkB site cold probe was used as a competitor, the two GAS-binding bands induced by
iLPS were abolished but not that induced by IFN-y (Fig. 5. Id). It was expected that
;STATl, as a transcription factor, binds to the GAS element in IRF-1 promoter in 
response to IFN-y, but it was surprising that NFkB P65 (formed a heterdimer with P50) f
'jwas found in the GAS-protein complex. It is possible that IRF-1 could also be 
upregulated by LPS alone. This possibility will be discussed later.
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Fig. 5.Id Identification of GAS-binding protein induced by LPS by 
means of competition assays. J774 cells were incubated with IFN-y ( KX) U/ml) 
and/or LPS (10 ng/ml) for 1 h, and nuclear proteins were extracted. EMSA was carried 
out by 30 min incubation of 5 pg of nuclear proteins with a ^^P-labelled 
oligonucleotide probe F containing the GAS sequence found in lRF-1 promoter, an 
activator of iNOS. For, competition assays, cold probes were added into the reaction 
mixture 20 min before adding the probe. D is the probe containing NFkB consensus in 
iNOS promoter; G is the probe containing IRF-E consensus in iNOS promoter.
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Following DNA-protein interaction, activation of transcription was examined. 
IRF-1 expression was measured by Northern blot analysis of total RNA extracted from 
IFN-y and/or LPS-treated cells. A PCR primer for IRF-1, designed by Dr. X.Q. Wei 
(Department of Immunology, University of Glasgow) according to the DATA BASE of 
GENE BANK, was used for amplifying cDNA of IRF-1. PCR cDNA products were 
cloned into TA-vectors followed by purification and sequencing. The cDNA fragments 
with the correct sequence were then labelled with [a^^P]-dATP and used as probes to 
detect mRNA of IRF-1.
Northern blot analysis performed on total RNA of J774 cells with the IRF-1 
cDNA probe showed that IRF-1 expression was induced when cells were treated with 
IFN-y at 100 U/ml but was undetectable in cells incubated with medium alone. IRF-1 was 
detectable 1 h after stimulated with IFN-y and reached maximum levels within 3-4 h and 
declining thereafter (Fig. 5.2).
Since LPS induced a DNA-protein complex as indicated by EMSAs using the 
GAS element as a probe (Fig. 5.1a). I investigated whether LPS can up regulate IRF-1 on 
its own. Alternatively, it was possible that LPS-induced DNA-binding protein(s) could 
work synergistically with IFN-y-induced transcription factor(s) to induce IRF-1. To 
answer these questions, IRF-1 expression in LPS or LPS plus IFN-y-treated cells was 
determined by Northern blot analysis. As expected, IRF-1 was induced by the treatment 
of IFN-y, and this was strongly increased by LPS (Fig. 5. 3). Interestingly, following 
prolonged expose of the film, it could be seen that LPS alone could induce weak IRF-1 
expression in 3-4 h (results not shown). This could perhaps be due to induction of IFN-y 
by LPS.
IRF-1 expression in J774 cells was further confirmed by Western blotting, using 
an antibody against IRF-1. IRF-1 protein was induced by the treatment of IFN-y and 
further enhanced by the combination of IFN-y and LPS (Fig. 5.4), but was not detectable 
in the untreated cells. When the cells were incubated LPS alone for prolonged periods (4 
h), IRF-1 protein was also weakly detectable (result not shown).
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Fig. 5.2 Northern blot analysis of IRF-1 expression induced by IFN-y
Total RNA was extracted from IFN-y treated cells using RNAzolB. Samples ( 10 pg each) 
was subjected to Northern blot analysis. IRF-1 mRNA was hybridised using labeled 
probes that represented the fragment of cDNAs for murine IRF-1 (a) or human GAPDH 
(b).
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Fig. 5.3 Northern blot analysis for IRF-1 induced by IFN-y and LPS.
J774 cells were incubated with IFN-y (100 U/ml) or /and LPS (10 ng/ml) for 2 h, and 
total RNA was extracted using RNAzolB. IRF-1 mRNA was hybridised with a murine 
IRF-1 cDNA probe, and after stripping, a human GAPDH probe was used for evidence 
of loadding.
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Fig. 5.4 IRF-1 expression in J774 cells induced by IFN-y and LPS. J774 
cells were incubated with IFN-y (100 U/ml) or /and LPS (10 ng/ml) for 1 h. Nuclear 
proteins were extracted and 20 pg of each sample resolved in 10% SDS PAGE, 
transfered to nitrocellulose membrane and followed by probing with a polyclonal anti- 
lRF-1 antibody. There were two IRF-1 bands.
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5.3 IRF-2 is upregulated by IFN-y but not by LPS.
IRF-1 and IRF-2 are both interferon regulatory factors which were originally 
identified as regulators of the IFN system (Fujita et a l, 1988; Harada et a l, 1989). IRF-1 
and IRF-2 function as a transcriptional activator and repressor, respectively, for the IFN 
and IFN-inducible genes. IRF-1 and IRF-2 show marked homology within their amino- 
terminal regions. Recombinant IRF-1 and IRF-2 bind to the same region within the virus- 
inducible element of the IFN-a and -p genes and the IFN-inducible genes (Harada et a l, 
1989). These observations suggest that IRF-2 binds to similar or identical DNA 
sequences, perhaps modulating the function of IRF-1.
Since a transient increase in the IRF1/IRF2 ratio may be a critical event in the IRF- 
1 mediated transcriptional activation and subsequent cellular response, IRF-2 expression 
was investigated in J774 cells by northern blot analysis. An IRF-2 cDNA probe was 
made the same way as that IRF-1 (provided by Dr. X.Q. Wei). In agreement with earlier 
reports, IRF-2 mRNA was found to be constitutively expressed at low level. This was 
increased in response to IFN-y treatment in a similar manner to that of IRF-1. However, 
generally IRF-2 mRNA levels were lower than those of IRF-l(Fig.5.5).
As observed earlier, LPS either by itself or in combination with IFN-y could 
upregulate IRF-1 expression as measured by Northern blots (Fig. 5.3), the effect of LPS 
on IRF-2 expression was examined. IRF-2 was constitutively expressed in untreated 
cells. Treatment of LPS did not increase the expression of IRF-2, and indeed in some 
experiments, there was a slight decrease in IRF-2 expression. Unlike IRF-1, IRF-2 
mRNA induced by IFN-y was markedly reduced by the combined treatment of IFN-y and 
LPS (Fig. 5.6). IRF-2 expression in cells treated with LPS alone was not detectable 
within 4 h of stimulation.
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Fig. 5.5 Northern blot analysis of IRF-2 expression in J774 cells. J774 
cells were incubated with IFN-y ( 100 U/ml) for 2 and 5 h, and total RNA was extracted 
using RNAzolB. lRF-1 mRNA was hybridised with a murine IRF-2 cDNA probe, and 
after stripping, a human GAPDH probe was used for evidence of loadding.
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Fig. 5.6 Northern blot analysis for IRF-2 induced by IFN-y and LPS.
J774 cells were incubated with IFN-y (100 U/ml) or /and LPS ( 10 ng/ml) lor 2 h, and 
total RNA extracted using RNA^^B. lRF-2 mRNA was hybridised with a murine IRF- 
1 cDNA probe, and after stripping, with a human GAPDH probe.
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Taken together, in J774 cells, IRF-1 mRNA and protein are upregulated by IFN-y 
and further enhanced by LPS whereas IRF-2 mRNA expression induced by IFN-y was 
reduced or unaffected by LPS within the 4 h period tested. The consenquence of the 
differential expression of IRF-1 and IRF-2, in response to IFN-y and LPS, leads an 
increase in the ratio of IRF-l/IRF-2. These results therefore indicated that one of the 
mechanisms of synergy between IFN-y and LPS in the induction of iNOS is to increase 
IRF-1 and decrease IRF-2 expression.
5.4 IRF-E activation in J774 cells treated with IFN-y and/or LPS
Cloning of the promoter of the murine iNOS gene (Xie et al., 1993; Lowenstein et 
al, 1993) has opened a molecular route to the analysis of iNOS induction. The promoter 
region of iNOS gene contains four copies of GAS, and two copies of the IFN-stimulated 
response element (ISRE), designated ISREu for upstream and ISREd for downstream. 
Finally, the complementary nucleotide sequence of the ISREd core closely matches a 
consensus sequence termed IFN regulatory factor element (IRF-E) (Tanaka et al., 1993).
IRF-1 and lRF-2 are both IRF-E binding proteins. Activation of J774 cells with 
IFN-y and LPS should therefore lead to changes in IRF-E binding activity in the iNOS 
promoter. An EMSA was carried out to determine if the changes in IRFl/IRF-2 ratio 
correlated with that of IRF-E binding. There was a constitutive binding complex in IRF-E 
(probe G, see section 2.16 in chapter 2), Upon stimulation with IFN-y, a IRF-E binding 
protein was induced which migrated faster than that of constitutive DNA-protein complex. 
Unexpectedly, a binding complex in LPS-treated cell nuclear extracts was also induced. 
The mobility of this complex was only slightly faster than that of the constitutive one, but 
was distinguishable from that of IFN-y-induced binding complex (Fig. 5.7a). When the 
same nuclear extracts were tested with another IRF-E oligo, which corresponding to the 
IL-6 inducible gene promoter sequence (probe F see section 2.16 in chpater 2), similar 
results were obtained (Fig.5.7b), except that there was no constitutive complex
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formation. This may due to slightly difference in sequence of oligonucleotides between 
two probes, which may be critical for the formation of this constitutive complex. 
However, with both IRF-E probe (G and F), LPS-induced binding complex was 
consistent. To identify the binding proteins, antibody super-shift assays were carried out. 
It was shown that IFN-y-induced binding complex could be abolished by either anti-IRF- 
1 or anti-IRF-2 (Fig, 5.7c), but the LPS-induced binding complex was not affected by 
anti-IRFs or anti-NFxB (P65 and P50) (data not shown). The low mobility of this 
binding complex suggests that it comprises a fairly large protein or a complex of multiple 
factors.
To analyse the LPS-induced IRF-E binding protein, a number of cold oligo 
competitors were used in EMSAs. When added at lOOx excess concentrations over the 
^^P labelled probe G (IRF binding element in iNOS promoter), cold probe D (NFkB site 
in iNOS promoter) had no effect on the binding activity; probe F (GAS element in IRF-1 
promoter) had some effect on the LPS-induced but not on that of IFN-y-induced binding 
activities (Fig. 5, 8). Further experiments proved that, under the same conditions, these 
two cold probes (D-NFkB, or F-GAS) could compete with their own 32P-labelled probe 
D (Fig. 5.9) and F (Fig. 5. Id) respectively. On the other hand, when NFkB binding site 
was used as a ^^P labelled probe, cold probe G (IRF-E) could not compete the binding 
either (Fig. 5.9). These results suggest that the LPS-induced IRF-E-binding complexes 
are not related to the NFkB but it may consist of one of the STAT-like protein.
To determine if protein synthesis is necessary for the activation of LPS-induced 
transcription factor, the effects of cycloheximide (CHY) was tested. When CHY was 
added Ih before IFN-y and LPS, both complexes (induced either by IFN-y or LPS ) were 
abolished (Fig. 5.10). In contrast, NFkB binding was not affected (See details in section
5.5 and Fig. 5.14). These results indicate that protein synthesis is necessary for IRF-E 
activation either by IFN-y (IRF-1) or by LPS (unknown factor), and further suggest that 
the LPS-induced IRF-E binding protein is unlikely to be p91 or NFkB.
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Fig. 5.7a IRF-E binding activity in INOS promoter induced by IFN-y 
and/or LPS. J774 cells were incubated with IFN-y (100 U/ml) or /and LPS (10 
ng/ml) for 2 h or 4 h, and nuclear proteins extracted. EMSA was carried out by 
incubation of 10 pg of nuclear protein with a ^^P-labeled oligonucleotide probe G 
containing the ISRE(IRF-E) sequence found in the iNOS promoter. For the supershift 
assay, antibodies were added into the reaction mixture 20 min before adding the probe. 
In this figure, supershift was not observed, since complexes were abolished by 
antibodies.
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Fig. 5,7b IRF-E binding activity induced by IFN-y and/or LPS. J774 cells 
were incubated with IFN-y (100 U/ml) and/or LPS (10 ng/ml) for 2 h or 4 h, and 
nuclear proteins extracted. EMSA was carried out by incubation of 10 pg of nuclear 
protein with a ^^P-labeled oligonucleotide probe H containing the ISRE (IRF-E) 
sequence found in the IL-6 inducible gene (see Materials and Methtxis) promoter. For 
the supershift assay, antibodies were added into the reaction mixture 20 min before 
adding the probe. In this figure, supershift was not observed, since complexes were 
abolished by antibodies.
142
■"ün t i"IR F “2 "“ün t i “IR F" 1 "■ — c o n t r o l —
I F N - g  - + - +  - + - + -  + -  +
L P S  - -i- + - ■ ! ■ + - - +  +
.W#' # # m m
Fig. 5.7c Anti body-supershift assay for IRF-E binding activity induced 
by IFN-y and/or LPS. J774 cells were incubated with IFN-y (100 U/ml) and/or 
LPS (10 ng/ml) for 2 h, and nuclear proteins extracted. EMSA was carried out by 
incubation of 10 pg of nuclear protein with a ^^P-labeled oligonucleotide probe G 
containing the ISRE (IRF-E) sequence found in the iNOS gene (see Materials and 
Methods) promoter. For the supershift assay, antibodies were added into the reaction 
mixture 20 min before adding the probe. In this figure, supershift was not observed, 
since complexes were abolished by antibodies.
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Fig. 5.8 Competition assay for IRF-E binding activity in iNOS promoter 
imduced by IFN-y and/or LPS. J774 cells were incubated with IFN-y (100 U/ml) 
and/or LPS (10 ng/ml) for 2 h, and nuclear proteins extracted. EMSA was carried out by 
incubation of 10 pg of nuclear protein with a ^^P-labeled oligonucleotide probe G 
containing the ISRE(IRF-E) sequence found in the iNOS promoter. For the competition 
assay, cold oligo competitors (at lOOx high concentrations) were added into the reaction 
mixture 20 min before adding the probe. Probe D contains NFkB site, probe F contains 
GAS element.
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Fig. 5.9 NFkB binding activity in iNOS promoter induced by IFN-y 
and/or LPS was not competed by cold G probe. J774 cells were incubated with 
IFN-y (100 U/ml) and/or LPS (10 ng/ml) for 2 h, and nuclear proteins extracted. EMSA 
was carried out by incubation of 10 pg of nuclear protein with a ^^P-labeled 
oligonucleotide probe D containing the NFkB site sequence found in the iNOS promoter. 
For the competition assay, cold probe (at l(X)x high concentration) were added into the 
reaction mixture 20min before adding the probe. Probe G contains IRF-E element, probe 
F contains GAS element.
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Fig. 5.10 Effect of cycloheximide on IRF-E binding activity in the iNOS 
promoter induced by IFN-y and/or LPS. J774 cells were incubated with or 
without cycloheximide (CHY, 30 pg/ml) for 1 h, and IFN-y (100 U/ml) and/or LPS 
(10 ng/ml) were added for 2 h before nuclear proteins were extracted. EMSA was 
carried out by incubation of 10 pg of nuclear protein with a ^ ^P-labeled oligonucleotide 
probe G containning the ISRE (IRF-E) sequence found in the iNOS promoter.
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5.5 NFkB activation in iNOS promoter after treatment of LPS or IFN-y
As mentioned above, to achieve transcription activity, transcription factors must 
be located in the nucleus, bind DNA and interact with basal transcription apparatus. To 
determine possible NFkB activation in response to LPS in J774 cells, a nuclear 
translocation experiment was carried out. Nuclear proteins extracted from IFN-y and/or 
LPS treated cells were Western blotted using an antibody against NFkB P65. NFkB was 
found to be absent in the nucleus of untreated cells. It was however translocated to the 
nucleus 15 min after LPS-treatment. There was no evidence of NFkB nuclear 
translocation after treatment with IFN-y for 15 min (Fig. 5.11). When the cells were 
incubated for longer time (> 2 h), NFkB translocation was also observed in IFN-y treated 
cells.
In the murine iNOS promoter, there are two NFkB elements and the one of them 
(beginning 55 base pairs upstream of the TATA box of the iNOS gene) was used for 
analysis by EMSAs. Constitutive binding activity was found in the nuclear extracts of 
untreated J774 cells, and it could be a single band or double bands. It was observed that 
both binding activities were upregulated by LPS as measured 15 min (Fig. 5.12a) and 2 h 
(Fig. 5.12b) after stimulation but the top band showed a stronger inducibility by LPS. 
IFN-y, however, had little effect on NFkB binding in these experiments. This consisted 
with translocation data.
To identify which components of the Rel family bind as upper or lower bands to 
the NFkB element, specific antibodies to P50 or P65 were used. Supershift analysis 
revealed that the lower NFkB band, the main constituent in nuclear extracts of J774 cells, 
was likely to compose P50-P50 homodimers . The upper band, which is the major NFkB 
shift in nuclear extract of LPS-activated J774 cells, was shown to represent P50-P65 
heterodimers, since it was shifted by both P50 and P65 antibodies (Fig. 5.13).
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Fig. 5.11 NFkB (p65) nuclear translocation upon the stimulation of LPS 
or IFN-y. J774 cells were stimulated with IFN-y (lOOU/ml) or /and LPS (lOng/mi) 
for 15 min (lanes 1-4) and 2 h (lanes 5-7). Nuclear proteins were extracted and 20 pg 
of each extracts were subjected to Western blotting detected by a polyclonal anti-NFKB 
(P65).
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Fig 5.12  Activation of NFKB-element by LPS or IFN-y. J774 cells were 
incubated with IFN-y (lOOU/ml) or /and LPS (lOng/ml) for 15 min (a) and 2 h (b). 
Nuclear proteins were extracted and 10 pg of each extracts were subjected to gel-shift 
assay using ^^P-labeled D (see materials and methods) oligomor (5'-CCCAACTGGGGACT 
CTC ; 5'-CCAAAGGGAGAGTCCCC ) as a probe.
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Fig. 5.13 Time course of activation of N FxB-binding activity in the iNOS 
promoter by IFN-y or LPS. J774 cells were incubated with IFN-y (100 U/ml) and 
/or LPS ( 10 ng/ml) for 30 min (lanes 2-4), 2 h (lanes 5-7), or 4 h (lanes 8-10) or medium 
alone (lane 1). Nuclear extracts (lOpg each) were assayed for EMSA using ^ ^P-labeled D 
oligomor as a probe. Supershift assay was carried out using the same method except that 
antibody (2 pi) was added (NFkB P65, lanes 11 and 13; NFkB P50, lanes 12 and 14) in 
the reaction mixtures.
150
As mentioned earlier (Fig. 5.12), IFN-y did not activate NFkB for the initial 1 h 
following stimulation, but it did when cells were cultured for more than 2 h and NFkB 
activity continued to increase steadily for up to 4 h. For LPS treated-cells, NFkB binding 
had declined at this time point (Fig. 5.13). Thus, while the activation of NFkB by LPS is 
an immediate event (less than 30 min), it taken a longer period for IFN-y to achieve a 
similar activation (more than 2 h). These results indicate that NFkB may be indirectly 
activated by IFN-y. To determine if protein synthesis is required for the NFkB binding 
activity, such experiments were repeated in the presence of cycloheximide. As shown in 
Fig.5.14, under the stimulation of IFN-y or LPS, the binding activity of NFkB in J774 
cell nuclear extracts was not reduced but actually enhanced by the pretreatment with 
cycloheximide. This suggested that NFkB activation, either by LPS or IFN-y, is a 
protein-synthesis independent process. The enhancement may be due to cycloheximide 
interfering with IkB protein synthesis leading to release of NFkB from the IkB-NFkB 
inactive complex and translocation to the nucleus and gene activation.
5.6 Discussion
In murine macrophages, following the stimulation with IFN-y, lRF-1 and lRF-2 
genes were transcriptionally activated by the binding of phosphorylated ST ATI to GAS 
elements in the promoters (at least in ÏRF-1). According to cDNA sequence analysis, 
Harada and colleagues' (1989) have reported that the lRF-2 cDNA sequence shows 
marked homology with lRF-1 in its N-terminal region but was rather different in its C- 
terminal region. Since the C-terminal region of lRF-1 possess the transcriptional 
activation domain, it is possible that lRF-2 may function as a controlling factor for IRF-1 
by binding site competition. Since the DNA-binding affinities of lRF-1 and lRF-2 are 
similar with respect to a wide variety of binding sequences (Tanaka et al, 1993), 
regulation of IFN-inducible genes may be determined simply by the ratio of lRF-1 and 
IRF-2. lRF-1, compared to lRF-2, was strongly induced by IFN-y in J774 cells. Such a 
transiently raised ratio in 1RF-1/1RF2 could allow the activation of ISRE in the iNOS 
promoter.
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Fig. 5.14 Effect of cycloheximide on activation of NFxB-binding activity 
in the iNOS promoter by IFN-y or LPS. J774 cells were incubated with or 
without cycloheximide (CHY, 30 pg/ml) for 1 h then IFN-y and /or LPS were added and 
cultured for a further 2 h. Nuclear extracts (10 pg each) were assayed for EMSA using 
^^P-labeled D oligomor as a probe.
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IRF-1 plays a critical role in the regulation of IFN-inducible genes including iNOS 
(Kamijo et at., 1994). The inability of macrophages from lRF-1 knockout mice (1RF-1“^ “) 
to produce NO or express detectable iNOS mRNA after stimulation with IFN-y in the 
presence or absence of LPS, demonstrated that lRF-1 plays a critical physiologic role in 
the induction of iNOS. IRF-E itself is a silencer element and lRF-2 is the silencer at the 
promoter. In a variety of cell types, as a result of its greater protein stability, IRF-2 
dominates over lRF-1, binding at approximately 10-fold-higher affinity to IRF-E 
(Watanabe et al, 1991). However, the lRF-1 gene is efficiently induced in response to 
viruses and IFNs, resulting in an increase in lRF-1 activity relative to that of IRF-2. In 
J774 cells, the treatment with IFN-y led to the induction of lRF-1 and also an increase in 
lRF-2. However, the increase in IRF-1 expression was markedly stronger than that of 
lRF-2, and thus positive ratio of lRF-l/lRF-2 could provde a mechanism for the 
transcriptional activation of IFN-y-inducible genes including iNOS.
Previous reports strongly suggested that both the IRF and NFkB binding 
domains are necessary for the full transcriptional activation of the iNOS promoter 
(Lowenstein et al., 1993). NFkB was found to be rapidly and transently translocated into 
the nucleus in response LPS in J774 cells. Activated NFkB appeared in the nucleus as 
P65-/P50 heterdimer or P50/P50 homodimer and bound to a NFkB response element in 
the iNOS promoter where it transcriptionally activated iNOS gene. In this study, 
experiments regarding the expression or activation of tanscription factors, like IRF-1/2 
and NFkB, have demonstrated that IFN-y can activate lRF-1 and lRF-2 transcriptional 
activities whereas LPS can activate NFkB. The expression of lRF-1 induced by IFN-y 
and the activation of NFkB induced by LPS may work synergistically to activate the 
expression of iNOS gene (Xie et al, 19940) which is responsible for the large amount of 
NO production.
Recent reports using gene targeting technique have emphasised the importance of 
ST ATI in cell responsiveness to IFN-a and IFN-y (Meraz et a l, 1996; Durbin et a l, 
1996). However, LPS induced two GAS-binding proteins in J774 cells, and rather
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surprisingly these proteins were not STATL There was no evidence for LPS-induced 
ST AT 1 activation (see chapter 4 )  in J774 cells and the binding complexes induced by 
LPS were different from that GAS-binding STAT protein induced by IFN-y. Antibody 
supershift and cold-probe competition assays indicated that the transcription factors in the 
complexes were NFkB or NFKB-like proteins. According to the migration patterns, the 
binding sequence of the NFxB-like protein and STATI were similar or the binding sites 
between two transcription factors were very close. Northern and Western blot proved that 
IFN-y-induced IRF-1 induction was enhanced by LPS, and IRF-1 was transcriptionally 
activated at low expression levels by LPS alone. These results suggest that LPS alone can 
also activate IRF-1 and one of the possible mechanism is through NFkB activation. 
Hence, lRF-1 may, as well as NFkB, plays a role in LPS induced iNOS expression.
An early report using site-specific mutation of IRF-E within the context of the full- 
leiigth iNOS promoter/enhancer region demonstrated the importance of this site in the 
response of iNOS to IFN-y (Martin et al, 1994). Interestingly, within the iNOS promoter 
region, the IRF-E site not only binds IRF-1 and lRF-2 but also binds a protein (or a 
protein complex) induced by LPS. Antibody suppershift and cold-probe competition 
assays excluded the possibility of IRF-1, lRF-2, NFkB (P65, P50). Furthermore, 
protein synthesis is required for the IRF-E binding activity of both lRF-1 and the LPS- 
inducible protein, it is not required for the NFkB binding activity. The LPS-inducible 
IRF-E binding protein is therefore likely to be a new protein (or protein complex) which 
belongs to the IRF transcription factor family. An LPS-stimulated binding factor (kBF-A) 
from murine peritoneal macrophages has also been reported to bind the ISRE regulating 
the IP-10 , D3 (Tebo et al, 1992) and Ig k light chain genes (Damore et al., 1996). 
Further experiments are needed to establish the identity of the factor(s) involved in IRF-E 
binding.
Macrophages from IRF-1 deficient mice accumulate only a reduced level iNOS 
mRNA after stimulation with LPS in the presence or absence of IFN-y. Thus, the 
synergistic induction of NO induced by IFN-y and LPS is not only through the
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combinatorial activation of NFkB (by LPS) and IRF-1 (by IFN-y), but is also through 
synergistic activation of IRF-E by IRF-1 (induced by IFN-y) and IRF-like protein 
(induced by LPS).
Finally, transcription factors other than IRF-1 may involved be in IFN-y-induced 
iNOS induction. NFkB, for example, was activated and translocated to the nucleus 2 h 
after the treatment with IFN-y. Such activated NFkB bound to its responding element in 
the iNOS promoter, to work co-operatively with IRF-1 to activate the iNOS gene. Since 
the JAK-STAT pathway is a relatively direct cascade which is an immediate and transient 
event (peak at 1 h), it is not likely that IFN-y-induced NFkB activation is the direct effect 
of JAK-STAT activation in this case. Addition of cycloheximide revealed that this NFkB 
process is protein synthesis independent. This indicated activation of NFkB by IFN-y 
does not involve any newly synthesised protein. Further work will be headed to identify 
the pathway which leads to NFkB activation in IFN-y-treated cells.
The mechanisms of the regulation of iNOS in murine macrophages identified by 
these studies is summarised in Fig 5.15. Basically, upon stimulation of IFN-y, multiple 
signalling pathways are activated. One of the signalling pathways is JAK-STAT pathway. 
JAK kinases (JAKl and JAK2) are activated which are responsible for phosphorylation 
of STATI. Phosphorylated STATl forms homodimers and translocates to the nucleus 
where it binds to GAS element within IFN-y responsive genes, for example, IRF-1. IRF- 
1, as a transcription factor, plays a crucial role in the regulation of NO synthesis in 
response to IFN-y. The binding of STATl to the IRF-1 promoter permits activation of 
IRF-1 gene expression. Binding of LPS to its receptor on cell surface leads to 
phosphorylation and degradation of IkB therefore releasing activated NFkB which then 
translocates to the nucleus where it binds to the kB element in LPS responsive genes, for 
example, IRF-1 and iNOS. In addition, an IRF-like protein is transcriptionally activated 
in response to LPS which also participates in regulation of iNOS expression. With the 
combination of IRFs, NFkB, and possible the other transcription factors, iNOS 
expression is achieved upon the stimulation of IFN-y and LPS.
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Fig. 5.15 The induction of iNOS expression by a combination of IFN-y 
and LPS, In J774 cells, a number of transcription factors may participate in the iNOS 
activation. Basically, upon stimulation of IFN-y, multiple signalling pathways are 
activated. One of the signalling pathways is the JAK-STAT pathway. JAK kinases (JAKl 
and JAK2) are activated which are responsible for phosphorylation of STATl. 
Phosphorylated STATl forms homodimers and translocates to the nucleus where it binds 
to GAS element within IFN-y responsive genes, for example, IRF-1. IRF-1, as a 
transcription factor, plays a crucial role in the regulation of NO synthesis in response to 
IFN-y. The binding of STATl to the IRF-1 promoter permits activation of IRF-1 gene 
expression. Binding of LPS to its receptor on cell surface leads to phosphorylation and 
degradation of IkB therefore releasing activated NFkB which then translocates to the 
nucleus where it binds to the kB element in LPS responsive genes, for example, IRF-1 
and iNOS. In addition, an IRF-like protein is transcriptionally activated in response to 
LPS which also participates in regulation of iNOS expression. With the combination of 
IRFs, NFkB, and possible the other transcription factors, iNOS expression is achieved 
upon the stimulation of IFN-y and LPS.
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Chapter 6
Mechanism of IL-4-medlated suppression of iNOS expression
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6.1 Introduction
IFN-y and IL-4 are produced by functionally different subsets of T helper cells 
(Thl and Th2, respectively ) in the murine (Mossman, et al., 1987) as well as in the 
human system (Romagnani, 1991).The opposing regulatory effects of IL-4 and IFN-y are 
crucial in the regulation of the immune response, as has been demonstrated in the murine 
Leishmaniasis model (Heinel, et al., 1988). IFN-y is an important cytokine with antiviral 
activity and regulatory functions (Dijkmans and Billiau 1988) on antibody formation 
(Leibson et al., 1984; Pinkelman et al., 1988) , T-cell differentiation (Bernton et al., 
1988; Giovarelli et al., 1988), and macrophage activation (Talmadge et al., 1986; 
Schreiber et al., 1983), enhancement of expression of class II antigens of the major 
histocompatibility complex (Basham and Merigan 1983), and production of other 
cytokines such as tumor necrosis factor and interleukin-1 (Collar et a l, 1986; Miossec et 
al, 1986). In contrast, IL-4 displays anti-inflammatory effects on macrophages. As aTh2 
cytokine, IL-4 exerts a variety of biologic effects on cells of most haemopoietic lineages 
such as B cells (Isakson et al, 1982; Noëlle et al, 1984; Oliver et al, 1985),T cells 
(Carding et a l, 1991; Fernandez-Botran et a l, 1986; Paul and Ghara 1987), and mast 
cells (Brown et a l, 1987) In particular, IL-4 seems to be essential for induction of 
differentiation of naive CD4+ T helper (Th) cells toward the Th2 phenotype (Maggi et al, 
1992; Parronchi et a l, 1992). Th2 cells produce IL-4, IL-5, IL-6, and IL-10 and promote 
humoral immunity (Mosmann and Coffman 1989; Mosmann eta l, 1991). In the absence 
of IL-4, CD4+ Th cells develop mainly into the Thl phenotype which produces IL-2, 
IFN-y, TNF, and lymphotoxin and promotes cell-mediated immunity. IL-4 has also been 
shown to limit the expression of protective Thl functions (Liew et a l, 1991). Therefore, 
IL-4 is an important immune modulator.
Macrophages activated by cytokines (i.e. IFN-y) and microbial products (i.e. 
LPS) protect the host from certain tumour cells and microbes to a large part by a pathway 
dependent on production of nitric oxide (NO) from L-arginine and molecular oxygen. 
Previous studies have demonstrated that IL-4 inhibits the expression of NO synthase and
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NO production by IFN-y-activated macrophages, and this mechanism is thought to 
provide down-regulation of Thl functions by disease-promoting Th2 cells (Cenci et al, 
1993). IL-4 produced by Th2 cells can neutralise the macrophage-activating and 
leishmanicidal effect of IFN-y produced by Thl cells (Liew et al, 1989). IL-4 and IL-10 
are potent inhibitors of parasite killing and NO production by IFN-y-activated 
macrophages (Liew et at., 1991; Gazzinelli et al, 1992). However, the detailed 
mechanism of IL-4 mediated inhibition of NO synthase is not known. The present study 
focused on how IL-4 suppresses NO release from J774 cells. This may provide useful 
information for understanding the mechanism of interaction between Thl and Th2 
cytokines.
6.2 Optimal conditions for inhibiting NO synthase by IL-4
Firstly, the time course and dose-response of IL-4-mediated inhibition of NO in 
J774 cells were determined using Griess reaction to measure N02“ accumulation in the 
culture supernatants.
IL-4 suppressed NO release from IFN-y and LPS-activated J774 cells. When 
J774 cells were cultured (simultaneously or following pre-incubated (18 h)) with IL-4 (at 
100 U/ml), NO release was suppressed by 30% (Fig. 6.1). Further experiments showed 
that to inhibit NO production, IL-4 has to be added before or simultaneously with IFN-y 
and LPS. There was no effect if IL-4 was added 2 h after IFN-y and LPS (Fig. 6.2).
6.3 IL-4 affects the transcriptional activation of iNOS
Diminished NO2" accumulation after IL-4 treatment suggested that IL-4 down 
regulates the enzymatic activity of iNOS. This was confirmed by demonstrating that iNOS 
activity was indeed decreased when cells were co-incubated with IL-4 (Fig. 6.3).
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Fig. 6.1 Dose-dependence of IL-4 mediated inhibition of NO 
synthesis. J774 cells were cultured at 10^ cell / well in 96-well plate. IL-4 was 
added either -18 h or simultaneously with IFN-y and LPS. Culture supernatants 
were collected at 24 h. Griess Reaction was used for NO2" measurement. Data are 
shown as means of triplicate cultures (±SD). The results are representative of two 
experiments.
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Fig. 6,2 Time course of IL-4 mediated inhibition of NO synthesis.
J774 cells were cultured at 10^ cells / well in DMEM in 96-well plate. IL-4 (100 
U/ml) was added at -5 to 5 h in combine with IFN-y and LPS for 24 h. NO2" in 
culture supernatants were measured using Griess Reaction. Data are shown as 
means of triplicates (±SD). The results are representative of five experiments.
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Fig 6.3 IL-4-mediated inhibition on iNOS activity by enzyme assay.
J774 cells were cultured in 25 cm^ flasks. IL-4 (100 U/ml) was added 
simutaneously with IFN-y (100 U/ml) and LPS (10 ng/ml). Cells were harvested at 
16 h after stimulation. Total proteins were extracted, and iNOS enzyme activity was 
measured using a dual-wavelenth method. Data are presented as means of triplicates 
(±SD).
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1sDecreased enzyme activity indicated that IL-4 may interfere with iNOS protein t
synthesis or iNOS transcription. Immunoblotting with an monoclonal antibody to murine 
macrophage iNOS shows that in the presence of IL-4 (either in a pre-treatment or added 
simultaneously), iNOS expression induced by IFN-y and LPS was decreased and 
delayed: For example, whilst the maximum level of NOS expression achieved was about 
8 h following the stimulation with IFN-y and LPS, it took 10-12 h to obtain maximal 
expression in the case of cells pre-treated with IL-4. Moreover, protein expression were 
generally lower in all time points. These Western blotting results demonstrate that the
;ï|diminished iNOS enzyme activity was paralleled by a marked reduction of iNOS protein 
(Fig. 6.4) and thus, the inhibition is at, or before, the level of iNOS protein synthesis.
Further experiments were carried out to investigate the effect of IL-4 on iNOS 
transcription. Total cellular RNA was isolated and analysed by Northern blotting, using a 
^^P-labelled murine iNOS cDNA fragment as a probe. As shown in Fig. 6.5, IFN-y and 
LPS incubation resulted in iNOS mRNA expression as early as 2 h, increasing to a | |
maximum level at 4 h. It was however reduced and delayed in the samples treated with 
IFN-y, LPS and IL-4.
This disruption of iNOS transcription therefore suggests that IL-4 mediated 
inhibition of NO synthase may involve either a mechanism of blocking IFN-y/LPS 
signalling pathways or interfering directly with gene regulation of NOS expression.
6.4 IFN-y or LPS induced NO production is inhibited by IL-4
To address whether IL-4 targeted signals derived from IFN-y, LPS or the 
synergistic pathway, IFN-y or LPS alone was used to stimulate J774 cells. NO 
production induced by IFN-y plus LPS was only partially reduced (<30%) by the addition 
of IL-4 (Fig. 6.6). However, when cells were stimulated by LPS alone, NO induction 
was completely blocked by IL-4 (Fig. 6.7). In this experiment, LPS was used at 2 pg/ml.
At such a high concentration, LPS-induced NO accumulated in the culture supernatants to 
a level of about 15pM.
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Fig. 6.4 Effect of IL-4 on iNOS protein synthesis induced by IFN-y and 
LPS. J774 cells were cultured in 25 cm- flasks and incubated with IFN-y (100 U/ml) 
and LPS (10 ng/ml) in the presence or absence of IL-4 (100 U/ml). Non-adherent cells 
were removed before cells were lysed 0-24 h after stimulation. Total protein (20 pg each) 
were resolved in 7.5% SDS PAGE and followed by immunoblotting using an monoclonal 
antibody against murine macrophage NOS and visualised by ECL reagents.
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Fig. 6.5 Effect of IL-4 on iNOS mRNA transcription in J774 cells. Cells 
were stimulated with IFN-y (100 U/ml) and LPS (10 ng/ml) with or without lL-4 (100 
U/ml) for 2-6 h. Total RNA was isolated with RNAzol B. Samples (10 pg each) were 
analysed by Northern blotting and hybridized with iNOS cDNA fragment (372bp) 
labelled with ^^P-dATP. The results are representative of two experiments.
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Fig. 6.6 Effect of IL-4 on LPS- or LPS plus IFN-y-induced NO 
synthesis. J774 cells were incubated with LPS (10 ng/ml) and/or IFN-y (100 
U/ml) in the presence or absence of IL-4. Culture supernatants were collected 24 h 
after stimulation , and assayed for nitrite by the Griess method. Data are presented as 
means of triplicates (±SD). The results are representative of three experiments.
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Fig. 6.7 Effect of IL-4 on LPS -induced NO synthesis. J774 cells were 
cultured with LPS (10 ng/ml) at different concentrations with or without IL-4 (100 
U/ml). Culture supernatants were collected at 24 h after stimulation, and assayed 
for nitrite by the Griess method. The value of IL-4-treated samples were zero. Data 
shown are the means of triplicate cultures (±SD). The results are representative of 
two experiments.
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The effect of IL-4 on IFN-y-induced NO production was also tested. Cells were 
stimulated with IFN-y at concentrations of 10, 100 and lOOOU/ml. IFN-y alone can 
induce low but significant amount of NO2" reaching a plateau at 10 U/ml. IL-4 showed a 
stronger inhibition at the lower rather than higher concentrations of IFN-y, but it did not 
completely block NO synthase (Fig. 6.8). These results indicated that IL-4 exerts its
',1inhibitory effect on NO synthesis on both the IFN-y and LPS pathways.
6.5 IL-4 does not interfere with LPS-induced NFkB binding activity
Transcription factor NFkB is composed of two subunit of 50 and 65 kDa, which 
form a heterodimer that binds to kB motifs. This factor is normally present in the cytosol 
in an inactive form bound to an inhibitor protein, IkB. Phosphorylation of IkB induces 
dissociation of NFkB from IkB followed by translocation of NFkB to the nucleus in an 
active form that binds to DNA (reviewed in Takasuka et al., 1995), Protein kinase C
a(PKC) is one of the kinases that phosphorylates IkB directly and is involved in the
■ /activation pathway of NFkB (Ghosh and Baltimore 1990; Shirakawa and Mizel 1989). It i
was reported that LPS or lipid A (biologically active lipid moiety of LPS) induce the 
activation of PKC in macrophages (Wightman and Raetz 1984) and B cells (Chen et al.,
1986).
'ïIn J774 cells, upon the stimulation of LPS, NFkB was activated and translocated 
to the nucleus where it binds to the specific DNA elements in the LPS responsive genes.
Previous results (chapter 5) have shown that LPS-treated cells contains a protein which is 
able to bind to the NFkB element found in the iNOS promoter. To determine whether 
NFkB activation could be altered by IL-4, immunoblotting was carried out in the nuclear
i'extracts using antibody against NFkB P65 to detect NFkB nuclear translocation. Upon i
stimulation with LPS, NFkB (P65) was translocated to the nucleus within 15 min and 
interestingly, there was no significant difference in translocation between the samples 
stimulated with LPS in the presence or absence of IL-4 (Fig. 6.9).
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Fig. 6.8 Effect of IL-4 on IFN-y-induced NO production. J774 cells 
were stimulated with IFN-y at different concentration with or without IL-4 (100 
U/ml) for 24 h. Culture supernatant were collected and assayed for N02" by the 
Griess method. Data are shown as means of triplicates (±SD). The results are 
representative of three experiments.
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Fig. 6.9 Effect of EL-4 on NFkB nuclear translocation induced by LPS.
J774 cells were incubated with IFN-y (100 U/ml) or /and LPS ( 10 ng/ml) in the presence 
or absence of IL-4 (100 U/ml) for 15 min (lanes 1-8) or 2 h (lanes (9-16). Nuclear 
proteins were extracted and 20 pg of each were resolved in 10% SDS PAGE, and 
transferred to nitrocellulose membrane followed by probing with a polyclonal anti-NFKB- 
P65 antibody.
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Nuclear extracts were prepared from the cells treated with IFN-y and for LPS in 
the presence or absence of IL-4 for 2 h and EMSAs were carried out with the NFkB 
specific oligonucleotide probe corresponding to the promoter region of the iNOS gene. As 
shown in Fig. 6.10, there is a constitutive binding activity by the p50/p50 homodimer 
(Shown by antibody super shift assay as seen in chapter 5). Following stimulation with 
LPS , a slower migrated binding complex also appeared which is due to a complex, 
p65/p50 heterodimer (See chapter 5). IL-4 did not induce the same binding activity on its 
own, nor did it interfered with the binding activity induced by LPS.
MAP kinase activation was another response observed in LPS-treated cells, 
although the link between MAP kinase and iNOS expression was not clear. Here, MAP 
kinase tyrosine phosphorylation was used as a tool to test whether IL-4 alters LPS 
signalling. Immunoblotting showed that MAP kinase (ERK2) was tyrosine 
phosphorylated within 30 min of stimulation with LPS. IL-4 did not induce MAP kinase 
phosphorylation by itself, nor did it interfere with the activation induced by LPS (Fig. 6. 
11). However, when cells were treated with LPS and IFN-y, tyrosine phosphorylation of 
MAP kinase was down-regulated by IL-4. This was of interest, because a similar pattern 
of results was obtained with respect to IL-4 modulation of IRF-1 expression. This will be 
discussed later.
6,6 Effect of IL-4 on LPS-inducible IRF-E binding activity
IRF-E is another important gene site regulated by IFN-y and LPS in the iNOS 
promoter. In J774 cells, LPS-treatment leads to the activation of an IRF-E binding protein 
whose activity is dependent on protein synthesis. IL-4, however, did not interfere with 
such binding activity induced by IFN-y or LPS (Fig. 6. 12).
172
time.min 
IL-4 
LPS  
IFN-r
15 120 15 120 120 120 120 120 120
«.tap
0 1 10
Fig.6.10 NFkB binding activity induced by LPS in the presence or 
absence of EL-4. J774 cells were incubated with IFN-y (100 U/ml) or /and LPS (10 
ng/ml) in the presence or absence of IL-4 (lOOU/ml) for 2 h, and nuclear proteins 
extracted. EMSA was carried out by incubation of 5 pg of nuclear protein with a 32p- 
labeled oligonucleotide probe D containing the NFkB specific sequence found in the 
promoter of the murine iNOS. There are two binding complexes: the faster migrated band 
is P50/P50 homodimer whereas the slower one is the P65/P50 heterodimer.
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Fig.6.11 Effect of IL-4 on MAP kinase tyrosine phosphorylation 
induced by LPS. J774 cells were incubated with LPS ( 10 ng/ml) with or without 
IL-4 (100 U/ml) for 30 min before lysed.Total protein (20 pg each) were resolved in 
10% SDS PAGE, and subjected to Western blotting using anti-phosphotyrosine 
(PY54) (a). Following stripping, the blot was re-probed with anti-MAP kinase (erk2) 
antibody (b). The arrows indicate the same position of the blot.
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Fig. 6.12 Effect of lL-4 on IRF-E binding activity induced by IFN-y 
and/or LPS. J774 cells were incubated with IFN-y (100 U/ml) or /and LPS (10 
ng/ml) in the presence or absence of lL-4 (200 U/ml) for 2 h, and nuclear proteins 
extracted. EMSA was carried out by incubation of 10 pg of nuclear protein with a ^-P- 
labeled oligonucleotide probe G containing the ISRE (IRF-E) sequence found in the 
iNOS promoter.
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Fig. 6.13. Effect of IL-4 on iNOS mRNA induced by LPS. J774 cells were 
stimulated with IFN-y (100 U/ml) and/or LPS (10 ng/ml) in the presence (lanes 5-8) or 
absence ( lanes 1-4) of IL-4 ( 1(X) U/ml) for 3 h. Total RNA was isolated with RNAzolB. 
Samples (lOpg/each) were analysed by Northern blotting and hybridized with iNOS 
cDNA fragment (372bp) labelled with ^ ^P-dATP. The lower pannel showed the GAPDH 
in each sample by reblotting using a human GAPDH cDNA probe.
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Is the IL-4 inhibition of iNOS induced by LPS alone different from that on the 
response induced by costimulation with IFN-y and LPS? iNOS mRNA was detected in 
J774 cells after stimulation with IFN-y and /or LPS for 3 h. iNOS mRNA induced by 
IFN-y and LPS was significantly reduced by the co-incubation with IL-4, whereas there 
was little or no difference in the levels of iNOS mRNA induced by LPS in cells treated 
with or without IL-4 (Fig. 6.13) (see ppl76).
6.7 IL-4 blocked LPS Induced TNF-a production
Tumor necrosis factor alpha (TNF-a) is a cytokine produced by activated 
macrophages which plays an important role in the regulation of immune and inflammatory 
responses (Lieberman et aL, 1989). TNF-a is induced by LPS. To test the correlation 
between TNF-a production and iNOS induction in J774 cells, ELISA was used for 
detecting TNF-a production in the culture supernatants of samples treated with IFN-y and 
/or LPS with or without IL-4. While there is no detectable TNF-a in unstimulated cell 
cultures, treatment with LPS for 24 h led to a significant amount of TNF-a accumulating 
in the culture supernatants (up to 1 ng/ml). In the presence of IL-4, TNF-a production 
was markedly decreased (down to less than 100 pg/ml) (Fig. 6.14). Similar results were 
obtained from cells treated with IFN-y and LPS in the presence or absence of IL-4. 
However, while synergistically enhancing NO production by LPS, IFN-y showed a 
down-regulatory effect on LPS-induced TNF-a production. It is perhaps that IFN-y and 
LPS together altered the kinetic of cytokine production.
6.8 JAK-STAT pathway was not affected by IL-4
Previous studies from my work (Chapter 5) and others demonstrated that tyrosine 
kinase activity is required for IFN-y and /or LPS-induced iNOS expression, and protein 
tyrosine kinase inhibitors modify expression of iNOS. We have also demonstrated that 
IFN-y induces the tyrosine phosphorylation of ST ATI (P91), one of the components of
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the ISGF3 transcription complex (Lee 1995; Darnell 1994). Tyrosine phosphorylation of 
STATl in response to IFN-y has also been shown to require tyrosine phosphorylation and 
activation of two protein tyrosine kinases, JAKl and JAK2 (Chapter 4; Muller etaL, 
1993; Muller e/a/., 1993).
To determine whether IL-4 interferes with IFN-y-induced signalling, the effect of 
IL-4 on IFN-y-induced tyrosine phosphorylation of JAKl, JAK2, and STATl was 
examined. In J774 cells, IFN-y induced the tyrosine phosphorylation of JAKl and JAK2. 
Treatment of J774 cells with IL-4 alone induces tyrosine phosphorylation of JAKl but not 
JAK2. Culture with IL-4 (either following pretreatment for 1 h or 18 h) before or during 
costimulation with IFN-y did not inhibit IFN-y-induced tyrosine phosphorylation of JAK2 
(Fig. 6.15). In the presence of IL-4, IFN-y-induced tyrosine phosphorylation of JAKl 
was also not affected (Fig. 6.16). Furthermore, IL-4 alone did not phosphorylate P91, 
and IFN-y-induced tyrosine phosphorylation of P91 was unaffected by treatment with ILr 
4 (Fig. 6.17. and 6.18).
6.9 STAT6 activation and IL-4 induced GAS binding activity
After binding to its receptor, IFN-y rapidly induces transcription of target genes. 
Essential to this rapid activation is the presence of a latent cytoplasmic pool of JAK-STAT 
molecules. Binding of IFN to its receptor activates these preformed cytoplasmic factors, 
rendering them competent for nuclear translocation and DNA binding. JAK activation in 
IL-4-treated cells potentially indicated a similar latent cytoplasmic factor (IL-4-STAT, also 
named STAT6) involved in the inhibitory pathway. To ascertain whether IL-4-STAT is 
induced by a similar mechanism, J774 cells were cultured with IL-4 for 2 h and nuclear 
extracts prepared for the nuclear translocation assay by western blotting using an antibody 
against STAT6 . In J774 cells, there was a basal level of STAT6  in the nucleus. This was 
enhanced by the treatment of IL-4 but not by IFN-y or LPS (Fig. 6.19).
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Fig. 6.14 Effect of IL-4 on TNF-a production. J774 cells were incubated 
with LPS (10 ng/ml) and /or IFN-y (100 U/ml) in the presence or absence of IL-4 
(100 U/ml). Culture supernatants were collected 24 h after stimulation, and assayed 
for TNF-a production by ELISA. Data are presented as means of triplicates (±SD).
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Fig.6.15 Effect of IL-4 on JAK2 tyrosine phosphorylation induced by 
IFN-y. IFN-y-induœd tyrosine phosphorylation of JAK2 was assayed in whole cell 
extracts of J774 cells. IFN-y ( 100 U/ml) or LPS ( 10 ng/ml) were added with or without 
IL-4 ( 1001 I/ml) for 30 min. Extracts were immunoprecipitated with polyclonal antisera 
to JAK2 and probed after SDS-PAGE (7.5%) analysis with anti-phosphotyrosine 
(RC20).
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Fig. 6.16 Effect of lL-4 on JAKl tyrosine phosphorylation. IFN-y-induced 
tyrosine phosphorylation of JAK 1 was assayed in whole cell extracts of J774 cells. IFN- 
y (100 U/ml) was added in the prsence or absence of IL-4 (100 U/ml) for 30 min. 
Extracts were immunoprecipitated with polyclonal antisera to JAKl and probed after 
SDS-PAGE (7.5%) analysis with (a) anti-phosphotyrosine (RC20) and, after stripping, 
(b) antibody to JAKL
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Fig. 6.17 Effect of IL-4 on STATl phosphorylation induced by IFN-y.
Culturing in the 25 cm^ flasks, J774 cells were incubated with IFN-y ( 100 U/ml) and/or 
LPS ( 10 ng/ml) in the presence or absence of lL-4 ( 100 U/ml) for 30 min. Total proteins 
were extracted and 20pg of each were resolved in 7.5% SDS PAGE, followed by 
probing with a polyclonal anti-STATl antibody. The antibody recognised both P91 and 
P84. The bands (from top to bottom) are phosphorylated P91, P91, phosphorylated P84, 
and P84.
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Fig. 6.18 Effect of IL-4 on STATl nuclear translocation induced by IFN-
y. J774 cells were incubated with IFN-y (100 U/ml) and/or LPS (10 ng/ml) in the 
presence or absence of IL-4 ( 100 U/ml) for 1 h. Nuclear proteins were extracted and 20 
pg of each were resolved in 7.5% SDS PAGE, followed by probing with a polyclonal 
anti-STATl (P91/84) antibody. The antibody recognised both P91 and P84.
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Fig. 6.19 STAT6 (1L-4-STAT) activation and nuclear translocation 
induced by IL-4. Culturing in the 75 cm^ flasks, J774 cells were incubated with IFN- 
Y (100 U/ml), LPS (10 ng/ml), or lL-4 (100 U/ml) lor 2 h. Nuclear proteins were 
extracted and 20pg of each were resolved in 7.5% SDS PAGE, followed by probing with 
a polyclonal anti-STAT6  antibody, detected by ECL system.
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The low level of STAT6 constitutively present in the nuclear extracts may reflect 
the basal activity of STAT6 -DNA binding in J774 cells or may be due to the 
contamination of cytoplasmic proteins in nuclear phase.
Most biological functions of cytokines rely on their ability to stimulate the 
transcription of particular cytokine-responsive genes. Being members of the same 
hematopoietin receptor superfamily, the pathways of IFNs and IL-4 are likely to involve 
similar mechanism of signal transduction. It is known that the ability of IFN-y to stimulate 
transcription can be mediated through STATl, which in the form of homodimers is 
known to bind to GAS elements in responsive promoters. Several other cytokines have 
been shown to activate factors that bind the GAS site of IRF-1 gene or closely related 
sequences.
To determine if IL-4 stimulated STAT6 binds to the GAS element of IRF-1 
promoter, J774 cells were cultured with IL-4, IFN-y or both IFN-y and IL-4 for 1 h. 
Nuclear extracts were isolated and assayed by EMSAs with an oligonucleotide 
corresponding to the IRF-1 GAS consensus element (Fig. 6.20). Extracts isolated from 
IFN-y-treated cells contained a induced binding protein relative to those of untreated cells. 
The binding protein has already been shown to be STATl in chapter 5 (Fig. 5. lb). When 
the cells were cultured with IL-4 for 1 h, they also contain a GAS- binding activity. The 
IL-4-induced DNA binding complex migrated more slowly than the IFN-y STAT-DNA 
complex. It was super-shifted by an antibody against STAT6 but not by anti-STATl. In 
untreated cells, there was a low level constitutive binding of the GAS element and the 
binding complex was also super-shifted by anti-STAT6 . When these cells were co­
cultured with IL-4 and IFN-y, both activities were induced at levels comparable with 
those seen when the cytokines were added individually.
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6.10 IL-4 up-regulates IFN-y-induced IRF-1 and IRF-2
IL-4, appears to exert its biological function mostly through ST AT activation 
(Kiyoshi et al, 1996, Kazuya et al, 1996). In J774 cells, nuclear extracts from IL-4 
treated cells contained a GAS-binding protein (Fig. 6.20a) which is recognised by an 
antibody against STAT6  (Fig. 6.20b). Since the GAS-element plays a key role in the 
IRF-1 gene activation by IFN-y, it is possible that IL-4 may work through STAT6  to 
interfere the STATl GAS-binding and therefore to interfere with IRF-1 gene 
transcription. Northern blot analysis was therefore carried out to detect mRNA expression 
of IRF-1 and IRF-2 under the stimulation of IFN-y with or without IL-4.
Although undetectable in cells treated with IL-4 alone within an initial 6  h period, 
the mRNA of IRF-1 induced by IFN-y was enhanced by co-incubation with IL-4 (Fig. 
6.21). Initially, this was hard to explain as whilst IL-4 up-regulates the iNOS-activator, 
IRF-1, it down-regulates iNOS expression. However, upregulation of IRF-2 by IL-4 
may provde a mechanism to resolve this paradox. Earlier reports of site-specific mutation 
of IRF-E, within the context of the full-length iNOS promoter / enhancer region, has 
revealed the action of a silencer (Martin et al., 1994): the IRF-E itself is the silencer 
element while IRF-2 (Harada, et al., 1989) and the IFN consensus sequence binding 
protein (ICSBP) are the inhibitory factors which act as constitutive repressors in other 
systems (Driggers et aL, 1990). In the J774 system, although IL-4 acts as a enhancer for 
IRF-1 induced by IFN-y, it may fail to up-regulate IRF-E whose activation is dependent 
on the ratio of IRF-1/IRF-2.
Unlike IRF-1, IRF-2 mRNA is constitutively expressed in J774 cells incubated 
with medium alone although the expression is very low. There was no significant changes 
in this basal level in the cells treated with IL-4 alone. However, for the IFN-y-induced 
IRF-2, it was enhanced when cells were co-cultured with IL-4, in a similar manner to as 
that of IRF-1 (Fig. 6.22). Taken together, both IRF-1 and IRF-2 were upregulated IL-4.
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Fig. 6.20a lL-4 induced GAS binding activity. Nuclear extracts were prepared 
from J774 cells after 1 h of culture with IFN-y ( 100 U/ml), or LPS (10 ng/ml) or both in 
the presence or absence of lL-4 (100 U/ml), and examined by EMSA with labeled lRF-1 
GAS probe. Samples (5 pg of nuclear protein) was incubated with a ^^P-labeled 
oligonucleotide probe F containning the GAS sequence (5-TACAACAGCC 
TGATTTCCCCGAATGACGGC-3') found in the IRF-1 promoter.
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Fig. 6.20b Antibody supershift assay on EL-4-induced GAS binding 
protein. Same samples as that in Fig. 6.20a (Mobility shift analysis of IRF-1-GAS 
binding activity in IL-4 and IFN-y stimulated cells) except that, in some samples, 
antibodies were added into the reaction mixture 20  min before the probe.
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Fig. 6.21 Effect of IL-4 on IRF-1 expression induced by IFN-y and/or 
LPS. Total RNA was extracted from IF^-y (100 U/ml) and/or LPS (10 ng/ml) treated 
cells with or without lL-4 (100 U/ml) using RNAzolB. 10 pg of each sample was 
subjected to Northern blot analysis. IRF-1 mRNA was hybridised using ^^P labeled 
probes that represented the fragment of cDNAs for murine IRF-1 (a) or human GAPDH
(b).
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Fig. 6. 22 Effect of IL-4 on IRF-2 expression induced by IFN-y and/or 
LPS. Total RNA was extracted from IFN-y (100 U/ml) and/or LPS (10 ng/ml) treated 
cells with or without lL-4 ( 100 U/ml) using RNAzolB. 10 pg of each samples was 
subjected to Northern blot analysis. lRF-2 mRNA was hybridised using ^^P labeled 
probes that represented the fragment of cDNAs for murine lRF-2 (a) or human GAPDH 
(b).
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Thus, IL-4 mediated inhibition of iNOS expression induced by IFN-y is not likely due to 
disruption of the IRF-l/IRF-2 ratio.
6.11 IL-4 interferes with IFN-y-induced NFkB binding activity.
In chapter 5, I presented data that NFkB was activated by IFN-y 2 h after 
stimulation. This response is observed later than that induced by LPS alone. Moreover, 
both IFN-y and LPS-induced NFkB binding is protein synthesis-independent. In fact, the 
binding activity was enhanced by pre-treatment with cycloheximide for 1 h. The 
mechanism of NFkB activation induced by IFN-y is not yet understood, but may 
contribute to the iNOS transcriptional activation in co-operation with IRF-1 in response to 
IFN-y.
As shown in Fig. 6 . 23, NFkB binding was partially blocked when J774 cells 
were stimulated with IFN-y in the presence of IL-4. It therefore appears that IL-4, 
somehow, interferes with the pathway of NFkB activation by IFN-y by a presently 
unknown mechanism.
6.12 Effects of IL-4 on IRF-1 and IRF-2 activation by IFN-y and LPS
Northern blotting has revealed that IRF-1 mRNA induced by IFN-y is further up- 
regulated in cells stimulated with IFN-y in combination with lLr4 or LPS. However, IL-4 
and LPS play opposite roles in the regulation of iNOS expression induced by IFN-y. 
What if all three stimuli were put together? Northern blot analysis shows a complicated 
picture. When stimulated with IFN-y and LPS, IRF-1 expression in J774 cells was 
significantly higher than that stimulated with IFN-y alone. However, when IL-4 was 
added to the same culture, IRF-1 mRNA level was decreased (Fig. 6.21).
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Fig.6.23 NFkB binding activity induced by IFN-y in the presence or 
absence of IL-4. J774 cells were incubated with IFN-y (100 U/ml) or /and LPS (10 
ng/ml) for 2-4 h, and nuclear proteins were extracted. EMSA was carried out by 
incubation of 5 pg of nuclear protein with a ^^P-labeled oligonucleotide probe D 
containning the NFkB specific sequence found in the promoter of the murine iNOS. There 
are two binding complexes: the faster migrated band is P50/P50 homodimer whereas the 
slower one is the P65/P50 heterodimer.
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In contrast, IRF-2 was induced by IFN-y and down-regulated by stimulation of cells with 
IFN-y in combination with LPS, However, if IL-4 was added to such cultures, IRF-2 
mRNA was further enhanced (Fig. 6.22).
Taken all these results together, both IRF-1 and IRF-2 are upregulated by IFN-y 
in J774 cells. Moreover, although LPS can further enhance the expression of IRF-1, it 
reduces the expression of IRF-2. In contrast, IL-4 enhances both IRF-1 and IRF-2. In the 
case of costimulatory combination of IFN-y, LPS and IL-4, IRF-1 mRNA was reduced 
whereas IRF-2 was further enhanced leading to a decreased change in IRF-1/IRF-2 ratio. 
The change in the ratio of IRF-l/IRF-2 may thus play a role for IL-4 suppressing iNOS 
expression in J774 cells, under the stimulation of IFN-y and LPS.
6.13. Inhibition of iNOS by IL-4 is STAT6-dependent
Since the results are rather complex, it is important to investigate directly the IL-4 
signalling pathways that inhibit iNOS expression. Engagement of the IL-4 receptor (IL- 
4R) leads to the activation of at least two distinct signalling pathways. One involves the 
activation of STAT6  through phosphorylation by JAKl and JAK3 (Johnston et aL, 1994; 
Witthuhn et aL, 1994), and of the presently known STAT proteins, only STAT6  is 
activated in response to the cytokine IL-4 (Kotanides and Reich, 1993; Hou et aL, 1994; 
Schindler et al, 1994; Quelle et aL, 1995). In addition to STAT6 activation, stimulation 
of the IL-4R has also been shown to induce the phosphorylation of an insulin receptor 
substrate (1RS) termed 4PS or IRS-2 (Keegan et aL, 1994; Sun et aL, 1995). To 
determine the relative importance of STAT6  signalling pathway in mediating the biologic 
functions of IL-4, particularly the inhibitory effect on NO synthesis, ST AT 6  gene targeted 
mice was used. Recently developed gene knockout mice provide a useful tool to answer 
this questions. To address the involvement of STAT6 in iNOS gene regulation, N02 
production in peritoneal macrophages of STAT6  knockout mice (Shimoda et aL, 1996) 
was tested (These experiments were carried in Dr. James N. Ihle's lab, USA). NO
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synthesis by peritoneal macrophages from the STAT6+/+ mice induced by IFN-y plus 
LPS or LPS alone was strongly inhibited by IL-4 (Fig. 6.24). NO2" concentrations 
produced by peritoneal macrophages from STAT6 “^ “ mice induced by IFN-y and LPS 
was at a identical level as that produced by macrophages from the STAT6+^+ mice. In 
contrast to the STAT6+/+ mice, however, NO2" production resulting from stimulation 
with IFN-y and LPS was not affected by IL-4 (Fig. 6.24). These results therefore 
demonstrated that the IL-4 regulatory effect on iNOS is strictly STAT6 -dependent. The 
role of STAT6 in the present system is unclear. STAT6  itself may directly affect the iNOS 
gene or indirectly activate some other gene expression which in turn regulates iNOS 
activation. Unexpectedly, STAT6-/- mice produce markedly more NO than those from the 
STAT6+/+ mice in response to LPS alone (Fig. 6.24).
6.14 Discussion
IL-4 is a multipotent cytokine derived from Th2 cells and mast cells (Paul 1991). 
It promotes the proliferation of subsets of lymphocytes, induces B-cell immunoglobulin 
isotype switching to IgE and IgGl, and mediates susceptibility to Leishmania in mice. 
The complex actions of IL-4 on macrophages include both activating and deactivating 
effects, among them enhanced anti-tumor activity in the face of either increased or 
decreased production of specific anti-tumor products, such as TNF-a (Stenger et aL, 
1991; Somers and Erickson 1989), H2O2 (Lehn et al, 1989) and NO (Liew et aL, 1991; 
Al-Ramdi et aL, 1992; Oswald et aL, 1992). Since IFN-y and IL-4 have been shown to 
display opposite effects and to antagonize each other's actions on a number of cells types 
(Paul 1991; Becker, et aL, 1990; Cox et aL, 1991; Hart et aL, 1989; Lehn et aL, 1989; 
Swisher et aL, 1990; Plum et aL, 1991), in this study I have examined the ability of IL-4 
to inhibit iNOS gene expression induced by IFN-y and LPS in J774 cells.
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Fig. 6.24 The critical role of STAT6 in IL-4 regulation of iNOS in  
murine macrophages. Four days after intraperitoneal injection with 4% Brewer's 
thioglycollate broth, peritoneal cells were harvested with DMEM from STAT6  +/+ and 
STAT6 -/- mice (young adult). The cells were cultured with DMEM medium 
containing 2mM L-glutamine, 50U/ml penicillin/streptomycin and 10% heat-inactivited 
fetal bovine serum in 96-well plates (2x10^cells /well /250pl) at 37"C with 5% 
C0 2 /95% air. After 2 h adherence step, nonadherent cells were removed by replacing 
medium. Cells were pretreated either with IL-4 (200 U/ml) or medium alone for 18 h 
before stimulated with IFN-y (100 U/ml) and /or LPS (10 ng/ml) and incubated for 
further 36 h. At the end of incubation, supernatants were collected and NO2 " 
concentrations measured by Griess Reactions. The data are presented as a mean of 
triplicate cultures (±SD).
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IL-4 was shown to inhibit both iNOS protein and mRNA induction by IFN-y
■|and/or LPS. This inhibition was dose- and time-dependent. Other cytokines can also 
suppress NO synthase by macrophages. For example, TGF-P has been shown to 
decrease the expression of iNOS protein by three distinct post-transcriptional effects;
■V-decreased stability and translation of iNOS mRNA, and enhanced degradation of iNOS 
protein (Vodovotz et al., 1993). The mechanism of IL-4 mediated suppression of NO 
synthesis is different. If IL-4 is added 2 h after IFN-y and LPS, inhibition was 
undetectable. For effective suppression, IL-4 has to be added at the initial stages (before 
or simultaneously with IFN-y and/or LPS) of iNOS induction. Northern blot and Western 
blot analysis showed that the levels of both iNOS mRNA and protein were reduced and 
delayed from the early time points. A previous report has shown that once iNOS mRNA 
has been expressed, IL-4 has no detectable inhibitory effect (Bogdan et al., 1994). Thus, 
the IL-4 affects on iNOS induction are likely to be stage of at the transcriptional activation 
of the gene.
IL-4 does not inhibit all IFN-y-induced gene expression, because the induction of 
IRF-1 and IRF-2 by IFN-y was further enhanced by IL-4. IL-4 also does not seem to 
affect some of the early intracellular signaling pathway induced by IFN-y, such as 
tyrosine phosphorylation of JAKl, JAK2 and STATl (p91). These findings are of 
interest because IFN-y-induced tyrosine phosphorylation of STATl is required for 
subsequent iNOS expression in murine macrophages (Meraz et al, 1996). Furthermore,
IL-4 induced a GAS binding activity but this is distinct from STATl as detected by 
EMSA. These complexes differed in terms of their electrophoretic mobilities and in their 
content of the transcription factors. In cells treated with both cytokines, IFN-y-inducible 
GAS binding activities were still observed and almost unchanged. Thus, IL-4 did not act 
by inhibiting the IFN-y-mediated activation of an GAS binding activity, and did not act by 
inhibiting IRFs transcription either. However, IFN-y induced NFkB binding activity was 
inhibited by IL-4 when both agents were added together. The mechanism by which of 
IFN-y induces NFkB binding activity is not clear, but this event is protein-synthesis
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independent. The activated NFkB in combination with STATl and IRF-1 could then 
participate in iNOS gene transcription activation. IL-4, however, interfered with this 
signaling pathway by an unknown mechanism.
It has been reported that IL-4 strongly inhibited IFN-y-induced NO release by 
inflammatory murine macrophages while simultaneously enhancing IFN-y-induced 
release of TNF-a (Bogdan et al., 1994). However, quite different results were obtained 
in this study. For example, upon stimulation with LPS, significant amounts of TNF-a 
and low level of NO accumulated in the culture supernatants. Both products were 
suppressed by the addition of IL-4. On the other hand, IFN-y alone did not up-regulate 
TNF-a production in J774 cells as detected within 24 h. Moreover, IL-4 failed to enhance 
the production of TNF-a while NO production induced by IFN-y was markedly reduced 
by IL-4. This discrepancy may be due to the differences in source and species of 
macrophages, their state of differentiation, and culture and stimulation conditions, 
especially with respect to the time course of IL-4 addition. Nevertheless, TNF-a 
production is unlikely the target for IL-4 inhibition of NO synthesis in the case of IFN-y 
alone.
Previous studies showed that TGF-p decreased the expression of iNOS protein by 
post-transcriptional effects since it could abolish iNOS expression even when it was 
added after the iNOS mRNA was expressed. IL-4, however, has no detectable inhibitory 
effect if it is added once iNOS mRNA has been expressed (Bodgdan et al, 1994), The 
results from my experiments are consistent with this. My data, however, demonstrated 
that the levels of both iNOS mRNA and protein were reduced at all time points following 
stimulation, which differs from the earlier report (Bodgdan et a l, 1994). In the earlier 
study, iNOS mRNA was first increased at 6 h and then decreased when cell treated with 
IFN-y and LPS in the presence of IL-4. Furthermore, although IL-4 could enhance both 
levels of IRF-1 and IRF-2 mRNA induced by IFN-y alone, it down-regulated IRF-1 
mRNA and upregulated IRF-2 mRNA in cells costimulated with a combination of IFN-y 
and LPS. It could be due to a cocktail of transcription factors responding to the
197
combination of stimuli, competing to bind to the same iNOS promoter region. While 
every single factor requires a distinct binding condition (or structure), too many factors on 
a single gene site may cause changes in the binding affinity of oligos, so that transcription 
activation is relatively affected. The other possibility is that IL-4 affects signals induced 
by IFN-y and LPS together which differ from those induced by IFN-y or LPS alone. 
Changes in the ratio of IRF 1/IRF-2 in this case may contribute to the inhibitory effect of 
IL-4 on iNOS expression induced by IFN-y and LPS.
Taken together, IL-4 affects iNOS is a complex manner which includes interfering 
with NFkB activation induced by IFN-y, blocking TNF-a production induced by LPS, 
changing the IRF-l/IRF-2 ratio induced by IFN-y and LPS or perhaps even interfering 
with MAP kinase activation by IFN-y and LPS. The different responses and inhibitory 
effects of IL-4 on the iNOS signalling pathway are dependent on the different 
combination of cytokines or stimuli, since some of the signalling events which are not 
important under the condition of combination of IFN-y and LPS, may become relatively 
crucial when stimuli are used separately (i.e. IFN-y or LPS alone). For, example, when 
cells are stimulated with LPS, NFkB is rapidly and strongly activated, no matter the other 
transcription factor activated by LPS, if there is another signalling event come along at 
same period (i.e, STATl or IRF-1 activation by IFN-y), these transcription factors will 
work synergistically to activate multiple gene expression. When LPS is used alone, 
NFkB activation may be not efficent for LPS-responsive gene activation, it demands more 
trascription factors to participate this process, it may account for TNF-a production, IRF- 
like protein, AP I activation, etc. At this moment, the signals from the other transcription 
factors become relatively important. If anything that could interferes with this process, it 
may well interfere LPS-induced gene (iNOS) expressions. Moreover, when cells are 
costimulated with more than two cytokines, there may be a signalling cascade that differs 
from any of signalling pathways which are induced by cytokine alone.
Finally, preliminary results show that STAT6  plays a crucial role in IL-4-mediated 
suppression of iNOS induction in murine macrophages. This STAT pathway is thought to
198
199
be important because the promoters of several genes known to be regulated by IL-4 
contain the consensus STAT6 -binding site TTCN4GAA (Schindler et al, 1995). It has
been revealed that STAT6 plays a central role in exerting IL-4-mediated biological
,responses since STAT6  knockout mice (STAT6“' “) do not respond to IL-4 in terms of
upregulation of CD23 and MHC II expression in B cells, induction of B or T cell
proliferative responses, Th2 cytokine production from T cells or indeed, IgE and IgGl 
responses after nematode infection (Shimoda et al., 1996; Takeda et a l, 1996). We now 
show that IL-4 does not inhibit NO synthesis in peritoneal macrophages from STAT6 "^ ~ 
mice.
Taken together, the results of this thesis have allowed me to conduct a model for 
induction and regulation of iNOS expression by IL-4 ( summarised in Fig. 6.25).
■ , v i .
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Fig. 6.25 Diagram of IL-4 inhibitory effects on NO production in J774 
cells. In the presence of IL-4, IFN-y induced JAKl, JAK2, and STATI activation 
were not interfered, but the IFN-y-induced expression of IRF-1 and IRF-2 were 
synergistically enhanced. However, IFN-y-induced NFkB was inhibited by IL-4. On 
the other hand, IL-4 interfered with LPS-induced TNF-a production. Furthermore, 
When cells were treated with a combination of IFN-y and LPS, IL-4 downregulated 
IRF-1 expression while upregulated IRF-2 expression. Finally, STAT6 plays a critical 
role in IL-4 regulation of iNOS in murine macrophages, STAT6 may act as a 
transcriptional activator which binds to IL-4 responsive genes which inhibit the 
activation of the iNOS gene, or may directly binds to responsive genes (such as iNOS) 
where it may works as a repressor of transcription.
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The enzyme responsible for the synthesis of NO, nitric oxide synthase (NOS), 
exists at least in three isofonns: ncNOS, ecNOS and iNOS. In many systems, NO derives 
from two or more different cellular sources, forming networks of paracrine 
communication. NO exerts a number of diverse activities: beneficial as a messenger or 
modulator and for immunologic self-defence, but potentially toxic. In several different 
scenarios, with factors such as oxidative stress, generation of reactive oxygen 
intermediates (ROls), and deficient antioxidant systems, NO switches from friend to foe. 
Large amounts of NO produced by activated cells serve on the one hand to protect the 
host from viruses (Croen 1993; Karupiah et a/., 1993), bacteria, protozoa, helminths 
(Nathan and Hibbs 1991), and tumor cells (Hibbs et al., 1987), but on the other hand can 
suppress the function of macrophages (Albina et at., 1989), lymphocytes (Hoffman et al, 
1990), dendritic cells (Holt et al., 1993), cardiac myocytes (Roberts et al., 1992), and 
pancreatic p cells (Corbett et al., 1993), contribute to the inflammatory destruction of 
joints(McCartney-Francis et al, 1993) and the pancreas (Burkart et al., 1992) and 
provoke fatal multiorgan hypoperfusion (Kilboum et al., 1990). Thus, the aim of this 
project is to understand the mechanisms by which iNOS is regulated.
7.1 JAK-STAT pathway and inducible nitric oxide synthase
Multiple cell types exhibit the capacity to express the inducible NOS (iNOS) gene 
when appropriately stimulated. Some normal tissues express iNOS, such as in the rabbit 
(Sladek et al, 1993) and large airways in human (Nathan and Xie 1994). However, 
expression of iNOS is more often reserved for infection or inflammation and geared 
toward host defense. Inductive signals include a wide range of microbes and microbial 
products, some tumor cells, and numerous cytokines, acting alone or in synergy (Nathan
1992). Interferon-y, as the one of most common self-defence cytokines, exerts one of its 
most important actions through promoting the co-ordinated induction of NOS (to make 
NO), GTP cyclohydrolase (promotes production of the cofactor (tetrahydrobiopterin) for 
NOS), and argininosuccinate synthase (generates the substrate (L-arginine) of NOS).
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The identification of a novel intracellular signaling pathway termed the JAK-STAT 
pathway has led to the rapid expanding of an knowledge of cytokine receptor signaling
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IFN-y, like most cytokines, exerts its biological functions by binding to a specific 
cell surface receptor, and the interaction of IFN-y with its cognate receptors stimulates the 
induction of a set of genes. The IFN-y receptor is a member of the class 11 cytokine 
receptor family. Although the receptor binds IFN-y with high affinity, signal transduction
" lrequires a species-specific accessory protein (Schreiber et al., 1992; Aoh et al., 1994;
Hemmi é ta l, 1994) which associates with the extracellular domain of the receptor, the 
IFN-y receptor P-chain. The intracellular part of the IFN-y receptor is more promiscuous, 
as it can be inter-changed between species without loss of function (Pellegrini and 
Schinkler 1993); Hemmi et a l, 1994). The IFN-y receptor does not express endogenous 
kinase or phosphatase activities, yet may become rapidly and reversibly tyrosine 
phosphorylated following ligation in intact cells. Mutational studies of the IFN-y receptor 
have defined two cytoplasmic domains necessary for biological function, a membrane- 
proximal region and C-terminal sequence including an essential tyrosine (Cook et a l.
ï
"A1992; Farrar et a l, 1992).
7.1.1 JAK kinases and IFN-y induced iNOS
(Darnell et al., 1994; Ihle et al., 1994; Schindler and Darnell 1995). In this type of
pathway, individual JAK kinases (JAKl, JAK2, JAK3, and Tyk2) preferentially and 
constitutively associate with the intracellular domains of particular cytokine receptors and
become activated following ligand-induced assembly of receptor subunits at the cell 
surface.
At the beginning of this project, 1 used SDS PAGE and two-dimension gel 
techniques in combination with Immunoblotting to obtain some information on the 
molecular weight of proteins that are tyrosine phosphorylated following stimulation with 
IFN-y and LPS. Proteins of 120-140k, 90-95, 50-70, 40-45 kDa were observed (data not A
shown). Within these, the 90-95 kDa group was clear one. Since IFN-y activates cells
■■VA:
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signalling though the JAK kinases, and a group of proteins were tyrosine phosphorylated 
in that molecular weight range (120-140 kDa), I investigated the role of the JAK kinases 
in iNOS expression. Inducible nitric oxide synthase activity in J774 cells was markedly 
reduced following pre-incubation with tyrphostin 25 (T25), a tyrosine kinase inhibitor, 
compared with untreated cells. Herbimycin A was also used and its effect was similar 
with that of T25. In addition , a tyrosine phosphatase inhibitor (Vanadate) was found to 
enhance iNOS activity. JAKs were therefore tested for their ability to be phosphorylated 
in response to IFN-y. Immunoprécipitation with JAKl and JAK2 antibodies revealed that 
both JAKl and JAK2 were tyrosine phosphorylated in response to IFN-y. Tyrphostin 
AG490, a recently discovered JAK2-selective inhibitor (Meydan et al., 1996) also 
suppressed iNOS expression. These results therefore suggest that JAK2 plays a crucial 
role in IFN-y receptor signalling that lead to NO synthesis in murine macrophages.
It has been reported that a cell line lacking JAKl is completely unresponsive to 
IFN-y (Muller et al., 1993), and JAKl can sustain substantial IFN-y-inducible gene 
expression (Briscoe et al., 1996). Interestingly, JAKl and JAK2 are inter-dependent in 
their responses to IFN-y: While JAK2 in wild type cells is phosphorylated in response to 
IFN-y, no such phosphorylation is observed in JAKl negative mutant cells, but is 
restored in the JAKl transfectants. Conversely, in JAK2-negative mutant cells JAKl is 
not phosphorylated when stimulated with IFN-y (Muller et al., 1993). It has been 
proposed that the initial phosphorylation of JAKl and JAK2 is mediated by JAK2, 
whereas phosphorylation of the IFN-y receptor is carried out by JAKl (Briscoe et al., 
1996). For the expression of the antiviral state, a JAK-1-dependent signal, in addition to 
ST ATI activation appears to be required. It may also required for iNOS induction.
7.1.2 STATl and IFN-v induced iNOS
Signal transducers and activators of transcription (STATs) were first identified as 
a unique family of DNA-binding proteins approximately four years ago. Since then there 
has been an explosion of information and speculation regarding their biological roles. 
Following the cloning of STATl and STAT2, it became obvious that STAT-like activities
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were activated by various cytokines (reviewed in Ihle 1996). Cells and tissues from I
STATl"/" mice were unresponsive to IFNs and no NO production was detectable under
the stimulation of IFN-y plus LPS ( Meraz et al., 1996; Durbin et al., 1996). It is shown |
in the present study that P 91 (STATla) and P 8 4  (STATlp) were tyrosine j
I
phosphorylated and translocated to the nucleus when J774 cells were stimulated with |
IFN-y. Activated STATl appears as a a  (p91/p91)or pp (p84/p84) homodimer and binds
to the specific DNA elements called gamma interferon site (GAS). Antibody supershift !
assay revealed that the binding activity was abolished by antibodies against P91 and
phosphotyrosine (PY-54), indicating that the activation of GAS elements by STATl
requires tyrosine phosphorylation of STATl. The tyrosine phosphorylation of STATl is
mainly dependent on JAK2 (Briscoe et al., 1996). Recently, reports showed that DNA
binding by purified STATl is totally dependent upon tyrosine phosphorylation at a single
site (Tyr-701), carboxyl to the SH2 domain (Ihle 1996). Similarly, the DNA-binding i
activity of all STATs is dependent upon tyrosine phosphorylation and, where examined,
involves a comparably located tyrosine. Considerable evidence supports the hypothesis
that tyrosine phosphorylation results in dimerization of STATs through the intermolecular
interaction of the SH2 domains and the carboxyl sites of tyrosine phosphorylation and
that this dimerization is essential for DNA binding. i
In contrast, the highly divergent carboxyl-terminal domain of the STATs is 
required for, or influences, transcriptional activation. In the case of STATl, there exists a i
naturally occurring splice variant (STAT Ip, p84) that lacks the carboxyl 38 amino acids 
(Schindler et al., 1992). Although this variant is recruited to the receptor complex, 
becomes phosphorylated (as showed in chapter 4, Fig. 4.10) and binds DNA, its function 
is not clear. It has been suggested, however, that p84 does not activate gene transcription.
Indeed, ST AT ip may act as a naturally occurring dominant negative molecule (Schindler 
etal., 1992).
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7.1.3 MAP kinase and iNOS
The functions of STATs may also be influenced by serine phosphorylation. There 
were some reports recently regarding the importance of serine phosphorylation on STAT- 
STAT proteins dimerization and DNA-binding affinities. They have shown that there are 
two levels of regulation of STATl DNA-binding activity. One is by tyrosine 
phosphorylation as a prerequisite for dimerization. Another is by serine phosphorylation 
as a means of regulating the affinity of the STATl dimmer for the GAS (Eilers et al., 
1995). It was also reported that serine phosphorylation is required for the formation of 
stable STAT3-STAT3-DNA complexes (Zhang et al, 1995). Relative affinities of one 
transcription factor for different target sites can determine the overall biological responses 
of complex biological systems.
Mitogen-activated protein kinases (MAPKs) are a family of closely related 
serine/threonine-specific protein kinases whose prototype members are the mammalian 
extracellular signal-regulated kinases ERKl and ERK2 and the Saccharomyces cerevisiae 
pheromone-regulated kinases KSSl and FUS3. (reviewed in Hill and Treisman 1995). 
ERK2 is phosphorylated when J774 cells were stimulated with LPS (as shown in Chapter 
4, Fig. 4.12).Tyrphostin AG126, which inhibit MAP kinase, could inhibit NO synthesis 
induced by IFN-y and LPS in a dose dependent manner. MAP kinases are important 
mediators of signal transduction from the cell surface to the nucleus. Whether MAPK 
activation is linked to STATl phosphorylation was not investigated in the present study. 
A number of reports has indicated that substrates for these MAP kinases include a number 
of transcription factors, such as c-jun, c-myc and p62TCF/ELK-l (reviewed in Davis
1993). STATl has been shown to be phosphorylated at ser-727, a potential MAPK site, 
and this phosphorylation in return to influence transcriptional activation (Wen et al, 
1995). MAPK Erk-2 was reported to be directly associated with the IFN receptor (David 
et ah, 1995). However, I failed to observe any MAP kinase activation upon stimulation 
with IFN^. Furthermore, although MAPK was phosphorylated by LPS treatment in J774 
cells, there was no detectable STATl phosphorylation in term of mobility shift in SDS
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PAGE gel although tyrosine phosphorylation was clearly seen when the cells were 
stimulated with IFN-y. Nonetheless, if MAPK does contribute to the serine 
phosphorylation of STATl and therefore influence transcriptional activation, this could be 
one of the mechanisms for the synergistic effect of LPS with IFN-y to switch on IRF-1 
and other IFN-responsible genes.
7.2 IRF family transcription factors and iNOS
Recent studies have begun to address the molecular mechanisms by which iNOS 
expression is regulated. Promoter analysis has defined the regulatory regions involved in 
LPS" and IFN-y-induced transcription of iNOS.
7.2.1 IRF-1 and iNOS
A family of interferon regulatory factors (IRFs) plays an important role in 
transcription of IFN genes as well as IFN-stimulated genes. IRF-1 was originally 
described as a nuclear factor specifically binding to cis-regulatory elements in the p- 
interferon enhancer (Fujita et aL, 1988; Miyamoto et al., 1988). It has been shown that 
IRF-1 is required for the induction of NO synthase in macrophages ( Kamijo et al.,
1994). In the present study, the expression of IRFs and the activation of ISRE in iNOS 
promoter have been investigated. Without cytokine stimulation, IRF-1 was not detectable 
in J774 cells by Northern or by Western blotting. As a result of IFN-y treatment, both 
mRNA and protein of IRF-1 were strongly induced together with the DNA binding 
activity to IRF-E in the iNOS promoter.
J774 cells also expressed IRF-1 in response to LPS, although the levels of mRNA 
or protein observed were very low and exhibited an prolonged lag period (4 h). There are 
two possibilities for this: first, the NFKB activated by LPS can bind directly to a DNA site 
which has, at least partially, a similar sequence to GAS. The binding of NFkB to the 
IRF-1 promoter participates in upregulating the gene expression. This is supported by
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Macrophages from IRFl"/" mice have been reported to produce only small 
amounts of NO and barely detectable levels of iNOS mRNA in response to the combined 
treatment with IFN-y and LPS (Kamijo et al., 1994). In the present study, I have shown 
that IRF-1 is not only transcriptional activated by IFN-y but by LPS as well. 
Electromobility supershift assays showed an IFN-stimulated response element/IRF- 
element (ISRE/IRF-E) binding complex induced by IFN-y which was recognised by anti- 
IRF-1 antibody. The binding of IRF-1 to IRF-E was detectable 1 h after stimulation with 
IFN-y, and it was protein-synthesis dependent since cycloheximide could abolish this 
activation. Genes that are induced by IFN-y, such as GBP and IRF-1, are generally 
activated by STATl binding to a GAS, whereas genes that are more slowly induced by 
IFN-y, such as iNOS, are activated by IRF-1 binding to an ISRE.
7.2.2 IRF-2 and iNOS
Another member of the IRF family of transcription factors is IRF-2. In most 
cases, IRF-1 functions as an activator for IFN-inducible genes, whereas IRF-2 represses 
the effect of IRF-1 ( Fujita, et al., 1989; Harada et al., 1989). Since IRF-2 recognises the 
same consensus sequence as IRF-1, the activation of IRF-2 is important in my study. 
Following gene targeting, however, unexpected phenotypes were recently reported 
(Salkowski et al., 1996): NO%" production in IRF-2"/" mice was about half of that 
observed in IRF-2 +/" mice while the iNOS mRNA levels in both groups were
•';îresults from EMSA experiments (using oligomers with GAS specific sequence) which 
showed an increased binding activity followed LPS-treatment in J774 cells, and the 
binding protein was recognised by an antibody against NFkB (P65). Secondly, it is 
possible that other transcription factors controlling the IRF-1 gene expression were 
activated upon the stimulation of LPS, Data from the EMSA do not necessarily reflect 
transcriptional involvement and protein occupation of a binding site in vivo. Whatever the 
mechanism(s) involved, it is clear that IRF-1 can be transcriptionally up-regulated by 
LPS.
208
indistinguishable. It was suggested that IRF-2 is required for optimal production of NO 
and that IRF-2 plays a role in the post-transcriptional regulation of iNOS.
NOV is specifically inhibited by the protein kinase inhibitor, Staurosporine (Watanbe et 
aL, 1991). One may also postulate that IRF-1 binding to its recognition site may be
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It has also been reported that IFN-y, and LPS are both inducers of IRF-2 (Hayes 
and Zoon 1993; Barber et aL, 1995). In my experiments, however, IRF-2 could only 
induced by IFN-y, but not by LPS. Furthermore, IRF-2 was slightly down-regulated by 
the combination of LPS with IFN-y. It may be that the ratio of IRF-1/IRF-2 rather than 
IRF-2 post-transcriptional regulation is of crucial importance. As a constitutively 
expressed factor, IRF-2"/" deficiency could lead to other yet unknown gene regulation.
7.2.3 The change in ratio of IRF-l/IRF-2 plav a role in IFN-inducible genes
Regulation of IFN-inducible genes may be determined simply by the ratio of IRF- 
1 and IRF-2 (Tanaka et aL, 1993). In a variety of cells, both the IRF-1 and IRF-2 genes 
are constitutively expressed at low levels. In such cells, IRF-2 protein normally 
accumulates to an intracellular concentration higher than that of IRF-1 as a result of its 
greater stability (protein half-life of > 8  h versus 30 min) (Watanabe et al, 1991). 
Therefore, it is possible that most IRF-binding elements are occupied by IRF-2 in the 
absence of stimulation. Gene activation may thus occur as a result of the transient 
displacement IRF-2 by IRF-1 (Tanaka et al, 1993).Although the similarity in binding 
affinities observed in vitro suggests that IRF-1 could displace IRF-2 via a simple 
competition, whether such mechanisms could operate in vivo is unclear. It may involves 
other mechanisms. For example, TNF-a, IFN-p and NDV (Newcastle disease virus) all 
efficiently induce de novo synthesis of the short-lived IRF-1 in L929 cells (Watanabe et 
aL, 1991), but the high affinity for the IRFs to a synthetic IRF-E can be only efficiently 
activated by NDV while such activation was very weak in IFN-p- or TNF-a-treated 
cells. IRF-1 and/or IRF-2 could undergo some type of post-transcriptional modification
elicited by IFN or other cytokine stimulation since efficient activation of the IRF-E by
facilitated by protein-protein interactions with nearby transcription factors and/or that the i
DNA-binding affinity of IRF-1 increases as a result of interaction with some unidentified 
adapter molecule(s) (Dalton et al, 1992; Leid et al, 1992; Li et al, 1991; Veals, 1993).
7.2.4 Unidentified IRF-like protein and LPS-induced iNOS
Different members of the IFN response factor (IRF) family bind to ISRE motifs. 
This diverse family includes ISGF-3y (Veals et aL, 1992), Pip/NFEM5 (Eisenbeis et aL,
1995), ICSBP ( Driggers et aL, 1992), IRF-1 (Miyamoto et aL, 1988), IRF-2 (Harada et 
aL, 1989) and IRF-3 (Au et aL, 1995). These proteins comprise a conserved DNA- 
binding domain in the N-terminal region and a divergent C-terminal region that serves as 
the regulatory domain (Holtschke et al., 1996). In the present study, ISRE binding 
activity induced by LPS was observed. The binding complex is distinct from IRF-1 and 
IRF-2 and has a lower electrophoretic mobility, suggesting a large protein or protein 
complex. Cold probe competition assay showed that the binding activity could be 
competed by a probe including GAS sequence but not that containing a NFkB site. It may 
well be a complex containing at least an IRF-family protein and a STAT-like protein. A 
recent report showed that an IFN-stimulated response element (ISRE) was found in Ig
kappa light chain gene intron enhancer region in 70z/3 pre-B cells, and the ISRE 
specifically bound IRF-1 and IRF-2. This ISRE is a multifunctional motif that also binds
the LPS-inducible factor kappa BF-A, and is located within the kappaBS region, which 
confers B cell specific activity to this enhancer (Damore et aL, 1996). This raises the 
possibility that the same factor could be induced and bind to the IRF-E in the iNOS 8promoter. Since the factor shows an affinity to at least the IRF-E motif, it may be a f
member of the IRF family protein.
Another possibility is the interferon consensus sequence binding protein (ICSBP). "I
In contrast to IRF-1 and IRF-2, which are expressed in most cells, ICSBP has been 
shown to be expressed exclusively in cells of the immune system (Driggers et aL, 1992).
While ICSBP expression is very low in resting T cells and macrophages, its expression is 
strongly induced in these cells upon immune stimulation and IFN-y treatment. Previous 
studies indicated that ICSBP has negative effects on transcription of ISRE-carrying
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promoters (Nelson et al,, 1993; 1996). However, ICSBP has negative effects on 
transcription of ISRE-carring promoters (Nelson et aL, 1993,1996). Furthermore, 
ICSBP has been shown complex with IRF-1 and IRF-2 (Bovolenta et al, 1994). On the 
other hand, in another report using spleen cells, IFN-y production in response to ConA 
was reduced by more than 3-fold in ICSBP"/" mice, while IFN-y production in response 
to LPS was reduced by more than 100-fold compared with ICSBP+/+ mice ( Holtschke et 
aL, 1996). Therefore, to identify the LPS-induced IRSE binding protein, experiments 
using ICSBP antibody for supershift assay, or using ICSBP cold probe for competition 
assay should be carried out in the future.
7,3 Activation of NFkB and the induction of nitric oxide synthase
The murine iNOS promoter region contains potential binding sites for 
transcription factors and many of them, like ISRE/IRF-E and NFkB, are associated with 
stimuli that induce iNOS expression. Maximal expression of iNOS depends on two 
discrete regulatory regions upstream of the TATA box. Apart from the region containing 
motifs for binding IFN-related transcription factors, another important region contains 
LPS-related responsive elements, including a binding site for nuclear factor NF-IL-6  and 
NFkB (Lowenstein et aL, 1993).
7.3.1 LPS-induced NFkB activation
LPS-induced NFkB activation is a quick and transient event (as measured by 
EMSA) happening within minutes following treatment of J774 cells with LPS (at 
concentration of 10 ng/ml), and reaching peak levels at about 30-120 min. This is 
presumably because NFkB exists as an inactivated IkB-NFkB complex in the cytoplasm 
of untreated cells. Following a signal that triggers phosphorylation and degradation of 
IkB, NFkB is released from the inactive complex and then translocates to the nucleus 
where it binds to specific DNA elements. This procedure does not involve protein 
synthesis. Although IkB is an inhibitor of NFkB, NFkB is an activator of the IkB gene
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transcription. Once NFkB is activated by stimuli, it binds to IkB promoter as well as 
other NFkB regulated genes. The newly synthesised IkB then gets into the nucleus, 
captures NFkB and returns it to the cytoplasmic phase in an inactivated form. It was 
shown in the present study that cycloheximide not only did not block LPS-induced NFkB 
activation, but enhanced the NFkB binding activity on iNOS promoter. It may due to the 
effect of cycloheximide on IkB. It has been reported that cycloheximide-treatment could 
lead to enhanced TNF-a mRNA accumulation ( Zuckerman et al, 1991). This may be 
due to blockage of IkB protein synthesis. Constant expression of IkB is needed to 
maintain inactivated form of NFkB complex, and when this synthesis procedure is 
blocked, NFkB is released and activated.
7.3.2 IFN-y-induced NFkB activation
In the present study, it was found that NFkB was activated and translocated to the 
nucleus in response not only to LPS but to IFN-y as well. However, IFN-y-induced 
NFkB binding activity was delayed and weak compared to that induced by LPS (see 
chapter 5), and it is not clear whether they utilise similar pathways to activate NFkB.
Unlike the rapid kinetics observed with LPS, IFN-y-induced NFkB activation 
could only be detected after 2 h. Initially, it was thought that such NFkB activation was 
due to a secondary signalling triggered by some new protein or protein kinase that is 
transcriptionally regulated by IFN-y. However, if cells were pre-treated with 
cycloheximide, NFkB activation by IFN-y was shown to be enhanced compared to cells 
not treated with cycloheximide. This suggests that the pathway involved in IFN-y-induced 
NFkB activation, is not a secondary stimulatory event, and protein synthesis is not 
involved in the activation of NFkB. This result may be used to explain some previous 
puzzling observations: Lowenstein et al, (1993) used transfected luciferase report gene 
constructs in macrophages to demonstrate that IFN-y acts primarily as a enhancer and 
does not induce synthesis of mac-NOS in RAW 264,7 cells (a murine macrophage cell- 
line). Cells transfected with a construct containing one IFN-stimulated response element
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(ISRE) and one NFkB element have little independent regulatory effect on induction, but 
in conjunction with region containing NFkB (the same site used in my study), it can 
augment iNOS expression. In the present study, IFN-y by itself can induce NO synthesis 
in J774 cells, although the amount of NO was relatively low.
Although there are a number of nuclear transcription factors which have been 
reported to participate in the activation of iNOS gene, a crucial role of IRF-1/2 and NFkB 
in the regulation of NO synthesis has been particularly postulated in recent years (Martin 
et a l, 1994; Lowenstein et al, 1993; Xie et a l, 1993; Salkowski et a l, 1996; Xie et al,
1994). For murine iNOS gene, maximal expression depends on two discrete regulatory 
regions on the promoter region. The first region contains LPS-related responsive 
elements, including a binding site for nuclear factor interleukin 6 (NF-IL-6 ) and kB 
binding site for NFkB; the second region is crucial for responses to IFN-y and includes 
ISRE and GAS (Lowenstein 1993). PDTC, a relatively specific inhibitor of the activation 
of NFkB in macrophages, has been reported to block both the production of nitrite and 
the binding of NFkB/RcI to NFkB site (Schreck et al, 1992). Moreover, using reporter 
gene constructs containing truncated-NFKB site in iNOS promoter region, Xie et a l 
(1994) demonstrated that activation of NFkB/Rel is critical in the induction of iNOS by 
LPS. Furthermore, experiments using gene targeted mice has revealed that macrophages 
from IRFl"/" mice produced barely detectable NC^" in response to IFN-y and LPS 
(Salkowski et a l, 1996). Thus induction of NO synthesis, both IRF-1 and NFkB 
participate in the response to IFN-y.
7.4 Effects of IL-4 on NO synthesis
7.4.1 IL-4 affects the JAK-STAT pathway and IRF-l/IRF-2 gene expression
iNOS expression induced by IFN-y and LPS was reduced at both the mRNA and 
protein levels by pre-incubation of cells with IL-4. These suggest that IL-4 inhibitory
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effects on NO synthesis are transcriptional effects. So I did a serial experiments to 
examine the effects of IL-4 on the signal pathways that lead to NO synthesis induced by 
IFN-y and LPS. JAKl was shown to be tyrosine phosphorylated in response to IL-4, but 
IL-4 did not activate JAK2 and no effect on JAK2 activation induced by IFN-y in J774 
cells either. The activation of JAKl by IFN-y seemed unaffected since the downstream 
component of JAKl and JAK2, STATl phosphorylation was also unchanged. 
Furthermore, IL-4 treatment did not interfere with STATl binding to its specific DNA 
sequence, the GAS element, in the IRF-1 promoter. Moreover, IL-4 could activate 
STAT6 binding to the same element. As result, IRF-1 expression was enhanced in the 
presence of IL-4 compared to cells treated with IFN-y alone. The increased IRF-1 
expression did not correlate with decreased NO production, because the suppressor of the 
IRF-E, IRF-2 was enhanced too. On the other hand, the activation of NFkB induced by 
IFN-y was inhibited by IL-4. These results suggested that the mechanism of IL-4- 
mediated suppression of iNOS expression induced by IFN-y is not through the 
interference with JAK 1/2-STATl activation but may involve other transcription factors 
which is also activated in response to IFN-y, like NFkB.
Compared with IFN-y alone, IRF-1 expression in the cells treated with IFN-y and 
LPS was markedly enhanced. This enhancement was inhibited in the presence of IL-4. 
IRF-2, however, was also enhanced in the same cells which treated with a combination of 
IFN-y, IL-4 and LPS compared to cells treated with IFN-y and LPS. The changes in ratio 
of IRF-l/IRF-2 may have pushed the balance towards to the suppression of iNOS 
transcription. However, other mechanisms may be involved in the IL-4-mediated 
inhibition of iNOS expression in murine macrophages. Candidate mechanisms include 
post-transcriptional modification or destabilisation of iNOS mRNA, post-translational 
modification or interference with iNOS protein phosphorylation, or even disrupt of the 
protein-protein interaction between iNOS and its cofactors.
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7.4.2 IL-4 mediated inhibition of NO synthesis is STAT6 dependent
The inhibition of NO synthesis by IL-4 in murine peritoneal macrophages is 
totally dependent on the presence of STAT6  in these cells. Since NO%^  was not detected 
in cells treated with IFN-y alone, it is unclear what STAT6 does in this system. However, 
in cells treated with either LPS alone or with IFN-y and LPS, NO production was 
abolished by IL-4 only in STAT6+/+ mice, but not in STAT6 -/- mice. There are a 
number of possibilities by which STAT6  exerts its inhibitory effect on iNOS. STAT6 
may directly binds to responsive genes (such as iNOS) where it may worlŒ as a repressor 
of transcription. Alternatively, STAT6 may act as a transcriptional activator which binds 
to IL-4 responsive genes which inhibit the activation of the iNOS gene. These 
possibilities need further clarification.
7,5 Summary of the signalling pathways leading to iNOS gene activation
7.5.1 IFN-y signaling and iNOS induction
Upon the stimulation of IFN-y, at least two distinct signalling pathways are 
involved in iNOS induction in murine macrophages. One of them is the JAK-STAT 
pathway which involves phosphorylation of JAKl and JAK2 on tyrosine; tyrosine 
phosphorylation of STATl (p91 and p84) by JAKs; and nuclear translocation of di 
merised STATl. Activated STATl binds the GAS elements which are located in IRF-1 
and IRF-2 or possibly the iNOS promoters. At promoter regions, STATl could either 
exist as a homodimer, bind to GAS elements in IRFs promoter, or as a complex with 
IRFs, binds to ISRE in the iNOS promoter. IRFl and IRF-2 are early expressed genes 
induced by IFN-y, whose transcriptional activation do not involve de novo protein 
synthesis. However, iNOS gene activation is dependent on latent proteins as well as 
newly synthesised transcription factors, like IRF-1 and IRF2. Another possible pathway 
is through activation of nuclear transcription factor NFkB. However the details of how
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IFN-7 receptor binding leads to NFkB activation are unclear and the participation of other 
nuclear transcription factors can not be excluded. The IFN-y signalling pathway leading to 
iNOS induction suggested by the results in this thesis is summarised in Fig. 7.1.
7.5.2 LPS signaling and iNOS induction
Upon stimulation with LPS, a number of nuclear transcription factors are activated 
which are involved in iNOS induction. NFkB play a cricial role in LPS induced NO 
synthesis by binding to DNA elements not only in the iNOS promoter, but also to GAS 
element in the IRF-1 promoter. The later may contribute to the LPS-induced IRF-1 
expression. Another transcription factor induced by LPS is an IRF-like protein (or protein 
complex) that recognise IRSE/IRF-E element. The activation of this complex is protein- 
synthesis dependent, and it may contain a STAT-like protein. Activation of NFkB and 
IRF-E in iNOS promoter in co-operation with other transcription factors lead to 
transcriptional activation of iNOS gene. The signaling pathway of iNOS induction 
induced by LPS is represented in Fig. 7.2.
7.5.3 iNOS induction bv a combination of IFN-y and LPS
iNOS expression in J774 cells is at a relatively low level when stimulated by IFN- 
y or LPS alone. However, upon the stimulation with IFN-y plus LPS, the two major 
signalling pathways are both activated simultaneously and promptly. Signals derived from 
the IFN-y receptor include: JAKl and JAK2 phosphorylation and activation; STATl 
tyrosine phosphorylation, dimérisation, and translocation to the nucleus; STATl binds to 
GAS elements in the IRFs promoter to promote gene activation. On the other hand, 
signals derived from the LPS receptor promote phosphorylation and degradation of IkB 
to release NFkB (p65/p50, p50/50) which therefore translocates to the nucleus where it 
not only binds to NFkB site within iNOS promoter region, but also binds to GAS element 
within the IRF-1 promoter. Furthermore, the activated lRF-1 (which is mainly from IFN- 
y signalling) and NFkB (which is mainly from LPS-signalling), together with other 
transcription factors (AP-1, etc.) bind to their specific binding sequences on iNOS.
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Fig. 7.1 Schematic representation of the IFN-y signalling pathway.
Upon the stimulation of IFN-y, at least two distinct signalling pathways are involved in 
iNOS induction in murine macrophages. One of them is the JAK-STAT pathway which 
involves phosphorylation of JAKl and JAK2 on tyrosine; tyrosine phosphorylation of 
STATl (p91 and p84) by JAKs; and nuclear translocation of dimmerised STATl. 
Activated STATl binds the GAS elements which are located in IRF-1 and IRF-2 or 
possibly the iNOS promoters either as a homodimer (bind to GAS elements in IRFs 
promoter), or as a complex with IRFs (binds to ISRE in the iNOS promoter). Activated 
IRFs then bind to iNOS promoter. Another possible pathway is through activation of 
nuclear transcription factor NFkB. However the details of how IFN-y receptor binding 
leads to NFkB activation are unclear and the participation of other nuclear transcription 
factors can not be excluded.
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Fig. 7.2 Diagrammatic representation of the LPS signalling pathways 
leading to iNOS activation. Upon stimulation with LPS, a number of nuclear 
transcription factors are activated which are involved in iNOS induction. NFkB play a 
crucial role in LPS induced NO synthesis by binding to DNA elements not only in the 
iNOS promoter, but also to GAS element in the IRF-1 promoter. The later may 
contribute to the LPS-induced IRF-1 expression. Another transcription factor induced 
by LPS is an IRF-like protein (or protein complex) that recognise IRSE/IRF-E element. 
The activation of this complex is protein-synthesis dependent, and it may contain a 
STAT-like protein. Activation of NFkB and IRF-E in iNOS promoter in co-operation 
with other transcription factors lead to transcriptional activation of iNOS gene.
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Fig. 7.3 The induction of iNOS expression by a combination of IFN-y 
and LPS. In J774 cells, a number of transcription factors may participate in the iNOS 
activation. The JAK-STAT and IRFs pathway play an important role in the IFN-y 
pathway, while NFkB plays a crucial role in the LPS pathway. Upon the stimulation 
with IFN-y plus LPS, the two major signalling pathways are both activated 
simultaneously and promptly. Signals derived from the IFN-y receptor include: JAKl 
and JAK2 phosphorylation and activation; STATl tyrosine phosphorylation, 
dimerization, and translocation to the nucleus; STATl binds to GAS elements in the 
IRFs promoter to promote gene activation. On the other hand, signals derived from the 
LPS receptor promote phosphorylation and degradation of IkB to release NFkB 
(p65/p50, p50/50) which therefore translocates to the nucleus where it not only binds to 
NFkB site within iNOS promoter region, but also binds to GAS element within the 
IRF-1 promoter. Furthermore, the activated IRF-1 (which is mainly from IFN-y 
signalling) and NFkB (which is mainly from LPS-signalling), together with other 
transcription factors (AP-1, etc.) bind to their specific binding sequences on iNOS 
promoter and may interaction with each others to switch on the gene.
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promoter and may interaction with each others to switch on the gene, the induction of 
iNOS signalling pathway is summarised in Fig. 7.3.
7.6 Future work
7.6.1 To identify the LPS-inducible IRF-E binding protein
Although previous reports suggested that both IRF-1 and IRF-2 could be 
regulated by LPS, it was not known that LPS can induce an additional IRF-like protein. 
Preliminary results indicated that this is not IRF-1 nor IRF-2. Antibody supershift assay 
and cold probe competition suggest it is not NFkB either. Cycloheximide treatment 
abolished the formation of IRSE-binding complex, indicating that the factor is 
transcriptionally activated by LPS. It will be of considerable interest to identify and 
characterise this factor. Antibody supershift and cold probe competition assays using 
ICSBP and related reagents could be used initially to approach identifying this factor.
7.6.2 To investigate the upstream of signaling pathway of NFkB that activated by IFN-y
Activation of NFkB is triggered by different stimuli including LPS, muramyl 
peptides, viruses, TNF-a and IL-lp, UV irradiation, and reactive oxygen intermediates 
(H2O2) (Baeuerle et al., 1991 and 1994). Previously, activation of NFkB in response to 
IFN-y has not been reported. It would of interest to investigate the early signal cascade 
that lead to NFkB activation by IFN-y. The unravelling of the involvement of protein 
kinase(s) and protein phosphatase(s) in this system will provide useful information in the 
understanding of the regulatory mechanism of NFkB, one of the most important 
transcription factors in the immune system.
7.6.3 To study the mechanism of the involvement of STAT6 in iNOS gene activation
Since cells from STAT6  knockout mice were refractory to IL-4-mediated 
inhibition of NO synthesis, STAT6 plays a crucial role in this system. It will be of interest
223
to investigate the molecular basis of the effects of IL-4 on IFN-y regulated genes, 
especially iNOS gene. Northern blot analysis on the involvement of IRFs, and later DNA 
foot printing may be used to trace the possible correlation between STAT6  binding 
activity and iNOS gene regulation.
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